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Abstract 
 
Introduction 
 
Nuclear magnetic resonance spectroscopy (NMR) resonances from lipids and 
metabolites in tumours are associated with tumour grade and treatment response.  The 
origin of NMR lipid signal is mainly considered to be cytoplasmic lipid droplets (LDs). 
The aim of this study is to investigate the lipid species of LDs in nervous system 
tumour cells and identify potential lipidic or metabolic markers in treatment response. 
Methods 
Density-gradient ultracentrifugation was performed on homogenised cells to isolate 
LDs. Staining and microscopy were used to characterize LDs. NMR was performed on 
whole cells, isolated LDs and their extracts. Cisplatin exposure was used to induce cell 
death. 
Results 
NMR spectroscopic analysis revealed that the LDs contain phosphatidylcholine, 
cholesterol and cholesterol ester with saturated, mono-unsaturated and polyunsaturated 
fatty acid species. Both saturated and unsaturated lipids are accumulated into LDs in 
cancer cell death. It is shown that Uridine diphosphate N-acetylglucosamine (UDP-
GlcNAc) and Uridine diphosphate N-acetylglucosamine galactosamine (UDP-GalNAc), 
the main donors of glycosylation, in parallel with 1H NMR detected lipids, increased in 
apoptotic cancer cells. 
Conclusion 
 
LDs in nervous system cancer cell lines contain specific lipid species. To the best of 
our knowledge, it is the first study mechanistically links UDP-GlcNAc and UDP-
GalNAc to cancer cell death. 
 
iii 
 
Declaration 
 
I confirm that this work is my own and that I have been involved in the design and 
conduct of this study, analysis of data and preparation of this thesis. The following 
aspects of this study were undertaken as part of collaboration:  
 
1. Dr. Martin Wilson set up and validated the pulse sequence for NMR experiments. 
 
2. Dr. Martin Wilson and Dr. Greg Reynolds developed the TARQUIN algorithm and 
Martin analysed the data using this algorithm.  
 
3. Mass spectrometry and the following spectra analysis was performed by Dr. Julian 
Griffith, Department of Biochemistry, University of Cambridge 
 
4. Mr Paul Stewart, manager of the Centre for Electron Microscopy, performed the 
negative staining and transmitted electron microscopy on isolated lipid droplets.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
 
Acknowledgements 
 
First of all, I would like to thank my leading supervisor Dr Andrew Peet for creating 
the opportunity of my study in UK. I am deeply grateful for his invaluable guidance 
and for his consistent encouragement during the past three years. Without his offering 
and guidance in this research, I would not be able to finish my study. 
 
I would like to thank my co-supervisors, Dr Martin Wilson for his continued support 
and inspiration, Dr Carmel McConville for her patience and guidance in experimental 
techniques and data analysis and Dr Theodoros Arvanitis for his guidance and 
encouragement during my study.  
 
Many thanks to Professor Risto Kauppinen for his input in my PhD study. 
 
I would also like to thank all the members in our brain tumour research group, James 
Davison, Yu Sun, Eleni Orphanidou, Simrandip Gill, Nigle Davies and Rachel 
Grazier. It has been a great pleasure to work with them. 
 
I am very appreciative of the staff in Henry-Wellcome Building, Sara Whittaker, 
Christian Ludwig and Susan Rhodes, for their assistance with NMR experiments.  
 
School of Cancer Sciences is a great place to study and work. I thank Dr Roger Grand 
for his help with ultracentrifuge and Dr Sally Robert for her support in microscopy. I 
thank all the members for their friendship and help.  
 
v 
 
I wish to express my gratitude to the Andrew McCartney Trust Fund, Mr Charles 
Grant and Mrs Olga Grant for their support to my study.  
 
I would especially like to thank my family. Thanks go to my parents who have 
supported me all my life, my husband who has contributed and sacrificed much for 
me to accomplish this thesis and a great couple who have supported me all along. 
  
Conference abstracts based on this work 
 
Oral presentation: 
 
2009 18th ISMRM British symposium for post-doc and phD, London   
Liquid-state 1H NMR spectroscopy detects differences in the metabolic profiles of four high 
grade nervous system tumours.  
X Pan, M. Wilson, C. McConville, T. N. Arvanitis, J. Griffin, R. A. Kauppinen and A. C. Peet 
 
2010 16th BC-ISMRM, Nottingham 
The size of cytoplasmic lipid droplets is a critical factor to the visibility of NMR lipid signal.  
X Pan, M. Wilson, C. McConville, T. N. Arvanitis, J.L Griffin, R. A. Kauppinen and A. C. 
Peet (Abstract No: O31) 
 
2011 19th ISMBM, Montreal Canada 
An in vitro metabonomic study detects increases in UDP-GlcNAc and UDP-GalNAc, as early 
phase markers of cisplatin treatment response in brain tumour cells.  
X Pan, M Wilson, C McConville, T. N. Arvanitis, J.L Griffin, R. A. Kauppinen and A. C. 
Peet (Abstract No: 252) 
 
2011 20th ISMRM British symposium for post-doc and phD, Cambridge 
The lipid composition of lipid droplets is different from the whole cell lipid pool in brain and 
nervous system tumour cells. 
X Pan, M. Wilson, C. McConville, T. N. Arvanitis, J.L Griffin, R. A. Kauppinen and A. C. 
Peet (Abstract No: O22)   
 
Poster presentation: 
 
2010 14th ISPNO, Vienne 
Cytoplasmic lipid droplets - a novel indicator of tumour type and potential theraputic target in 
childhood brain and nervous system tumours.  
X Pan, M. Wilson, C. McConville, T. N. Arvanitis, J.L Griffin, R. A. Kauppinen and A. C. 
Peet (Abstract No: P-BIO.11) 
 
2010 18th ISMRM, Stockholm. 
1H NMR spectroscopy analysis of isolated intracellular lipid droplets from a human cancer 
cell line, BE(2)M17. 
X Pan, M. Wilson, C. McConville, T. N. Arvanitis, J.L Griffin, R. A. Kauppinen and A. C. 
Peet  (Abstract N0: 3360) 
vi 
 
 
2011 19th ISMBM, Montreal Canada 
The alteration of the lipids in cytoplasmic lipid droplets after cisplatin treatment in human 
brain tumour cells. 
X Pan, M Wilson, C McConville, T. N. Arvanitis, J.L Griffin, R. A. Kauppinen and A. C. 
Peet (Abstract No:4262) 
 
2011 17th British Chapter of ISMRM, Manchester, UK 
 1H NMR demonstrates that oleic acid (18:1) and linoleic acid (18:2) accumulate during cell 
death in human Primitive Neuroectodermal Tumour cells.  
X Pan, M Wilson, C, McConivelle, T. N. Arvanitis, J. L. Griffin, R. A. Kauppinen and A. C. 
Peet  
 
Journal papers based on this work  
 
2011 An in vitro metabonomic study detects increases in UDP-GlcNAc and UDP-GalNAc, as 
early phase markers of cisplatin treatment response in brain tumour cells, X. Pan, M. Wilson, 
L. Mirbahai, C. McConville, T. N. Arvanitis, J.L. Griffin, R. A. Kauppinen and and A.C. 
Peet, Journal of Proteome Research 
 
2012 The lipid composition of isolated cytoplasmic lipid droplets from a human cancer cell 
line, BE(2)M17. 
Xiaoyan Pan, Martin Wilson, Carmel McConville, Marie-Anne Brundlerc, Theodoros N. 
Arvanitis, John P. Shockcor, Julian L. Griffin, Risto A. Kauppinen and Andrew C. Peet , 
Molecular Biosystems  
 
2012 The size of cytoplasmic lipid droplets varies between tumour cell lines of the nervous 
system and can be probed by the 1H NMR lipid signal. 
Xiaoyan Pan, Martin Wilson, Carmel McConville, Theodoros N Arvanitis, Risto A 
Kauppinen and Andrew C Peet  Magnetic Resonance Materials in Physics, Biology and 
Medicine  
 
2012 Increased unsaturation of lipids in cytoplasmic lipid droplets in DAOY brain cancer 
cells in response to cisplatin treatment  
Xiaoyan Pan, Martin Wilson, Carmel McConville, Theodoros N Arvanitis, Risto A 
Kauppinen and Andrew C Peet  Metabolomics  
 
2013 Cytoplasmic lipid droplets in nervous system tumour cell lines: Size and lipid species as 
analysed by 1H nuclear magnetic resonance spectroscopy 
Xiaoyan Pan, Martin Wilson, Carmel McConville, Theodoros N. Arvanitis Risto A. 
Kauppinen and Andrew C. Peet  BSI  DOI 10.3233/BSI-130035 
 
 
 
 
 
 
 
 
 
 
 
 
vii 
 
Table of contents 
Chapter 1 General introduction to lipids and metabolites ............................................................... 1 
1.1 Lipids and Lipidomics ............................................................................................................... 2 
1.2 Categories of lipids ................................................................................................................... 2 
1.2.1 Fatty acyls ......................................................................................................................... 3 
1.2.2 Glycerophospholipids ....................................................................................................... 5 
1.2.3 Sterol lipids ....................................................................................................................... 6 
1.2.4 Sphingolipids .................................................................................................................... 7 
1.3 Lipid composition in normal human brain ................................................................................ 7 
1.4 Lipids in cancer ......................................................................................................................... 8 
1.4.1 Lipids in cancer cell lines ................................................................................................. 9 
1.4.2 Lipids in human brain tumours ......................................................................................... 9 
1.4.2.1 Variation of lipids in brain tumours ....................................................................... 10 
1.4.3 Lipids in cancer therapy .................................................................................................. 10 
1.5 Methods for detecting lipids in biological systems .................................................................. 11 
1.5.1 NMR detection of lipids ................................................................................................. 11 
1.5.2 Mass Spectrometry ......................................................................................................... 12 
1.5.3 Extraction of lipids from cells ........................................................................................ 12 
1.5.4 Lipid staining .................................................................................................................. 12 
1.6 Metabolites and Metabonomics ............................................................................................... 14 
Chapter 2 Detection of lipids and metabolites by nuclear magnetic resonance 
spectroscopy ........................................................................................................................................ 15 
2.1 An introduction to nuclear magnetic resonance spectroscopy ................................................ 16 
2.2 NMR detection of lipids and metabolites ................................................................................. 18 
2.2.1 In vivo MRS .................................................................................................................... 18 
2.2.2 In vitro NMR for cancer specimen ................................................................................. 18 
2.2.3 NMR spectral assignment ............................................................................................... 20 
2.2.4 HSQC to assign lipid species and metabolites ................................................................ 21 
2.2.5 Total Correlation Spectroscopy (TOCSY) ..................................................................... 22 
Chapter 3 NMR detectable lipids and metabolites .......................................................................... 24 
3.1 NMR detectable lipids ............................................................................................................. 25 
3.1.1 Clinical applications ....................................................................................................... 25 
3.1.1.1 Diagnostic use ........................................................................................................ 25 
3.1.1.2 Prognostic use and treatment monitoring ............................................................... 26 
3.1.2 NMR lipid signal in cancer research............................................................................... 26 
3.2 Origin of NMR lipid signal ...................................................................................................... 27 
3.2.1 Mobile and immobile lipids ............................................................................................ 29 
3.3 NMR detectable metabolites .................................................................................................... 30 
3.3.1 In vivo MRS metabolite signal ....................................................................................... 30 
3.3.2 In vitro NMR metabolite signal ...................................................................................... 30 
3.3.3 NMR in metabonomic studies ........................................................................................ 31 
3.4 NMR spectroscopy in biomarker identification ....................................................................... 31 
3.5 The Lipid droplet ..................................................................................................................... 32 
3.5.1 Structure .......................................................................................................................... 32 
3.5.1.1 Lipoproteins and  lipid droplets ............................................................................. 33 
viii 
 
3.5.1.2 Lipid rafts and lipid droplets .................................................................................. 34 
3.5.2 Formation of lipid droplets ............................................................................................. 35 
3.5.3 Biological function of lipid droplets ............................................................................... 37 
3.5.3.1 Lipid storage .......................................................................................................... 37 
3.5.3.2 Interaction with other organelles ............................................................................ 38 
3.5.3.3 Cellular signalling .................................................................................................. 39 
3.5.4 Lipid droplets in tumours................................................................................................ 39 
3.5.5 Lipid droplet alterations with cancer treatment .............................................................. 40 
3.5.6 Microtubular system in cytoplasm .................................................................................. 41 
3.5.7 Isolation of lipid droplets from cell lines ........................................................................ 42 
3.6 Aims and objectives ................................................................................................................. 43 
Chapter 4 Materials and methods ..................................................................................................... 46 
4.1 Nervous system tumour cells ................................................................................................... 47 
4.1.1 Cell culture ..................................................................................................................... 47 
4.1.2 Cell counting ................................................................................................................... 48 
4.1.3 Cisplatin treatment of cancer cell lines ........................................................................... 48 
4.1.4 Cell harvest ..................................................................................................................... 49 
4.1.4.1 Cell pellets for isolation, extraction and NMR investigation ................................. 49 
4.1.4.2 Cell suspension for staining ................................................................................... 49 
4.2 Lipid droplets visualization ..................................................................................................... 49 
4.2.1 Slides preparation ........................................................................................................... 50 
4.2.2 Fluorescent microscopy .................................................................................................. 50 
4.2.2.1 Nile red staining ..................................................................................................... 50 
4.2.2.2 Observation and fluorescent image capture ........................................................... 50 
4.2.3 Light microscopy ............................................................................................................ 51 
4.2.3.1 Oil red O staining ................................................................................................... 51 
4.2.4 Transmission electron microscopy (TEM) ..................................................................... 51 
4.2.4.1 Negative staining ................................................................................................... 51 
4.2.4.2 TEM observation and image capture ..................................................................... 51 
4.2.5 Post-processing for stained LD images .......................................................................... 51 
4.3 Lipid droplets isolation ........................................................................................................... 52 
4.3.1 Homogenous preparation ................................................................................................ 53 
4.3.2 Sucrose-gradient ultracentrifuge ..................................................................................... 53 
4.4 Gel electrophoresis of extracted protein from different fractions after isolation ................... 53 
4.4.1 Protein extraction and measurement of concentration .................................................... 54 
4.4.2 Measurement of total protein concentration ................................................................... 54 
4.4.3 SDS-PAGE gel electrophoresis ...................................................................................... 55 
4.4.4 Coomassie blue staining ................................................................................................. 55 
4.5 Lipid and metabolite extraction from cell pellets and isolated fraction .................................. 56 
4.5.1 Homogenate preparation in methanol and deionised water ............................................ 56 
4.5.2 Partition of sonicated homogenate on ice ....................................................................... 56 
4.5.3 Vacuum centrifugation ................................................................................................... 56 
4.6 Cell Viability assessment ......................................................................................................... 57 
4.6.1 Alamar blue assay ........................................................................................................... 57 
4.6.1.1 Cell growth curve ................................................................................................... 57 
4.6.1.2 Cisplatin treatment and cell incubation .................................................................. 58 
4.6.1.3 Fluorescence measurement and calculation ........................................................... 58 
4.6.2 DAPI staining ................................................................................................................. 59 
4.6.3 RNA fragmentation ........................................................................................................ 59 
4.6.3.1 RNA extraction ...................................................................................................... 59 
ix 
 
4.6.3.2 Agarose gel electrophoresis ................................................................................... 59 
4.7 Nuclear Magnetic Resonance .................................................................................................. 60 
4.7.1 Sample preparation for liquid state 1H NMR .................................................................. 60 
4.7.2 Sample preparation for HR-MAS ................................................................................... 60 
4.7.3 Performing NMR spectroscopy ...................................................................................... 60 
4.7.3.1 Liquid-state 1H NMR with HCN probe ................................................................. 61 
4.7.3.2 HR-MAS ................................................................................................................ 62 
4.7.3.3 HSQC (1H and 13C) ................................................................................................ 62 
4.7.3.4 TOCSY .................................................................................................................. 63 
4.7.4 Spectra post-process and analysis ................................................................................... 63 
4.7.4.1 Totally Automatic Robust Quantitation in NMR (TARQUIN) ............................. 64 
4.7.4.2 wxNUTS software ................................................................................................. 64 
4.7.4.3 Spectral analysis with R ......................................................................................... 65 
4.8 Characterization of lipid species in isolated LDs by mass spectrometry ................................ 66 
4.9 Statistical tests ......................................................................................................................... 67 
Chapter 5 The lipid composition of isolated cytoplasmic lipid droplets from a human 
cancer cell line, BE(2)M17 ................................................................................................................. 68 
5.1 Introduction ............................................................................................................................. 69 
5.2 Methods ................................................................................................................................... 70 
5.3 Results ..................................................................................................................................... 71 
5.3.1 LDs from BE(2)M17 cells .............................................................................................. 71 
5.3.2 1H NMR spectra of lipids ............................................................................................... 74 
5.3.3 HSQC spectra of extracted lipids ................................................................................... 78 
5.3.4 Characterization of isolated LDs by mass spectrometry................................................. 79 
5.4 Discussion ............................................................................................................................... 82 
5.5 Conclusion ............................................................................................................................... 86 
Chapter 6 The size of cytoplasmic lipid droplets varies between tumour cell lines of the 
nervous system .................................................................................................................................... 87 
6.1 Introduction ............................................................................................................................. 88 
6.2 Methods ................................................................................................................................... 89 
6.3 Results ..................................................................................................................................... 90 
6.3.1 Size of LDs ..................................................................................................................... 90 
6.3.2 1H NMR lipid signal ....................................................................................................... 94 
6.3.3 Correlation  between LD size and NMR lipid signal intensity ....................................... 95 
6.4 Discussion ............................................................................................................................... 99 
6.4.1 Variations of LDs in five cell lines ................................................................................. 99 
6.4.2 NMR detection of LDs ................................................................................................... 99 
6.5 Conclusion ............................................................................................................................. 101 
Chapter 7 Lipids in cytoplasmic lipid droplets and whole cells in nervous system tumour 
cell lines ............................................................................................................................................. 102 
7.1 Introduction ........................................................................................................................... 103 
7.2 Methods ................................................................................................................................. 104 
7.3 Results ................................................................................................................................... 105 
7.3.1 Isolation of  LDs ........................................................................................................... 105 
x 
 
7.3.2 Lipid composition analysis ........................................................................................... 108 
7.4 Discussion ............................................................................................................................. 113 
7.5 Conclusion ............................................................................................................................. 116 
Chapter 8 An increase in unsaturated lipids of cytoplasmic lipid droplets in DAOY 
cells responding to cisplatin treatment ........................................................................................... 117 
8.1 Introduction ........................................................................................................................... 118 
8.2 Methods ................................................................................................................................. 119 
8.3 Results ................................................................................................................................... 120 
8.3.1 Survival with cisplatin treatment .................................................................................. 120 
8.3.2 Lipid droplet accumulation with cell death .................................................................. 120 
8.3.3 Validation of isolation .................................................................................................. 122 
8.3.4 NMR Lipid signal ......................................................................................................... 123 
8.3.5 Lipid composition analysis ........................................................................................... 129 
8.3.6 HSQC............................................................................................................................ 131 
8.4 Discussion ............................................................................................................................. 133 
8.4.1 Cell death and LD accumulation .................................................................................. 133 
8.4.2 1H NMR of isolated LDs  from treated DAOY cells .................................................... 133 
8.4.3 Lipid composition analysis ........................................................................................... 134 
8.5 Conclusion ............................................................................................................................. 136 
Chapter 9 An in vitro metabonomic study detects increase UDP-GlcNAc and UDP-
GalNAc in early phase of cisplatin treatment in brain tumour cells ........................................... 137 
9.1 Introduction ........................................................................................................................... 138 
9.2 Methods ................................................................................................................................. 141 
9.3 Results ................................................................................................................................... 142 
9.3.1 Cell survival and cell death ........................................................................................... 142 
9.3.2 HR-MAS peak assignment ........................................................................................... 145 
9.3.3 HR-MAS spectral changes in cisplatin exposed tumour cells ...................................... 148 
9.4 Discussion ............................................................................................................................. 154 
9.5 Conclusion ............................................................................................................................. 158 
Chapter 10 Conclusion ..................................................................................................................... 159 
10.1 Contribution of LDs to NMR lipid signal .......................................................................... 160 
10.2 LDs in the progression of cancer cells .............................................................................. 161 
10.3 Early detection of treatment response with NMR spectroscopy ....................................... 162 
10.4 Summary ........................................................................................................................... 163 
10.5 Future work ....................................................................................................................... 163 
10.5.1 LD component analysis ............................................................................................ 163 
10.5.2 Investigation on cancer cell survival ........................................................................ 164 
References ...................................................................................................................................... 165 
Appendix: Publications based on this thesis .................................................................................. 178 
 
 
xi 
 
Table of Figures 
Figure 1.1 The structure of phosphatidylcholin (dm16:0/20:4(5Z,8Z,11Z,14Z)) with a choline 
head group, glycerol back bone, palmitic acid (C16:0) and arachidonic acid 
(C20:4,5,8,11,14) HMDB11220 .................................................................................................... 6 
Figure 1.2 The structure of cholesterol (a combination of steroid and alcohol) with its polar 
hydroxyl group (in red) which can be esterified by a fatty acyl residue HMDB00067. ................ 7 
Figure 1.3 The structure of sphingomyelin (d18:1/20:0) with a choline head group, a oleic 
acid (C18:1) and a arachidic acid (C20:0) HMDB12102. ............................................................. 7 
Figure 2.1  A The two spin states (positive and negative) of nuclei in an orbital are of the 
same energy (B
0
=0). The different energy states of nuclei when interact with an external 
magnetic field (B
0
)   B The excitement of the nuclei from the low-energy state to the 
high-energy one after application of a RF pulse.  C Subsequent emission of 
electromagnetic radiation. ............................................................................................................ 16 
Figure 2.2 An overlay of individually collected spectra of the fatty acids, oleic (blue), linoleic 
(red), linolenic (green) and arachidonic (black). ......................................................................... 22 
Fgiure 2.3 a. The structure and chemical shifts of J coupled protons in linoleic acids. Proton in 
bold participate in the J coupling. b. The TOCSY spectrum of linoleic acids to show the 
connectivity information [55]. ..................................................................................................... 23 
Figure 1.1 The structure of a lipid droplet (taken from project webpage of Dr. Mathias Beller) ........ 33 
Figure 1.2 The current model of endoplasmic reticulum(ER) formation of lipid droplets. a) 
Neutral lipids are synthesized between the leaflets of the ER membrane. b) The LD then 
bud from the ER membrane and c) matured with a monolayer of phospholipids and 
associated proteins [113]. ............................................................................................................ 36 
Figure 1.3 Examples of LDs with microtubule system in mammals (A-F), fish (G), insects (H, 
I) and fungi (J) [ ........................................................................................................................... 42 
Figure 4.1 Image J 1.41O platform for image measurements. The diameter of a lipid droplet is 
measured by drawing a line across the droplet and measuring the length of the line. ................. 52 
Figure 4.2 The standard curve of BSA the Bio-rad Protein Assay ....................................................... 55 
Figure 4.3 The growth curve of BE(2)M17 cells to assess the proper seeding density........................ 58 
Figure 4.4 A Varian 600 MHz spectrometer (left) and a Bruker DRX 500MHz spectrometer 
(right) at the Henry Wellcome Building for Biomolecular NMR Spectroscopy, The 
University of Birmingham. .......................................................................................................... 61 
Figure 4.5 Line fitting of 1H NMR signals from the –CH3 group of a lipid extract with 
wxNUTs. (Blue: peaks of interest, Green and red: simulated peaks, Grey: residue) .................. 65 
Figure 5.1 Nile red and DAPI staining (A) of BE(2)M17, Nile red staining (B), Oil red O and 
haematoxylin staining (C) and Negative staining (D) of isolated fraction. ................................. 72 
Figure 5.2 Oil red O and haematoxylin staining of different fractions after isolation. Bars 
represent 50µm. A isolated fraction, B middle sucrose zone, C pellet, Upper (D) and 
lower (E) fraction after first 2000xg centrifuge The membrane structure (pointed by 
arrows) were absent from isolated fraction and middle sucrose zone. ........................................ 73 
Figure 5.3 Protein extracts from different fractions after gel electrophoresis and Coomassie 
Blue staining.1.SeeBlue® Plus2 Pre-Stained Standard (invitrogen), 2. whole cell lysate, 
3. isolated fraction, 4. middle sucrose zone, 5.pellet, 6. upper fraction and 7. lower 
fraction of 2000xg centrifuge. ..................................................................................................... 74 
Figure 5.4 Liquid-state 1H NMR spectrum from the buoyant fraction (A) and HR-MRS 
spectrum from intact cell (B) ....................................................................................................... 75 
Figure  5.6 Liquid-state 1H NMR spectra vertically scaled to the resonance intensity at 
2.0ppm (left),1.25ppm  (centre) and 0.9ppm (right) highlighting the resonances around 
2.0–2.9ppm, 1.2–1.4ppm and 0.5-1.0ppm. A: lipid extract from the isolated lipid droplet 
fraction. B: whole cell lipid extracts and C: HR-MAS spectra from intact cells. ........................ 78 
Figure 5.7 The region of 5.45 to 5.25ppm of proton axis of HSQC spectra from the extracts of 
A: whole cells and B: isolated lipid droplet fraction. .................................................................. 79 
xii 
 
Figure 5.8 GC-FID chromatograms of lipid extracts from isolated LDs (A) and BE(2)M17 
cells (B).The peaks labelled on the bottom spectrum are as follows: 1. Deuterated 
tridecanoic acid (retention time and concentration standard), 2. myristic acid (C14:0), 3. 
palmitic acid (C16:0), 4. palmitoleic acid (C16:1, cis-9), 5. stearic acid (C18:0), 6. oleic 
acid (C18:1, cis-9), 7. linoleic acid (C18:2, cis-9, 12), 8. arachidic acid (C20:0), 9. 
gondoic acid (C20:1, cis-11), 10. arachidonic acid (C20:4, cis-5, 8, 11, 14) .............................. 80 
Figure 5.9 A two dimensional chromatogram and mass spectrum plot of the intact lipids 
detected in isolated lipid droplets by liquid chromatography mass  spectrometry. Each 
peak corresponds to an individual intact lipid and the  chromatography separates the 
polar lipids, largely phosphatidylcholines, and  the triglycerides. Mass and 
fragmentation patterns are then used to identify  the individual lipid species. ............................ 82 
Figure 6.1 Nile red and DAPI staining of five brain and nerve system tumour cells. LDs 
appear as green spots and the cell nuclei are in blue. .................................................................. 91 
Figure 6.2 Box-plot (B) of the diameters (µm) of lipid droplets to show the distribution and 
the number of LDs in five tumour cell lines. The middle black line represents the 
median and the box represents a distribution from 25% to 75%. The area between the 
whiskers represented the total distribution of all LDs except for the outliers shown as 
dots (mild outliers) and stars (extreme outliers). ......................................................................... 92 
Figure 6.3 Histogram of the diameters (µm) of lipid droplets to show the distribution of lipid 
droplet size in five tumour cell lines. ........................................................................................... 93 
Figure 6.4 HR-MAS spectra of five nervous system and brain tumour cells. ...................................... 95 
Figure 6.5 Line fit plot for the largest LD in a single cell of each cell line and the lipid signal 
intensity of the methyl groups at 0.9ppm (A) and the methylene groups at 1.3ppm (B). ............ 97 
Figure 6.6 Line fit plot for the sum of total LD volume in each cell and the lipid signal 
intensity measured from 0.9ppm, CH3 groups (A) and 1.3ppm, CH2 groups (B) ...................... 98 
Figure 7.1 Nile red stained LDs in whole cells (a, c) and isolated fraction after isolation (b, d) 
from two cell lines: BE(2)M17 (a, b) and DAOY (c, d). The size bars represent 5µm. ............ 105 
Figure 7.2 HR-MAS spectra acquired from BE(2)M17 (a) and DAOY (c) whole cell pellets 
and lipid-state 1H NMR spectra acquired from the isolated fraction of BE(2)M17 (b) and 
DAOY (d). Spectra were normalised to the maximum point of lipid peaks at 0.9ppm. 
The peaks labelled with numbers in the top spectrum are assigned as follows: 1–CH3 at 
0.9ppm, 2–(CH2) –at 1.3ppm, 3–CH2–CH2–C=O at 1.58ppm, 4 –CH2–CH= at 2.02ppm, 
5–CH2–CH2–C=O at 2.2ppm, 6 =CH–CH2–CH= at 2.8ppm. .................................................... 107 
Figure 7.3 Linear regression of the ratio of lipid/macromolecular at 0.9ppm peaks between 
HRMAS spectra and isolated LDs spectra for five cell lines. Each point in the plot 
represents one cell line and the error bars represent standard errors. ........................................ 107 
Figure 7.4 The whole spectra of lipid-state 1H NMR spectra acquired from the lipid extracts 
of isolated LDs of five cell lines: a BE(2)M17,  b BT4C, c U87MG, d PFSK-1 and e 
DAOY. The assignment for the peaks labelled in top spectra is as follows: 1 –CH3 at 
0.9ppm, 2 Chol+CholE at 1.0ppm 3 –(CH2) –at 1.3ppm, 4 N(CH3)3 at 3.4ppm 5, CH= 
at 5.4ppm. .................................................................................................................................. 108 
Figure 7.5 The whole spectra of lipid-state 1H NMR spectra acquired from the lipid extracts 
of whole cells of five cell lines a BE(2)M17,  b BT4C, c U87MG, d PFSK-1 and e 
DAOY. The assignment for the peaks labelled in top spectra is as follows: 1 –CH3 at 
0.9ppm, 2 Chol+CholE at 1.0ppm 3 –(CH2) –at 1.3ppm, 4 N(CH3)3 at 3.4ppm 5, CH= at 
5.4ppm. ...................................................................................................................................... 109 
Figure 7.6 The expanded region of CH= around 5.4ppm (A), TG around 4.3ppm (B), 
N(CH3)3 around 3.4ppm (C), =CHCH2CH= around 2.8ppm (D), and Chol+CholE 
around 1.0ppm (E) of 1H NMR spectra of lipid extracts of LDs   a BE(2)M17,  b BT4C, 
c U87MG, d PFSK-1 and e DAOY. .......................................................................................... 110 
Figure 7.7 The expanded region of CH= around 5.4ppm (A), TG around 4.3ppm (B), N(CH3)3 
around 3.4ppm (C), =CHCH2CH= around 2.8ppm (D),and Chol+CholE around 1.0ppm 
(E) of 1H NMR spectra of lipid extracts of whole cells. a BE(2)M17,  b BT4C, c 
U87MG, d PFSK-1 and e DAOY. ............................................................................................. 111 
xiii 
 
Figure 7.8 Bar plots of the signal intensity of different lipid groups in five cell lines. Black 
bars for isolated LDs and white bars for whole cells. The error bars represent standard 
deviation. ................................................................................................................................... 113 
Figure 8.1 Cell survival curve of DAOY and PFSK-1 cells after exposed to cisplatin with 
indicated concentrations at 48h. ................................................................................................. 120 
Figure 8.2 Nile red and DAPI staining of DAOY cells with and without 10µM cisplatin 
exposure. The size bars represent 5µm. ..................................................................................... 122 
Figure 8.3 Nile red and DAPI staining of PFSK-1 cells with and without 10µM cisplatin 
exposure. The error bars represent 5µm. ................................................................................... 122 
Figure 8.4 Nile red stained LDs in whole cell (a, c) and in isolated fractions (b, d) of DAOY 
(a, b) and PFSK-1 (c, d). The size bars represent 5µm. ............................................................. 123 
Figure 8.5 HR-MAS spectra from whole cell pellets of DAOY (A) and PFSK-1 (B) with and 
without cisplatin exposure.  The assignment for peaks labelled with numbers are as 
follows:1–CH3 at 0.9ppm, 2–(CH2) –at 1.3ppm, 3–CH2–CH2–C=O at 1.58ppm, 4 –CH2–
CH= at 2.02ppm, 5–CH2–CH2–C=O at 2.2ppm, 6 =CH–CH2–CH= at 2.8ppm‚ 7 –
CH=CH– at 5.4ppm. .................................................................................................................. 124 
Figure 8.6 HR-MAS spectra from whole cell pellets of control cells: DAOY (A) and PFSK-1 
(B).  The assignment for peaks labelled with numbers is as follows: 1–CH3 at 0.9ppm, 
2–(CH2) –at 1.3ppm. .................................................................................................................. 125 
Figure 8.7 Signal intensity of lipid peak at 0.9ppm (A), 1.3ppm (C), 2.8 ppm (B) 5.4ppm (D), 
double bond proton signal/methyl group proton signal (CH=/CH3) and methylene group 
proton signal/methyl group proton signal (CH2/CH3)  from HR-MAS spectra of treated 
and control DAOY and PFSK-1 cells. ....................................................................................... 126 
Figure 8.8 Liquid-state 1H NMR spectrum from the isolated fraction of cisplatin exposed 
DAOY cells. Spectra were normalised to the maximum point of MM peak at 0.9ppm. 
Structural assignments are made as following:: 1 CH3 at 0.9ppm, 2 CH2 at 1.3ppm, 3 
CH2CH2CO at 1.58ppm , 4 CH2CH=CH at 2.02ppm, 5 CH2COOH at 2.2ppm, 6 
=CHCH2CH= at 2.8ppm. ........................................................................................................... 127 
Figure 8.9 1H NMR spectra of lipid extracts from LDs of DAOY cells exposed to cisplatin 
with indicated times. whole spectrum (A) and the expansion for peaks at 1.3ppm (B), 
3.4ppm (C) and 5.4ppm (D). Arrows show the increased signal of methylene groups 
from unsaturated lipids. ............................................................................................................. 128 
Figure 8.10 1H NMR spectra of lipid extracts from DAOY cells exposed to cisplatin with 
indicated times. whole spectrum (A) and the expansion for peaks at 1.3ppm (B), 3.4ppm 
(C) and 5.4ppm (D). ................................................................................................................... 129 
Figure 8.11 The ratio of signal intensity of different lipid groups from the lipids extracted 
from isolated LDs of DAOY and PFSK-1 cells with and without cisplatin exposure. The 
error bars represent standard deviation. ..................................................................................... 131 
Figure 8.12 The ratio of signal intensity of different lipid groups from the lipids extracted 
from DAOY and PFSK-1 cells with and without cisplatin exposure. The error bars 
represent standard deviation. ..................................................................................................... 131 
Figure 8.13 HSQC spectra of 10μM cisplatin 48h treated DAOY cells............................................. 132 
Figure 9.2 Cell survival curve of four brain tumour cells treated with cisplatin for 48h at the 
indicated concentration .............................................................................................................. 143 
Figure 9.3 total-RNA of 50 µM cisplatin treated BT4C cells 1:1kb Plus DNA Ladder, 2: 0h, 
3-7: 3h, 6h, 12h, 24h and 48h exposed cells. ............................................................................. 144 
Figure 9.4 DAPI-stained cell nuclei with 10µM cisplatin treatment of DAOY(a), BT4C(b), 
PFSK-1(c) and U87-MG(d) at the following exposure time: 0h (i), 24h (ii) and 48h (iii). 
The size bar represents 10µm. ................................................................................................... 145 
Figure 9.5 1H NMR spectra for the metabolites extracted from 48h cisplatin- treated U87-MG 
cells with or without pure glycosylated UDP-compounds a: cell extracts, b: cell extracts 
and UDP-GlcNAc, c: cell extracts, UDP-GlcNAc and UDP-GalNAc. The peaks labelled 
in the bottom spectrum are 1. GCH3 at 2.09ppm, 2. G2 at 5.5ppm 3. U5 at 5.98ppm, 4.U6 
at 7.98ppm.  A whole spectrum region. B Expansion of the 2.09ppm region. C 
Expansion of the 5.5ppm region. ............................................................................................... 146 
xiv 
 
Figure 9.6 STOCSY analysis of all HR-MAS spectra acquired from BT4C cells. Peaks 
represent highly correlated spectral regions (the circled points). .............................................. 147 
Figure 9.7 TOCSY spectra from A: extracts of 48h 10µM cisplatin exposed U87-MG cells B: 
pure UDP-GlcNAc and UDP-GalNAc. (Rectangles to show the correlated peaks 
between 7.98ppm with 5.98ppm, 5.5ppm and the signals in 4.5ppm region.) .......................... 148 
Figure 9.8  HR-MAS spectra of a responder, 50 µM cisplatin treated BT4C cells. ........................... 149 
Figure 9.9 HR-MAS spectra of a non-responder,10 µM cisplatin treated U87-MG cell. .................. 150 
Figure 9.10 1H NMR spectra of cell extracts from A BT4C B U87-MG cells exposed to 
cisplatin at 0h, 24h and 48h The peaks labelled on the bottom spectrum are 1. U5 at 
5.98ppm, 2.U6 at 7.98ppm,3. G2 at 5.5ppm .............................................................................. 151 
Figure 9.11 Measurement of HR-MAS spectra. A, the UDP-GlcNAc and UDP-GalNAc peak 
at 7.98ppm. B, the lipid peak at 5.3ppm at 0h, 12h, 24h and 48h treatment with 10µM 
cisplatin. The error bars represent standard errors. *P<0.05 **P<0.001 ................................... 153 
Figure 9.12  The A 8.1-5.4ppm and B 4.5-0.5ppm region of HR-MAS proton spectra of BT4C 
cells at a: control at 0h, b: 24h untreated, c: 48h untreated d:24h cisplatin treated. The 
peaks labelled on the bottom spectrum are 1. Choline at 3.2ppm, 2. Lipid at 5.4ppm, 3. 
G2 at 5.5ppm, 4.H5 at 5.98ppm, 5. U6 at 7.98ppm C: The expansion to show the choline 
peak. ........................................................................................................................................... 153 
 
 
Table of tables 
Table 1.1 Major fatty acids of human brain (taken from Basic Neurochemistry 8th edition, 
page 83, Figure5-1). ....................................................................................................................... 4 
Table 1.2 Concentration of lipids in gray matter, white matter and myelin of human brains 
[8]. .................................................................................................................................................. 8 
Table 5.1 1H NMR resonance of extracted lipids from BE(2)M17 cells in CDCl3 .............................. 77 
Table 5.2 Summary of fatty acid composition as percentage of total fatty acids in lipid 
extracts studied by GC-FID (*P<0.05) ........................................................................................ 80 
Table 7.1 Statistical information of LD diameter from whole cell and isolated fraction of 
BE(2)M17 and DAOY cells. ..................................................................................................... 105 
Table 9.1 The level of UDP-GlcNAc + UDP-GalNAc in untreated cells .......................................... 152 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xv 
 
Abbreviations 
 
ADRP  Adipocyte differentiation related protein   
ATP Adenosine triphosphate  
CCMs Choline containing metabolites  
Cho Choline 
Chol Cholesterol 
CholE  Cholesteryl Ester 
Cisplatin Cis-dichlorodiammineplatinum II 
CNS Central Nervous System 
Cr Creatine 
D2O Dideuterium monoxide  
DAPI  4',6-diamidino-2-phenylindole 
D-PBS Dulbecco’s phosphate buffered saline  
DAG  Diacylglycerol  
DAPI  4’, 6-diamino-2-phenylindole  
DMEM Dulbecco’s modified Eagles medium  
DMSO  Dimethyl sulfoxide  
DNA Deoxyribonucleic acid 
DNase Deoxyribonuclease  
ER Endoplasmic reticulum  
FCS Foetal calf serum  
FID Free induction decay  
GC Gas chromatography 
GC-FID Gas chromatography with flame-ionization detector  
GCV gene therapy Ganciclovir thymidine kinase gene therapy 
Gly Glycine 
GPC Glycerophosphocholine  
GTP Guanosine-5'-triphosphate 
HBP Hexosamine biosynthesis pathway 
HCN Proton, nitrogen, carbon  
HDL High density lipoprotein 
HMDB Human Metabolome Database 
HR-MAS High resolution magic angle spinning magnetic resonance spectroscopy 
xvi 
 
HSQC Heteronuclear Single Quantum Coherence  
HSV-tk Herpes simplex virus thymidine kinase  
IDL Intermediate density lipoprotein 
IFN-γ Interferon-gamma  
IP3 Inositol triphosphate 
ISM Industrial methylated spirit 
LC-MS Liquid chromatography mass spectrometry 
LD Lipid droplet 
LDL Low density lipoprotein 
MAS Magic Angle Spinning  
MEM minimum essential medium  
MM Macromolecule 
MRI Magnetic resonance imaging 
MRS Magnetic resonance spectroscopy 
MS mass spectrometry 
MUFA Monounsaturated fatty acids 
NAA N-Acetylaspartic acid 
NEAA Non-essential amino acid 
Nile red Nile blue oxazone (9-diethylamino-5H-benzo[α]phenoxazine- 5-one)  
NMR Nuclear magnetic resonance spectroscopy 
O-GlcNAc O-linked β-N-acetylglucosamine  
O-GlcNAcylation O-linked β-N-acetylglucosamine glycosylation  
PC Phosphocholine 
PKC Protein kinase C 
PIP2 phosphatidylinositol bisphosphate  
PtCho Phosphatidylcholine  
PtdEtn Phosphatidylethanolamine  
PtdSer Phosphatidylserine 
PUFA Poly unsaturated fatty acid 
RNAi Ribonucleic acid interference 
S1P Sphingosine-1-phpsphate  
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis  
Shh Sonic Hedgehog  
SPL Sphingosine-1-phpsphate lyase 
xvii 
 
STOCSY Statistical total correlation spectroscopy  
ST-PNET Supratentorial primitive neuroectodermal tumour  
TARQUIN Totally automatic robust quantitation in NMR  
TBE Tris/Borate/ Ethylenediaminetetraacetic acid 
TEM Transmission electron microscopy 
TG Triglyceride 
TIP47 The 47-kDa tail interacting protein 
TMS Trimethylsilylproprionate d4 
TNF-α Tumour necrosis factor-alpha  
TOCSY Total Correlation Spectroscopy  
UFA Unsaturated fatty acid 
UDP-GlcNAc Uridine diphospho-N-acetylglucosamine 
UDP-GalNAc Uridine diphospho-N-acetylgalactosamine 
VLDL Very low intensity lipoprotein 
WHO World health organisation  
 
 
  
 
1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1 General introduction to 
lipids and metabolites 
 
 
 
 
 
 
 
 
 
 
 
  
 
2 
 
1.1 Lipids and Lipidomics 
The definition for lipids recently proposed by Dr. Christin [1] is that lipids are fatty acids, their 
derivatives (esters and amides) and substances related biosynthetically or functionally to these 
compounds. The structure of a lipid usually consists of various combinations of different fatty 
acids and functional head groups that are linked by a backbone, usually a glycerol or sphingoid 
base backbone. Many human diseases, such as cancers, diabetes and infectious diseases 
involve dysfunction of lipid synthesis, utilization and transport [2]. Therefore, lipid biology has 
become a major research target after the post genomic revolution [3]. 
 
Lipidomics is a comprehensive study of cellular lipids in a biological system which involves 
quality and quantity analysis of thousands of lipid molecules and the interaction with 
themselves and with other compounds such as proteins and metabolites [4]. Compared with the 
huge breakthrough in the fields of genomics and proteomics, the lipidomics research is 
hindered due to the complexity of lipids and the lack of powerful analysis tools [3]. Recently, 
the lipidomic profiling by mass spectrometry not only confirms the structural diversity of lipids 
but also reveals that lipids are dynamic molecules with multiple functions [3].   
1.2 Categories of lipids 
Lipid biology has become a major target for chemists, biologists and biomedical researchers 
since the post-genomic revolution, in order to deal with the massive amounts of data collected 
from different fields, a naming scheme that unambiguously defines a lipid structure was 
developed by E. Fahy et al. in 2005 [3]. 
 
Biological lipids originate entirely or partly from two distinct types of biochemical subunits: 
ketoacyl and isoprene groups [3]. Using this approach, lipids can be divided into eight 
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categories: fatty acyls, glycerolipids, glycerophospholipids, sphingolipids, saccharolipids, 
polyketides, sterol lipids and prenol lipids. This lipid classification includes almost all 
subgroups of lipids, however, only the lipid groups that are abundant in brain tissues will be 
discussed here. 
 
1.2.1 Fatty acyls 
Fatty acyl is a generic term for describing fatty acids, their conjugates and derivatives. 
The fatty acid structure is one of the most fundamental categories of biological lipids, and is 
commonly used as a building block of complex lipids. Most fatty acids are straight-chain 
carboxylic acids compounds with an even number of carbon atoms because their biosynthesis 
involves acetyl-CoA, a coenzyme carrying a two-carbon-atom group. There are more complex 
fatty acids with an odd number of carbon atoms, branched chains, or other various functional 
groups. However, they are mostly frequent in animals, plants and bacteria. The majority of the 
fatty acids found in lipids are monocarboxylic acids. 
 
Depending on double bonds, fatty acids can be saturated and unsaturated. Saturated fatty acids 
are commonly straight chain carboxylic acids that usually have between 4 and 24 carbon atoms 
and have no double bonds. Because saturated fatty acids have only single bonds, each carbon 
atom within the chain has 2 hydrogen atoms (-CH2-, the methylene group), except for the 
omega carbon at the end that has 3 hydrogen (-CH3, the methyl group).  The general formula 
for saturated fatty is CH3(CH2)nCOOH.  
 
Unsaturated fatty acids resemble saturated fatty acids, except that the chain contains double-
bonds (CH=). Monounsaturated fatty acids (MUFAs) have only one double bond while 
polyunsaturated fatty acids (PUFAs) have two or more double bonds. The PUFAs found in 
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brain tissue usually have from three up to six double bonds, generally separated by a single 
methylene group (methylene-interrupted unsaturation,-CH=CH-CH2-CH=CH-).Some 
uncommon PUFAs have two adjacent double bonds separated by more than one methylene 
group, they are named polymethylene-interrupted fatty acids.  
 
In addition to the degree of saturation, fatty acids can also be characterized by the chain length. 
Most naturally occurring fatty acids have a chain of 4 to 28 carbons. Short-chain fatty acids are 
fatty acids with aliphatic tails of fewer than six carbons and they are always saturated. 
Medium-chain fatty acids are fatty acids with aliphatic tails of 6–12 carbons, which can form 
medium-chain triglycerides. Long-chain fatty acids are fatty acids with aliphatic tails longer 
than 12 carbons and can be either saturated or unsaturated [5]. Very-Long-chain fatty acids are 
fatty acids with aliphatic tails longer than 20 carbons and they tend to be highly unsaturated. 
Their physical and biological properties are related to this partition in 4 classes. Major brain 
fatty acids contain 12 to 24 carbons (Table 1.1). Brain lipids contain some unusually long and 
polyunsaturated fatty acids which cannot be biosynthesized in the animal body de novo. 
 
Table 1.1 Major fatty acids of human brain (taken from Basic Neurochemistry 8th edition, 
page 83, Figure5-1). 
  
 
5 
 
 
 
1.2.2 Glycerophospholipids 
Glycerophospholipids essentially fall into glycerolipids as they are glycero-containing lipids as 
well, but they are made into a separate category because of their abundance and importance. 
The glycerophospholipids are ubiquitous in nature and are key components of the lipid bilayer 
of cells.  
 
Glycerophospholipids are defined into subclasses on the basis of the substituent base of the 
diacylglycerophosphoryl unit. The amount and distribution of these lipids varies with brain 
regions and with age. The most abundant ones in brains are phosphatidylethanolamine 
(PtdEtn), including plasmalogens, phosphatidylcholine (PtdCho, lecithin) (Figure 2.1) and 
phosphatidylserine (PtdSer) [6]. Each class in a given tissue has a characteristic fatty acid 
composition, though the same fatty acid may be present in a number of lipids, the quantitative 
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fatty acid composition is different for each class of lipids and remains fairly constant during the 
growth and development of the brain. 
 
Figure 1.1 The structure of phosphatidylcholin (dm16:0/20:4(5Z,8Z,11Z,14Z)) with a choline 
head group, glycerol back bone, palmitic acid (C16:0) and arachidonic acid (C20:4,5,8,11,14) 
HMDB11220 
 
1.2.3 Sterol lipids 
Sterol lipids have the unit structure of a five-carbon branched chain. The most abundant of 
these in the brain is cholesterol (Figure 1.2) which plays a central role in the formation of lipid 
rafts and is responsible for protein trafficking and signalling at the cell surface. Cholesterol 
ester is found in the developing brain and some brain tumours but not in normal adult brain [7]. 
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Figure 1.2 The structure of cholesterol (a combination of steroid and alcohol) with its polar 
hydroxyl group (in red) which can be esterified by a fatty acyl residue HMDB00067. 
 
1.2.4 Sphingolipids  
In sphingolipids, the long-chain amiodiol sphingosine serves as the lipid backbone. The amino 
group of sphingosine is acylated with long chain fatty acids and the N-acylated product is 
termed a ceramide which is linked to different head groups to form various membrane lipids. 
Sphingomyelin (Figure 1.3) is the phosphodiester of ceramide and choline and is formed by a 
reaction that transfers the head group of phosphatidylcholine to ceramide. In humans, 
sphingomyelin is the only membrane phospholipid not derived from glycerol. 
 
 
Figure 1.3 The structure of sphingomyelin (d18:1/20:0) with a choline head group, a oleic 
acid (C18:1) and a arachidic acid (C20:0) HMDB12102. 
 
1.3 Lipid composition in normal human brain 
Glycerophospholipids, sphingolipids and cholesterol are the three main brain lipids [8]. Unlike 
other tissues, normal adult brain contains virtually no cholesterol esters or triglyceride. The 
percentage of different lipid components of brain tissues from different ages are listed in Table 
1.2. 
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Table 1.2 Concentration of lipids in gray matter, white matter and myelin of human brains 
[8]. 
 
1.4 Lipids in cancer  
The correlation of dietary lipids and carcinogenesis has been known for a long time with 
investigations starting in the 1960s [9]. Since then, the importance of lipids in cancer 
development has been generally recognized. Variations in lipid composition, amount and 
preoxidation status have been observed in a wide range of cancer cells, tissues and patients 
[10-13]. Lipid metabolism genes are found to be important in tumour transformation and are 
up-regulated in cancer tissues [14]. Certain lipids can activate intrinsic and extrinsic apoptotic 
pathways through receptor-independent mechanism [14]. In addition, sphingolipids influence 
cell cycle progression, telomerase function, cell migration and stem cell biology. Considering 
the role of lipids in cell proliferation and cell death, some of them can be regarded as a tumour-
suppressor lipid or a tumour-promoting lipid [15]. Lipids are also found to be important to the 
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tumour progression and drug resistance in cancers [16]. However, the biological role of lipids 
in cancers still remains partially understood. 
1.4.1 Lipids in cancer cell lines 
Cell lines are widely used in laboratory-based research. Cell line models show a good ability to 
measure cellular component, assess cell growth/death and test treatment response [17]. Lipid 
composition of cancer cells varies in different  types of cells [18]. Lipid composition was 
found to be correlated with the differentiation and growth state of cancer cells [19]. A wide 
range of human cancer cell lines has been used to investigate the lipid signalling pathways, 
genetic modifications, protein expressions in lipid metabolism related to cancer progression 
[16, 20]. However, mono-layer cultured cells do not represent the whole characteristics of a 
tumour. Established tumour cell lines might develop multiple genetic changes over time, so 
that they no longer reflect the exact biology of the original tumour. 
 
1.4.2 Lipids in human brain tumours 
The World Health Organization (WHO) published a classification system to identify brain 
tumours according to cell origin and behaviour. Some tumour types are assigned a grade to 
predict the response to therapy and outcome. Medulloblastoma, glioblastoma and primitive 
neuroectodermal tumour are all highly aggressive malignant brain tumours that  are commonly 
seen in both children and adults [21]. 
 
Abnormal lipid metabolism may be particularly important to human brain tumours as lipids are 
a predominant content in brain tissues. In some parts of the brain, the percentage of lipid 
content is as high as 80% of the dry weight [8]. 
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1.4.2.1 Variation of lipids in brain tumours 
Lipid accumulation can be found in different types of cancer cells [22, 23]. Extensive lipid 
analysis of brain tumours has been performed since the introduction of thin layer 
chromatography [24]. Brain tumour tissue was found to contain more fatty acids, sterol esters 
and glycerol esters than normal brain. The lipid pattern in tumours resembled the pattern found 
in normal brain surrounding the tumour [24]. The presence of cholesteryl esters and 
triglycerides in high grade tumours were also confirmed using NMR, which is different from 
normal brain tissue and low grade neoplasm [25]. All these studies indicated that the contents 
of lipid fractions of brain tumours were significantly different from those of normal brain 
tissues [26]. 
1.4.3 Lipids in cancer therapy 
Two decades ago ,it was found that the fatty acid composition of cancer cell membranes could 
alter when cells were exposed to different types of lipids [27]. A substantial change was 
proposed to be the degree of unsaturation of membrane phospholipids [28]. Certain physical 
and functional properties of membranes are modified when PUFA content is increased and 
therefore cancer cells become more sensitive to drug treatment. Enrichment with PUFAs 
makes cancer cells more susceptible to lipid peroxidation and leads to an increased lipid radical 
formation in response to oxidant stress and photodynamic therapy [28]. In addition, the 
immune response in cancer can be improved by manipulating the lipid levels in dendritic cells 
[13].  All these observation suggests that PUFA supplementation can make certain forms of 
cancer treatment more effective.  
 
More interestingly, parinaric acid (C18:4), an PUFA containing conjugated double bonds is 
reported to be cytotoxic to several types of human tumour cells[28]. In a study of the 
cytotoxicity of PUFAs to pancreatic and leukaemic cells, a range of PUFAs including linoleic 
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acid (C18:2), linolenic acid (C18:3) and arachidonic acid (C20:4) together with oleic acid 
(C18:1), an MUFA, were all found to inhibit cell growth and induce cell death within varied 
exposure time [29]. 
 
The cytotoxicity of unsaturated fatty acids (UFAs) and their role in tumour growth inhibition 
was identified in animal studies [30, 31] and clinical trials of linolenic acid therapy of human 
gliomas [32].  Although the fatty acids induced cell killing is not as dramatic as other 
chemotherapeutic drugs and radiation, these lipid-based approaches to cancer therapy show 
selectivity for malignant cells without harming the normal cells [32, 33]. Their selective 
activity against tumours implicates the potential of lipid therapy to be used in less advanced 
tumours, to enhance the response of tumour cells to other anticancer drugs and to achieve a 
higher cytotoxic action with higher dose in future studies. 
 
Except for the external supplied fatty acids, internally synthesized fatty acids are reported to be 
involved in cancer cell death as well. Cancer cell apoptosis is a major mechanism for most 
chemotherapy and radiation therapy. Research found that there was NMR visible 
polyunsaturated lipid accumulation during cancer cell apoptosis [34]. Tumours with high 
apoptotic activity were found to have a higher content of -(CH2)n and -CH3 fatty acids while 
monitoring the effect of an antitumor agent [35]. These findings indicated the potential of 
lipids to be served as biomarkers for effective cancer therapy.  
1.5 Methods for detecting lipids in biological systems 
1.5.1 NMR detection of lipids 
Nuclear Magnetic Resonance Spectroscopy is a non-invasive analytical technique which is 
now widely used in both the research and clinical settings [36]. MRS is a term used for in vivo 
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studies while NMR is used when the same technique is applied in vitro. The information 
provided by MRS can be processed and presented as peaks in spectra (detailed explanation see 
section 2.1) and as density maps to show the spatial distribution of the detectable compounds 
such as mobile lipids, low molecular weight metabolites and macromolecules [37].  
1.5.2 Mass Spectrometry 
Mass spectrometry (MS) is a technique for measuring the mass of molecules in an ionized 
state. Both MS and NMR spectroscopy are common techniques used in lipid analysis. MS is 
more sensitive than NMR. It not only provides a specific molecular mass value, but also 
establishes the molecular formula of an unknown compound to give a clear identification [38]. 
However, the sample preparation for MS is relatively complicated and time consuming. 
1.5.3 Extraction of lipids from cells  
An effective method to reduce the problem of line shape broadening (details see section 2.1) in 
NMR is to extract lipids chemically from cells and tissues and re-suspend the extracts in 
solvents to produce homogeneous liquid state samples which are ideal for NMR analysis. In 
addition, the extraction can eliminate unwanted enzyme activity and enhance the stability of 
the samples. Methanol/chloroform/water extraction has been the classic way to extract lipids 
since 1960s and is still widely used today [39]. However, it is difficult to estimate the alteration 
to the detected sample caused by the chemical extraction and there is always the possibility that 
contamination might be brought into the samples in the process. 
1.5.4 Lipid staining  
Staining is an auxiliary technique used in microscopy to enhance contrast in the microscopic 
image. Stains and dyes are frequently used in biology and medicine to highlight structures in 
biological tissues for viewing and assessment. The lipid of cells and tissues can be 
demonstrated with specific lipid binding dye and the stained lipid can be observed using a 
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microscope [40].The ability to visualize lipids can help researchers to investigate the 
distribution, intensity and volume of lipids. However, the image elements are observed 
indirectly and lack molecular specificity.  
 
There are a range of lipophilic dyes that used to be applied in lipid analysis. Oil red O largely 
replaced Sudan III and Sudan IV, as it provides deeper red colour to be visualized under light 
microscope. The fluorescent dyes such as Nile red, Bodipy are becoming more and more 
popular as their high intensity can improve the clarity of images and also can track lipids in a 
non-destructive way in living cell [41]. 
 
Nile red exhibits properties of a near-ideal lysochrome. Nile red can be used with living cells. 
It fluoresces strongly when partitioned into lipids, but practically not at all in aqueous solution. 
The dye is very soluble in the lipids it is intended to show, and it does not interact with any 
tissue constituent except by solution. Nile red can be applied to cells in an aqueous medium, 
and it does not dissolve the lipids it is supposed to reveal [40]. 
 
A lipophilic dye based on the Bodipy fluorophore, LD540, was developed recently for 
microscopic imaging of lipid droplets. In contrast to previous lipid droplet dyes, it can be 
resolved from both green and red fluorophores allowing multicolour imaging in both fixed and 
living cells. Its improved specificity, brightness and photo-stability support live cell imaging, 
which can be used to demonstrate by two-colour imaging lipid droplet motility along 
microtubules[41]. 
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1.6 Metabolites and Metabonomics 
A general definition of metabolites is the intermediates and products of metabolism and 
metabolites are usually small molecules. A scientific definition of metabolite proposed by Prof. 
Harris ED in Biomedical Facts behind the Definition and Properties of Metabolites (FDA, 
USA) is that metabolites are the products of enzyme-catalysed reactions that occur naturally 
within cells. He proposed a summary of the major factors to designate a substance a metabolite 
is as follows: 1. Metabolites are compounds found inside cells. 2. Metabolites are recognised 
and acted upon by enzymes. 3. The product of a metabolite must be able to enter into 
subsequent reactions. 4. Metabolites have a finite half-life; they do not accumulate in cells. 5. 
Many metabolites are regulators that control the pace of metabolism. 6. Metabolites must serve 
some useful biological functions in the cell. 
 
Metabonomics/ Metabolomics is a systematic and untargeted study of all the metabolites in a 
biological cell, tissue, body fluid or organ [42]. These two terms are often been used as 
synonymous. Metabolomics emphasises metabolic profiling at a cellular or organ level. It is 
primarily concerned with normal endogenous metabolism. Metabonomics extends metabolic 
profiling to include information about the alteration of metabolism caused by environmental 
factors, toxins, disease processes, and etc [43]. 
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2.1 An introduction to nuclear magnetic resonance 
spectroscopy 
 
NMR is a spectroscopy technique established on  nuclear magnetic resonance phenomenon 
which was first described by Isidor Rabi in 1938 [44]. Some nuclei have magnetic spin, arising 
from a disparity in the number of protons and neutrons within them. Magnetic spin can have 
different energies; one is higher than the other. The basic principle of a NMR experiment 
involves two steps: the alignment of the atomic nuclei with intrinsic magnetic spin properties 
when placed in constant magnetic fields and the application of a NMR radio frequency (RF) 
pulse, resulting in the excitement of some of the nuclei from the low-energy state to the high-
energy one. Following the pulse, the high-energy-spin nuclei relax back to a low-energy state 
with an associated emission of electromagnetic radiation (Figure 2.1). 
 
Figure 2.1  A The two spin states (positive and negative) of nuclei in an orbital are of the 
same energy (B
0
=0). The different energy states of nuclei when interact with an external 
magnetic field (B
0
)   B The excitement of the nuclei from the low-energy state to the high-
energy one after application of a RF pulse.  C Subsequent emission of electromagnetic 
radiation. 
 
The electromagnetic radiation is at a specific resonance frequency which depends on the 
strength of the applied magnetic field, the atomic nuclei and their electronic environment. 
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These frequencies at which the radiation resonates are observed, registered and presented as 
peaks on a normalised frequency scale.  
 
The position and the shape of the peaks depend on the resonant frequencies of the specific 
atomic nuclei of the studied sample. Therefore, each compound has its own spectral pattern 
according to the molecular structure and the metabolite profile of the sample can be determined 
form these NMR spectral patterns. The area under the peaks, also called the signal intensity is 
proportional to the abundance of the detected nuclei which also represent the concentration of 
the sample. Therefore, NMR is not only a  qualitative technique but also a quantitative one.   
 
Only the NMR active nuclei with an non-zero overall spin can be studied using NMR and the 
commonly used nuclei are 1H, 19F, 31P, 13C, 15N, which are listed according to their sensitivity. 
Proton (1H) has a relatively large magnetic movement and a high sensitivity and protons are 
presented in almost all compounds, therefore 1H MRS is most extensively used in different 
field, especially in the investigation of lipids. All NMR techniques discussed in this paper use 
proton as the signal acquiring nuclei except for Heteronuclear Single Quantum Coherence 
(HSQC), a 2D technique which uses both proton and carbon signal. 
 
In NMR, relaxation is the process that nuclear magnetization in a non-equilibrium state returns 
to the equilibrium distribution. T1 relaxation, also called longitudinal relaxation, Spin-Lattice 
relaxation, describes the gain and loss of magnetization in the z-direction. T2 relaxation, also 
called transverse relaxation or Spin-Spin relaxation describes the gain and loss of 
magnetization in the x,y-direction. T2 is usually less than or equal to T1 as the return of 
magnetization to the z-direction inherently causes loss of magnetization in the x-y plane. The 
line width of an NMR signal is determined by T2. Shorter T2 means broader lines. 
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Rotational correlation time is the time it takes the average molecule to rotate one radian; it is a 
quantitative measure of the rate of a molecular motion and usually depends on the molecular 
size. The rotational correlation time becomes longer (molecule motion is slower, molecule size 
is bigger), T2 becomes shorter. In larger molecules, molecular motion is slower and T2 is 
much shorter than T1. The NMR signal from larger molecules is usually broader. 
2.2 NMR detection of lipids and metabolites 
2.2.1 In vivo MRS 
The clinical use of in vivo magnetic resonance spectroscopy has been limited for a long time 
due to the low sensitivity. MRS served as a new clinical tool from the 1990s [45] while the first 
MR image was published in 1973 [46]. With the advent of clinical MR systems with higher 
magnetic field strength and optimized pulse sequences, sensitivity has been largely improved 
and nowadays, magnetic resonance spectroscopy is being routinely used in the clinic especially 
in the management of brain tumour patients [47]. MRS can provide functional and metabolic, 
rather than morphologic, tissue properties. Therefore, it can be used to improve diagnostic 
accuracy, grade tumours, offer guidance for surgical intervention and drug treatment and 
determine early response to therapy [48]. 
 
2.2.2 In vitro NMR for cancer specimen 
Most NMR experiments are carried out in a solution state. A sample containing particles has a 
field homogeneity distortion around every single particle. In solution NMR, the inherent 
isotropy (same in all directions) means the NMR spectrum appears as a set of narrow, well 
defined lines. The homogeneity of liquid samples allows the dissolved compound to tumble 
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randomly at rates fast enough to average out anisotropic chemical (oriental dependant) shifts. 
Thus, most liquid-state samples can yield sharp signals in NMR spectroscopy. Cells and tissues 
are inherently not homogeneous. The subsequent local variation in the B0 field at the cellular 
level of these samples leads to line broadening. This effect is known as bulk magnetic 
susceptibility (BMS) [49] induced broadening which is the main contributor to the poor line 
shapes for small molecules in cells. 
 
Lipids and macromolecules have a characteristic broad appearance in 1H NMR spectroscopy. 
However, unlike to small molecules, BMS induced broadening is not the largest contributor to 
their broad line shape. The restricted rotational mobility due to the large mass becomes the 
main reason. In NMR spectroscopy, in order to give a narrow line shape, molecules must rotate 
fast enough to fall into the transverse relaxation rate (R2) [50]. R2=1/T2. The longer R2 
relaxation rate due to large and immobile molecules leads to broadening of frequencies and 
sometimes loss of resolvable NMR peaks. 
 
For biological macromolecules, their anisotropic features have largely limited their NMR 
observation. However, certain kinds of anisotropic interactions can be controlled by a method 
called Magic Angle Spinning (MAS) discovered by E. R. Andrew and I. J. Lowe in the late 
1950s. MAS is the process of spinning the sample about an axis at an angle of 54.74o to the 
static magnetic field B0. Spinning the sample at the magic angle significantly reduces line-
broadening interactions such as BMS induced broadening, chemical shift anisotropy and 
dipolar effects. Another advantage of MAS is that excellent signal to noise can be achieved. 
This is because MAS probes are optimised for samples volumes around 10 times smaller than 
conventional liquid state probes. This microprobe design gives an improved filling factor (the 
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fraction of the coil detection volume filled with sample) which is crucial to improving 
sensitivity. 
 
2.2.3 NMR spectral assignment 
Chemical shift describes the dependence of nuclear magnetic energy levels on the electronic 
environment in a molecule[51]. Specifically, the external magnetic field induces currents of the 
electrons in molecular orbital. These induced currents create local magnetic fields that often 
vary across the entire molecular framework so that nuclei in distinct molecular environments 
usually experience unique local fields from this effect. Because of the shielding effect, NMR is 
highly specific to the chemical structure of a molecule and distinct chemical species possess 
characteristic chemical shifts. Therefore, chemical shift information is suitable for 
identification and quantization of NMR detectable molecules[52]. Chemical shift is usually 
expressed in parts per million (ppm) by frequency, because it is calculated from the difference 
in precession frequency between tow nuclei over the operating frequency of the magnet. 
 
J-coupling or indirect nuclear spin-spin coupling is an indirect scalar interaction between two 
nuclear spins which arises from hyperfine interactions between the nuclei and local electrons. 
It describes the interaction of nuclear spins through chemical bonds. As an important 
observable effect in 1D NMR, it can provide some of the most useful information of the 
molecular structure. For example, in a CH3-CH2 group,the CH3 group is split into a triplet with 
an intensity ratio of 1:2:1 by  two neighbouring CH2 protons [25].   
 
Compared with metabolites, lipids usually have a larger molecular weight and give broader and 
less resolved peaks in the 1H NMR spectra. Several important moiety of lipids can be identified 
in the proton spectrum, including –CH3 at 0.9ppm, –CH2 –at 1.3ppm, –CH2–CH2–C=O 
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at1.58ppm, –CH2–CH= at 2.02ppm, –CH2–CH2–C=O at 2.2ppm,  =CH–CH2–CH= at 2.8ppm‚  
–CH=CH– at 5.4ppm [37, 50]. The spectra acquired from lipid extracts re-suspended in 
solvent, usually deuterated chloroform, are with better resolution [25]. 
 
2.2.4 HSQC to assign lipid species and metabolites 
2D HSQC experiment is frequently used in NMR studies of organic molecules and is of 
particular significance in the field of lipid and protein NMR. A HSQC spectrum is two-
dimensional with one axis for 1H and the other for a heteronucleus, most often 13C for lipid 
studies. The analysis of lipid composition and other non-lipidic metabolites is important in 
understanding the malignance transformation and the treatment of tumours. Most fatty acids 
and small-molecule metabolites can be differentiated by their NMR spectra; however a huge 
signal overlap of 1D 1H spectrum brought difficulties in the analysis of mixtures such as cell 
extracts. 1D 13C spectrum is capable of providing better resolution but its low sensitivity 
requires higher sample concentration, a major challenger for cell extracts.  HSQC spectrum 
contains information from each unique proton attached to the heteonucleus [53], the more 
sensitive proton signal acquired with extra information from carbon nuclei makes it possible to 
give a more accurate assignment to individual metabolite and  fatty acid side-chain (Figure 2.2) 
[54] in the extracts of tumour cells.  
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Figure 2.2 An overlay of individually collected spectra of the fatty acids, oleic (blue), linoleic 
(red), linolenic (green) and arachidonic (black). The peaks are overlapped in 1H spectra and 
distinguishable in HSQC spectra [54]. 
2.2.5 Total Correlation Spectroscopy (TOCSY) 
2D TOCSY experiment offers the correlation between all protons that interact through J-
coupling. Therefore, TOCSY spectra can link the signals belonging to the same molecule and 
the additional connectivity information can provide better resolution than 1D NMR (Figure 
2.3). Similar as HSQC, TOCSY, a 2D NMR experiment, involves a series of one-dimensional 
experiments and more complicated pulse sequence, therefore, requires much longer acquisition 
time than 1D experiments.   
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Fgiure 2.3 a. The structure and chemical shifts of J coupled protons in linoleic acids. Proton 
in bold participate in the J coupling. b. The TOCSY spectrum of linoleic acids to show the 
connectivity information [55]. 
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Chapter 3 NMR detectable lipids and 
metabolites 
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3.1 NMR detectable lipids  
A certain group of cell lipids can be detected using nuclear magnetic resonance spectroscopy 
(NMR) both in vivo and in vitro. Increasing evidence has been found to support that these 
NMR lipid signals can provide vital information on the life and death of cells [50] and have 
important applications to both clinical and research settings.  
3.1.1 Clinical applications  
With the involvement of NMR in the clinical management of brain tumour patients, this 
technique has been increasingly important in brain tumour diagnosis prior to biopsy [56], in 
monitoring the response of tumours to drugs or irradiation  and in early detection of tumour 
recurrence [57]. The biochemical profiles are established from the resonances of important 
metabolites such as choline, creatine, lactate and an important component among these are the 
mobile lipids [58]. 
 
Lipid resonances have been detected in different types of tumour cells and tissues and [37, 59] 
seen in the 1H NMR performed on brain tumour patients. Increasing clinical and experimental 
observations show that these lipid signals are related to the tumour type, grade [37, 60] and 
treatment response [34, 61], demonstrating the potential of these signals to be used as a 
diagnostic tool and to monitor the effectiveness of therapies. 
3.1.1.1 Diagnostic use 
The major metabolic alterations found using NMR in brain tumours compared to normal brain 
have been described in several studies which include the appearance of lipids[62-64]. A study 
across more than 100 primary brain tumour spectra showed that the  lipid signals occurred in 
some primitive neuroectodermal tumours and astrocytic tumours were not detected in other 
types such as oligodendrogliomas, ependymomas and meningiomas [60]. In addition, the lipid 
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signals are often associated with necrosis, which is a histological feature of high-grade 
tumours. While studying the lipid accumulation in astrocytoma tissues, it was found that the 
intensity of NMR lipid signal was correlated positively with the amount of histologically 
detected necrosis [63], suggesting that these signals can be used to assess the level of necrosis 
in a tumour. It has been reported that the quantified lipid signal increased with the grade of a 
tumour and therefore can be used as a good marker for tumour grade [37]. One study has also 
found that the profile of the mobile lipid/macromolecule signals of metastases and high grade 
gliomas are different and the ratio of the 1.3 ppm to 0.9 ppm lipid peaks can provide some 
distinction of these tumour types [65]. A study of in-vivo 1H NMR of untreated metastatic 
brain tumours showed that with the association of other metabolite information, NMR lipid 
signals can be used to estimate the stage of tumour development [64].  
3.1.1.2 Prognostic use and treatment monitoring 
The common pathway of cell death after anti-cancer treatment is apoptosis[66] which is 
usually associated with the accumulation of lipids that can be observed using in vivo 1H 
NMR[34]. A recent study using diffusion weighted MRI (DWI) and NMR showed that 
absolute and relative changes in mobile lipids may indicate initiation of tumour shrinkage even 
when changes in tumour histopathology are still small [61]. This indicates NMR lipid signals 
can be used in the earlier detection of cell response to treatments. The combination of DWI and 
1H MRS lipid signal  in the assessment of individual treatment can help to better understand 
the variation in the relative composition of  these NMR lipids at the end of treatment [61]. In a 
spectrum of radiation-induced brain lesion, the appearance of lipid with virtually complete 
reduction in the other peaks of metabolites [67] suggesting that these lipid signals are useful 
indicators in the process of radiation treatment.  
3.1.2 NMR lipid signal in cancer research 
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Increased NMR lipid signals at 0.9ppm and 1.3ppm have been reported in many cancer cells 
and tissues[50]. NMR lipid signals have also been linked to important cellular processes, such 
as proliferation[68],malignancy[50], necrosis[37], growth arrest[69] and apoptosis[12, 70]. 
Increased lipid signals have been reported in cancer cells exposed to anti-cancer drugs or to 
anti-Fas antibodies [71]. These observations suggest that NMR lipid signals can be used as a 
tool to study intact cancer cells undergoing biological changes.  
 
As an analytical technique, NMR is also capable of revealing a detailed chemical structure of 
target molecules. Therefore, NMR lipid signal has also been used to study the  lipid profile and 
lipid species of brain tumour tissues [25] and the difference of lipid composition between 
normal and malignant human tissues [72] .  
3.2 Origin of NMR lipid signal 
NMR is increasingly used in the research and clinical practice. It is important to clarify the 
origin of these lipid signals. The main controversy once lay in whether these resonances 
originate from inter-membrane micro domains or the cytoplasmic lipid droplets [73]. There is 
increasing evidence to support the latter. 
 
The origin of these lipid signals was first thought to be from globular plasma membrane micro-
domains. An earlier study about the subcellular location of these NMR visible lipids in a 
lymphocyte cell line proposed that these lipid signals mainly came from the lipid bilayers at the 
plasma membrane [74].  It is suggested that the increased lipid signals in leukaemic cells 
compared with normal lymphocytess was due to the increase of cell membrane fluidity caused 
by the leukaemic transformation and cell differentiation [74]. Then, it was further postulated 
that these signals came from lipoprotein like structures of the cell plasma membrane [74]. The 
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work on haematopoietic K562 cells showed that a portion of NMR visible lipid structures are 
compatible with Triton resistant membrane rafts and therefore biophysically distinct from 
NMR-visible Triton-soluble lipid droplets. It was pointed out that these lipid signals may arise 
from diverse cellular lipid structures, while relative contributions could vary under different 
cell states [75]. In addition, a recent study using simulation of triglyceride-phospholipids 
model showed that the model lipid bilayer can accommodate a higher concentration of 
triglyceride. The formation of neutral lipid aggregates in the bilayer centre implicated the 
possible contributions of plasma membrane micro domains to the NMR visible mobile lipid 
signals [76]. 
 
However, more recent evidence suggests that mobile lipid droplets in the cytoplasm are likely 
to be the main source of these NMR signals [50, 77]. The resonances in the 1H NMR spectrum 
should mainly arise from the mobile acyl chains of lipid droplets , sterol esters and free fatty 
acids in the cytoplasm [50]. Accumulation of mobile lipids enriched in polyunsaturated fatty 
acid (PUFA) chains has also been reported in experimental glioma tumours undergoing 
apoptosis after in vivo gene therapy and the lipid droplets were identified as the source of these 
mobile lipids [34]. In 1993, a study on a myeloma cell line showed that the appearance of lipid 
resonances detected in 1H NMR spectra correlated with the induced formation of cytoplasmic 
lipid droplets [78]. The accumulation of cytoplasmic lipid droplets in cells undergoing 
apoptosis was reported in apoptotic cells as well, therefore the increase in the 'H NMR lipid 
signal intensity associated with apoptosis could also be because of an increase in the amount of 
fatty acids within the lipid droplets [12].  Furthermore, the increased cell membrane fluidity 
mechanism that had been used to explain these lipid signals from apoptotic cells was 
questioned by the detection of similar mobile lipid signals in non-apoptotic lymphocytes [12]. 
It was further proposed that the formation of these mobile lipids was due to the activation of 
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biochemical pathways triggered in response to cell stimulation rather than the mechanisms of 
cell degradation and the loss of cell function[12]. Another study on C6 glioma cells found that 
the behaviour of these lipid signals is paralleled by the percentage of cells containing 
epifluorescence detectable Nile Red stained cytosolic droplets. It is also suggested that the 
amount of NMR detectable mobile lipid could correlate with the cell proliferation rate [79].  
3.2.1 Mobile and immobile lipids 
NMR detection depends largely on the mobility of the detected molecules due to transverse 
relaxation rate (R2) [50]. The evaluated lipid signal is caused by not only an increased amount 
of mobile lipid content but the increased mobility of these lipids as well. In the work from 
Blankenberg et al, it is pointed out that 1H NMR methylene resonances from intact, viable 
lymphoblasts are broad and rarely observed because the acyl chains of the plasma lipid bilayer 
are relatively immobile. A decrease in plasma membrane micro-viscosity must be sufficient 
enough to increase the mobility of these lipids to give rise to the 1H NMR signal found in 
apoptotic lymphoblasts [80].  Furthermore, the loss of cytoskeletal architecture may also allow 
for the increased membrane lipids mobility [81].  
 
Cytoplasmic lipid droplets are more often regarded as mobile lipids compared with the lipids in 
the membrane raft; however, they are not floating freely in the cytoplasm but oscillating in a 
restricted area formed by several cytoskeletal structures [82].Although they are under active 
motion, their movement is in a directed manner explained by the restriction or guidance of 
these cytoskeletal structures [82]. The restriction from cytoskeletal structures becomes loose 
when the restriction area expands. Therefore, the accumulation of lipids inside these droplets 
can increase their mobility due to the expanded size. 
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3.3 NMR detectable metabolites  
NMR is a powerful tool to detect small molecular weight metabolites. NMR metabolite signals 
can be used to assess the progression of tumour cells. It was first demonstrated that NMR could 
detect metabolites in biological samples in 1974 [83]. The commonly observed metabolites 
with NMR in brain tumours [84] and their cell lines [69] are: glycerophosphocholine (GPC), 
phosphocholine (PC), choline (Cho), creatine (Cr), glycine (Gly), glutamine, glutamate, lactate 
, alanine, taurine, myo-inositol, scyllo-inositol, valine and lactate. 
3.3.1 In vivo MRS metabolite signal 
MRS is a non-invasive technique for detection of the metabolites present in a selected volume 
of a tumour or a region of interest. The metabolite signal can be used to assess a range of 
diseases and conditions, such as brain tumours [85, 86], brain injury [87, 88] and some 
neurological conditions [88, 89]. The ratio between Cho/Cr is a strong indicator of cancerous 
tissue. Cho ratios have been used to monitor treatment response [90], recurrence and radiation 
changes with radiotherapy [91]. The ratio of  N-Acetylaspartic acid (NAA)/Cho can be used to 
differentiate high and low grade gliomas [92]. Gly has been shown to be a marker for 
malignancy and tumour aggressiveness [93].  
 
3.3.2  In vitro NMR metabolite signal 
NMR has been used to detect metabolites present in cells and tissues [69, 94]. A generally 
good agreement observed between in vivo MRS and in vitro NMR on the quantities of 
metabolites in brain tumours [84] showed that in vitro NMR studies can be used to improve the 
analysis and understanding of clinical data. The investigation of metabolites in a glioblastoma 
cell line shows that NMR can be used to reveal the metabolite alteration in tumour cell death  
[69].  
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A widely studied group of metabolites in brain tumours are choline containing metabolites 
(CCMs). Decreases in PC and increases in GPC have been observed in apoptotic rat glioma 
[95]. Similarly, reduced levels of PC were detected in HSV-tk gene therapy treated BT4C 
glioma cells leading to arrest in the G2/M phase of the cell cycle [34]. In addition to CCM , a 
number of  1H MRS detectable metabolites such as taurine, glycine, alanine, succinate and 
glutamate have been observed to undergo changes in cisplatin treated apoptotic BT4C cells 
[69]. Therefore, a large number of endogenous metabolites and their alteration under treatment 
can be monitored by NMR.  
 
3.3.3 NMR in metabonomic studies  
NMR is a powerful technique in metabonomic studies [96]. Many metabolites can be 
simultaneously identified to give a metabolite profile. With appropriate statistical analysis, 
metabolite profiles can be used to analyse the metabolism, important cellular processes of 
tumour cells [69, 97]. The metabonomic approach associated with this technique has also been 
used to build tumour classifiers as a diagnostic tool [98]. 
3.4  NMR spectroscopy in biomarker identification 
A biomarker is a substance used as an indicator of biological states. Biomarkers can be used to 
identify the presence, type, grade and progress of cancers and to determine the response to 
cancer therapy [99, 100].  
 
NMR, as a quantitative and qualitative method, can be used to investigate targeted metabolites 
or lipids. A verification of their biomarker value can be undertaken by performing formal 
assignment and quantitative analysis of NMR peaks [91, 93]. The level of apoptosis induced by 
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anti-cancer drugs was reported to be associated with the increase in the signal density of NMR 
lipid peak at 1.3ppm. The NMR lipid signal was proposed to be useful in the study of  
pharmacological effects of anti-cancer drugs [101]. 
The presence of 2-hydroxyglutarate, a metabolite accumulated in glioma patients carrying a 
genetic mutation, on MRS would differentiate a tumour from a non-neoplastic lesion. It can 
serve as a prognostic marker due to the association of this mutation with improved survival 
among gliomas. Biomarkers can also be used in treatment response and follow up [102]. 
3.5 The Lipid droplet  
Same as most sub-cellular structures, lipid droplets were first observed using an electronic 
microscope around half century ago [103]. Lipid droplets are one form of macromolecular 
proteolipid assemblies that present in most of the living organisms from animals, bacteria to 
plants [73]. It the past two decades, lipid droplets have gathered increasing attention from 
scientists due to their widespread distribution and dynamic metabolic role. 
3.5.1 Structure 
The structure of lipid droplets (Figure 3.1) is unique and quite different from other sub-cellular 
structures which usually consist of one or more aqueous compartments separated by bilayer 
lipid membranes. Lipid droplets have a spherical appearance surrounded by a monolayer of 
polar lipids [104] with embedded or attached proteins that encircles a hydrophobic core of 
various species of neutral lipids [73]. The same structure can be found both intracellular and 
extracellular. However, only a few cell types, such as the epithelial cells of the small intestine 
and liver cells have the capability to secret extracellular lipoprotein droplets, whilst almost all 
cells are capable of accumulating neutral lipids and store them in cytoplasmic lipid droplets 
[73].  
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Figure 3.1 The structure of a lipid droplet (taken from project webpage of Dr. Mathias 
Beller)http://www.mpibpc.mpg.de/groups/jaeckle/pages/Project_Beller/project_Beller.html 
3.5.1.1 Lipoproteins and  lipid droplets 
For a long time, cytosolic lipid droplets have been referred to by a range of different names 
within the literature, including lipid bodies, lipid particles, lipid globules, lipid-protein particles 
and lipoproteins [73]. A similar structure in the body circulation called lipoproteins has been 
studied in lipid metabolism much earlier than lipid droplets. Lipoproteins are classified to five 
classes according to their density: chylomicrons, very low density lipoprotein (VLDL), 
intermediate density lipoprotein (IDL), low density lipoprotein (LDL) and high density 
lipoprotein (HDL). They are assembled, transported and hydrolysed by a sophisticated network 
[105]. Both lipid droplets and lipoproteins are important in the lipid transport, storage and 
mobilization; however, they have their own features particularly in their location, mobilization 
and proteome [105].   
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Several apolipoproteins and their isoforms from apo-protein family were found in a detailed 
study of the protein composition of VLDL using both two dimensional electrophoresis and 
mass spectrometry [106]. The same combined technique was also performed on HDL and it 
was shown that 56 proteins including all known apolipoprotein and lipid transport proteins 
were associated with HDL [107]. 
 
The protein species on the lipid droplets are more complicated. A relatively well studied 
member of the lipid droplet proteome is the PAT domain protein family, which is composed of 
Perilipin, adipocyte differentiation related protein (ADRP) and the 47-kDa tail interacting 
protein (TIP47). It is suggested that Perilipin and ADRP are both constitutively localized to the 
lipid droplets [108]. Perilipin controls the rate of lipolysis [109] whereas ADRP modulates the 
intracellular neutral lipid transport [110]. Caveolins, which traffic lipids from the Golgi and 
plasma membrane, are frequently found in lipid droplets as well [111]. Recently, a 
comprehensive proteomic study using mass spectrometry on purified lipid droplets from 
Chinese Hamster Ovarian K2 (CHO K2) cells identified 125 proteins and some of them were 
involved in the protein phosphorylation and Guanosine-5'-triphosphate (GTP) -mediated 
protein translocation. The proteins that regulate trafficking pathways such as Rab proteins are 
also identified [112]. In addition to lipid storage, these cytoplasmic lipid droplets were also 
found to be able to serve as transient storage depots for proteins that lack appropriate binding 
partners and provide them until they are needed. 
 
3.5.1.2 Lipid rafts and lipid droplets 
Lipid rafts and droplets are two sub-cellular structures that mainly consisted of lipids. The 
former is a liquid ordered platform that compartmentalizes membranes while the latter is a 
lipid-enriched depot served for lipid storage, transportation and other important cellular 
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activities [113].  Phospholipid bilayers can accommodate about 3% Triglyceride (TG) or 5% 
sterol esters before the neutral lipids phase separate to form spherical domains [73] and these 
structures of neutral lipids sandwiched between the bilayer leaflets are referred as membrane 
micro domains, a possible contributor to the NMR visible lipid signal [74]. The simulation of 
the lipid bilayer membrane work reported that evidence for the formation of stable, disordered, 
mobile triolein aggregates at the centre of a lipid bilayer implicated the possible relation 
between the lipid rafts and lipid droplet biogenesis [76]. The proteome and genome of lipid 
droplets links lipid droplets with membrane trafficking. This indicates an active interaction 
between lipid rafts and droplets [114]. 
3.5.2 Formation of lipid droplets 
The biogenesis of lipid droplets including the site and process is still unclear.  It is generally 
believed that lipid droplets are formed de novo rather than duplicated from existing droplets 
based on the observation that lipid droplets formed rapidly with the supply of free fatty acid 
using live cell imaging [115]. The initial event of lipid accumulation cannot be spotted due to 
the limitation of microscope resolution. However, there is evidence to suggest that lipid 
droplets are likely to originate from the endoplasmic reticulum(ER). In some electron 
microscopic images, lipid droplets were found to be connected with the ER membrane [116, 
117]. In addition, the proteins that are involved in the synthesis of neutral lipids in the lipid 
droplet core are mostly localized on the ER [118]. Several models have been proposed to the 
ER formation of lipid droplets, the most frequently cited hypothesis (Figure 3.2) is that neutral 
lipids are deposited in the membrane of the ER and segregate the two membrane leaflets by 
phase separation. Then, the neutral lipids continue to accumulate towards the cytoplasm and 
finally separate from the ER membrane and are released into the cytoplasm [73, 113]. This 
model explains the origin of the phospholipids monolayer of lipid droplets and the continuity 
observed between ER membrane and lipid droplets. A recent study using simulation also 
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confirmed the possibility of the neutral lipid accumulation in lipid bilayer membranes [76]. 
However, more direct evidence is still needed to support this theory. 
 
Figure 3.2 The current model of endoplasmic reticulum(ER) formation of lipid droplets. a) 
Neutral lipids are synthesized between the leaflets of the ER membrane. b) The LD then bud 
from the ER membrane and c) matured with a monolayer of phospholipids and associated 
proteins [113]. 
 
There is other data that suggests that lipid droplet biogenesis or growth might occur at the 
plasma membrane. Lipid droplets were found to be formed from plasma membrane in some 
gram-negative prokaryotes [119]. Furthermore, the PAT proteins which are integral to the 
plasma membrane are found to be associated with lipid droplets [117] and caveolae, another 
important protein that mainly located in the plasma membrane has been implicated in the lipid 
droplet formation in adipocytes [120]. 
 
How neutral lipids are packaged into cytosolic droplets remains poorly understood. However, 
with the development of photometric technique, many proteins of the lipid droplets have been 
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identified and it is further suggested that they are the main controllers of the growth of nascent 
lipid droplets [41]. The observation that the majority of triglyceride in droplets is coated with 
the proteins from the PAT family [121] indicated that the PAT protein family actually order the 
neutral lipids packaging by managing the droplet interface with the cytosol.  
3.5.3 Biological function of lipid droplets 
Recent studies revealed that other than simply lipid inclusions, lipid droplets are dynamic 
intracellular organelles with multiple cellular functions [113, 114]. Lipid droplets have been 
involved in cell signalling, lipid metabolism, membrane trafficking and other important cellular 
processes such as cell proliferation, apoptosis and necrosis [59, 113, 122]. For instance, a 
recent study using ribonucleic acid interference (RNAi) screen in Drosophila identified 
hundreds of genes involved in lipid-droplet formation and utilization and potentially link 
diverse processes, such as protein synthesis and the cell cycle with lipid-droplet biology [123]. 
These findings indicate that lipid droplets are active cellular organelles that are vital to  cell 
growth and cell death. 
  
3.5.3.1 Lipid storage 
Traditionally, lipid droplets are viewed as specialized structures to store triacylglycerols, sterol 
esters and other neutral lipids. There are 44% triacylglycerol, 34% cholesterol esters and 20% 
other neural lipids stored in LDs of CHO K2 cells [112], and therefore it is widely accepted 
that lipid droplets are essential reservoirs of metabolic energy and lipids. Later, free fatty acids 
have been found in these lipid droplets [73] and it was proposed that in most cell types other 
than adipocytes, the main function of lipid droplets is to collect these free fatty acids exerted by 
cellular metabolism via triglyceride accumulation to avoid lipotoxic effects caused by these 
free fatty acids [124]. A lipidomic study on CHO K2 cells by Bartz et al. revealed that although 
lipid droplets contain only 1-2% phospholipids by weight, over 160 species were identified and 
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quantified. Phosphatidylcholine was the most abundant class and compared with total 
membrane, the phospholipids were enriched in lysophospholipids [112]. These results 
indicated that lipid droplets may function as a supply depot for the phospholipid biosynthesis 
and play an important role in phospholipid recycling [112]. 
 
3.5.3.2 Interaction with other organelles 
The evidence that lipid droplets interact with various organelles is extensive. The interaction 
between lipid droplets and ER is of much importance since ER is the most probable site for the 
biogenesis of lipid droplets [125]. However, some studies suggest there are regulated 
interactions between them other than the lipid droplet formation. In macrophages loaded with 
cholesterol and cholesterol esters, ER whorls were found to be embedded in the lipid droplets 
and the esterase that regulates cholesterol ester and cholesterol was located on the ER whorls 
[126].  
 
Using electron microscopic imaging, the association between lipid droplets and mitochondria 
has been identified [127]. The co-localization of lipid droplets and mitochondria in  skeletal 
muscle cells further supports their association [128]. Recent work using both electron and 
confocal microscopy demonstrated that lipid droplets could form complexes with mitochondria 
in NIH 3T3 fibroblasts. The presence of lipid droplet markers in isolated mitochondria was 
reported [129]. The fact that fatty acid oxidation occurs in mitochondria in mammalian cells 
suggests that lipid droplets are possibly one of the lipid suppliers for the beta oxidation in 
mitochondria. 
 
The members of Rab protein family which were frequently identified in the lipid droplet 
proteome [114] strongly support the interaction of lipid droplets with other intracellular 
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organelles since Rab proteins recruit a variety of functional proteins to mediate vesicle motility, 
docking and fusion to the target membranes [130]. For example, the work carried out by Liu et 
al. indicated a role for Rab5 protein in the association of lipid droplets with early endosomes 
[114]. Rab18, as a component of LDss induce  apposition of LDs to the ER [104].  Therefore, 
the current hypothesis is that each Rab specie on lipid droplets regulates interaction with a 
specific membrane system. 
 
3.5.3.3 Cellular signalling 
Cell signalling is part of a complex system of communication that governs basic cellular 
activities and coordinates cell actions. Although lipids may not be the direct actors to catalyze 
reactions, they can participate in cellular activities as mediators. Especially for fatty acids, they  
not only served as signalling molecules themselves but also  as precursors of the synthesis of 
other signalling lipids [131]. Signalling lipids, including eicosanoids, phosphoinositides, 
sphingolipids and fatty acids, control important cellular processes such as cell proliferation, 
apoptosis, metabolism and migration [131, 132]. Lipid droplets are expected to be involved in 
these activities since they naturally contain some groups of signalling lipids. Further evidence 
now shows that lipid droplets have been involved in the synthesis of eicosaniods [133] which 
are arachidonic acid-derived signalling lipids. Well P.F. et al. demonstrated that arachidonate is 
incorporated and etherified prominently in lipid droplets in leukocytes [134]. In addition, a 
recent proteomic study suggested that lipid droplets governs lipid homeostasis and intracellular 
trafficking through protein phophorylation and GTP-regulated protein translocation [112]. 
These studies further support the active role of lipid droplets in cellular signalling. 
3.5.4 Lipid droplets in tumours 
Initially, attention was drawn into lipid droplet research from the observation of excess lipid 
accumulation in some of the most widespread human diseases, such as atherosclerosis, diabetes 
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and obesity. Recently there is increasing evidence  that lipid droplets are also implicated in 
other important pathologies such as inflammation [134], virus infections [135] and particularly 
in  malignancy [136].  
 
The association between lipid droplets and tumours are largely emphasised by the 1H NMR, a 
powerful technique to detect mobile lipids. The NMR lipid signal which is thought to mainly 
rise from cytoplasmic lipid droplets is observed frequently in cancer cells [50, 59, 74, 137]. 
These lipid resonances have been more frequently observed in brain tumour patients 
implicating the association between NMR lipid signals and tumours [50]. An increased 
numbers of lipid droplets in human colon adenocarcinoma compared with the adjacent normal 
tissue was observed [138]. These data suggest that the increase of either the number or size of 
lipid droplets is a common feature in many malignant cells and tissues. It is also pointed out 
that the accumulation of lipid droplets occurring in cancers is more likely because of active cell 
proliferation or necrosis [37, 50].  
 
Some proteins known to be involved in cell transformation, tumourigenesis and metastasis 
such as PI3K, ERK1, ERK2, P38 ,P22 are found to localize in lipid droplets from various cells 
[114, 139, 140], which implicates the relationship of lipid droplets with tumour development. 
Another study demonstrated that lipid droplets were centrally involved in prostaglandin E2 
synthesis in colon cancer cells indicating the potential involvement of lipid droplets in the 
pathogenesis of colon andenocarcinoma [138]. 
3.5.5 Lipid droplet alterations with cancer treatment 
The observation of NMR visible lipid signals in drug-induced apoptotic cells [81, 141] 
suggests there is an alteration of lipid metabolism in lipid droplets during drug treatment. The 
accumulation of cytoplasmic lipid droplets was demonstrated using microscopic and flow 
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cytometric measurements in both murine lymphoma cells and animal tumour models 
undergoing etoposide induced apoptosis [141]. The similar accumulation of lipid droplets was 
reported by Massimo et al. in apoptotic T lymphoblastoid cells and they proposed that this 
process happened during an early and biochemically active phase of programmed cell death 
[12]. The increase of NMR lipid signal in a human prostatic carcinoma cells treated with 
differentiating agent phenylacetate suggests that lipid droplet accumulation can also be induced 
in cell growth arrest rather than cell death [142]. 
 
There are also studies indicating the lipid content alteration in lipid droplets with treatment. For 
example, polyunsaturated fatty acid accumulation (PUFA) in lipid droplets was observed in 
glioma cells with gene therapy [34].  
3.5.6 Microtubular system in cytoplasm 
Lipid droplets participate in various intracellular processes in various locations with the 
assistance of cytoskeletal polymers (Figure 3.3), also called the microtubules or the 
intermediate filaments [73]. It was firstly observed that the intermediate filament proteins, 
particularly vimentin, appeared to form cage-like structures around the small lipid droplets in 
newly differentiating 3T3-L1 cells [143]. Live cell imaging in cultured mammal cells showed 
that most droplets were oscillating in a restricted area and move in a directed manner along 
these fibrous network [41]. It is proposed that lipid droplets might be associated with various 
cytoskeletal elements in different cell types and these cytoskeleton related proteins might serve 
the role to protect lipid droplets from lipolysis and tether them to the general cytoskeleton 
network [73]. 
 
It is demonstrated in Bostrom et al’s study of NIH 3T3 cells that the growth of lipid droplets is 
independent of triglyceride biosynthesis but involves the formation of microtubule dependent 
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complexes [120]. Although these cytoskeleton networks are an indispensable part in the growth, 
split and motion of lipid droplets, the components and the mechanism of their regulation of 
lipid droplets remain partially understood.   
  
Figure 3.3 Examples of LDs with microtubule system in mammals (A-F), fish (G), insects (H, 
I) and fungi (J) [144]. LDs are shown in yellow. (A) most droplets are oscillating in a 
restricted area (left). Some droplets move in a directed manner along microtubules (right). 
(B) Chlamydia (pink) induces translocation of LDs from the cytoplasm of the host cell into 
the parasitophorous vacuole. (C) Expression of hepatitis C core protein causes droplets to 
accumulate at the microtubule-organizing centre. (D) In mammary-gland epithelial cells, LDs 
arise throughout the cell. Droplets transit from basal to apical regions; this redistribution is 
accompanied by a size increase. (E) During droplet biogenesis, nascent droplets can increase 
in size by dynein-mediated fusion. (F) On hormonal stimulation of adipocytes to induce 
lipolysis, lipid droplets fragment and disperse throughout the cell. (G) In fish eggs, LDs are 
initially distributed evenly and, after fertilization, accumulate at the vegetal pole. (H) In 
Drosophila ovaries, droplets arise in nurse cells and are transferred by actin-based 
cytoplasmic streaming to the oocyte. Microtubule-based streaming (right) mixes the contents 
of the oocyte. (I) In Drosophila embryos, LDs move along microtubules, pulled by 
alternatively active motors (right). (J) In arbuscular mycorrhizal fungi, lipid droplets spread 
from their sites of origin near the plant roots (left) throughout the hyphae. Droplet motion 
occurs in both directions, but is biased to cause net transport towards the growing tips. 
 
3.5.7 Isolation of lipid droplets from cell lines 
Lipid droplets have a low buoyant density because of their high lipid content; therefore 
gradient centrifuge is a suitable method of purifying them from the cytoplasm and from other 
organelles [82] and an important feature of using this method is the low contamination which 
was reported by many published results [82, 115, 137, 140]. The isolation of lipid droplets was 
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performed by Hood et al. on bovine mammary tissues using grinders as early as 1973 [145]. 
Various approaches of disrupting tissues and cells were  evaluated and the main issue was the 
low yield of lipid droplets due to the incomplete cell disruption and cellular damage [145].  
In1991, Weller’s group successfully isolated the cytoplasmic lipid droplets of human blood 
cells using gradient ultracentrifuge. In this work, nitrogen cavitation followed by 
deoxyribonuclease (DNase) treatment was chosen for cell disruption to optimise the lipid 
droplet release and recovery [146]. In 1998, Yu et al. got a satisfactory isolation of lipid 
droplets by the use of tight-fitting Dounce homogenizer and illustrated that a reasonable yield 
of isolated lipid droplets could be achieved just by the use of grinders with an appropriate 
clearance [137]. In this process, after the ultracentrifuge, the sample was separated into four 
fractions, Lipid droplet, Mid-zone, Cytosol and Pellet. All four fractions were subjected to the 
protein distribution and enzyme specific activity analysis and the lipid droplet enriched fraction 
was found to be essentially free of cytosolic and microsomal contamination [137]. 
3.6 Aims and objectives 
The aims of this research are to investigate cytoplasmic lipid droplets as the origin of NMR 
detectable lipids in nervous system tumour cell lines, determine how these droplets and their 
NMR signal alter with treatment and identify potential lipids/ metabolites as biomarkers in 
cancer cell death.Objectives 
The research was planned into five steps to achieve the main purpose: 
1. To isolate lipid droplets from cell lines and determine the composition of the LDs using 
NMR and MS.  
In chapter 5, BE(2)M17, a human neuroblastoma cell line, with the biggest LDs among the 
five tumour cell lines was chosen to optimise and validate the isolation protocol. NMR spectra 
from whole cells, the isolated fraction containing the LDs and their extracts were acquired to 
  
 
44 
 
characterize the LDs in BE(2)M17 cells. A more detailed chemical analysis on LD extracts was 
performed by MS. 
 
2. To investigate the correlation between LD size and NMR lipid signal intensity. 
 In chapter 6, Nile red staining was performed on whole cells to assess the size of LDs in five 
nervous system tumour cell lines. NMR was performed to investigate the visibility and signal 
intensity of NMR lipid signal. Statistics analysis was performed to investigate the correlation 
between LD size and NMR lipid signal intensity. 
3. To compare LD lipid composition with whole cell lipids using NMR for a range of cancer 
cell lines.  
In chapter 7, 1H NMR was performed on lipid extracts of whole cells and isolated LDs for five 
tumour cell lines to investigate the difference in lipid composition between whole cells and 
LDs.  
 
4. To establish the alterations which occur in the LDs when the tumours are treated with drug. 
In chapter 8, two brain tumour cells were treated with cisplatin, a deoxyribonucleic acid 
(DNA) damaging agent, which is known to be a key drug in treating medulloblastoma and 
primitive neuro-ectodermal tumours. LD accumulation was monitored by Nile red staining. 1H 
NMR was performed on isolated LDs, whole cell pellets and their extracts to investigate the 
alteration of LDs with cisplatin treatment. 
 
5. To identify other NMR detectable biomarkers for early treatment response of drug exposure, 
which may be related to LDs. 
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In chapter 9, 1H NMR metabolite profiles of two glioma and two neural tumour cell lines were 
examined to identify early markers for treatment response. Cell nuclei staining and RNA 
laddering was performed to assess the cell death/apoptosis. 
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Chapter 4 Materials and methods 
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4.1 Nervous system tumour cells 
Five nervous system tumour cells are investigated in this study: BE(2)M17, a human 
neuroblastoma cell line; BT4C, a rat glioblastoma cell line; U87-MG, a human glioblastoma 
cell line; PFSK-1, a human supratentorial primitive neuroectodermal tumour (ST-PNET) cell 
line; DAOY, a human medulloblastoma cell line. 
 
4.1.1 Cell culture 
Cells were grown in 25cm2 or 75 cm2 flasks with filter-vented caps (IWAKI, UK and Corning, 
UK) and maintained in 15-20ml Dulbecco’s modified Eagles medium (DMEM F:12, 
Invitrogen, UK) supplemented with 1% 200mM L-glutamine (100x) (Invitrogen, UK ), 10% 
(v/v) fetal calf serum (PAA, UK) and 1% minimum essential medium (MEM) non-essential 
amino acid solution (100x) (Sigma Aldrich, Dorset, UK). Cells were incubated at 370C in a 
humidified atmosphere with 5% CO2 and 95% air. Cells were seeded at approximately 1-
2x105/ml and were usually passaged on day 2 of culture at around 90% confluence. 
 
The detachment of cells was performed as follows: The culture medium was removed using 
sterile plastic pipettes. Cells were then washed with 5-6ml autoclaved phosphate buffered 
saline (Dulbecco’s A PBS, Sigma Aldrich, UK). After the removal of PBS, 1ml accutase 
solution (PAA, UK) was added in and the flask was placed in the incubator for 1-5 minutes 
until cells were lifted off from the flask surface. 
 
After the detachment, 10ml culture media was added in to stop the action of accutase and form 
a single cell suspension with gentle pipetting. Suitable number of cells, usually 1 to 3 ml of the 
cell suspension containing approximately 2x106 cells were transferred to a new flask and 
refilled with 15-20ml of culture medium.  
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4.1.2 Cell counting 
After the cells were detached from the flask, one drop (~20 μl) of the cell suspension in 
PBS/medium was added to the chamber of a Neubauer haemocytometer (Ruling 1/400 mm2, 
cell depth 0.1 mm+1%; Hawksley, UK) by a sterile plastic transfer pipette. The cells were then 
counted under a Nikon TMS microscope (Nikon Instruments Europe B.V., UK) with the 40 x 
magnification lens. 
 
4.1.3 Cisplatin treatment of cancer cell lines 
Cisplatin (cis-dichlorodiammineplatinum II) was used to treat the cells. 100 mg of this drug 
was purchased from Sigma-Aldrich, UK (P4394) in a yellow coloured powder form.  
2mM cisplatin stock solution was made with DMEM F:12 solution. Cisplatin powder was 
dissolved in DMEM and vortexed intensely with a whirler to ensure it was completely 
dissolved. 60-500µl aliquots of the stock solution were put in autoclaved eppendorf tubes and 
stored in -800C freezer under dark conditions. 
 
Cells were exposed to cisplatin for the indicated times. On the day of treatment, the required 
amount of cisplatin stock solution was thawed and diluted to a concentration of 0.1, 1, 10 or 
100µM in complete DMEM medium. 
 
Cells were incubated overnight to achieve a suitable confluence, usually 70%-90% and the 
cells were washed with PBS. Freshly made culture medium with cisplatin at a working 
concentration was added into the cells and was further incubated for the indicated treatment 
time in the same condition as regular cell culture. 
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4.1.4 Cell harvest 
Untreated cells were harvested at 80-95% confluence. Cisplatin treated cells and the untreated 
control cells were harvested at the indicated time point with a slightly different washing 
procedure and centrifuge speed in order to collect the dead cells. 
 
4.1.4.1 Cell pellets for isolation, extraction and NMR investigation 
After washing with 10ml ice-cold phosphate buffered saline, PBS (Invitrogen Ltd., Paisley, 
UK) three times, cells were then removed from the flask using a manual scraper and 
centrifuged at 250g for 6min to form a pellet. Cisplatin treated cells and control cells were 
scraped down directly into the medium and then washed with 10ml ice-cold PBS two times 
with centrifuge at 720g for 3 min. 1ml ice-cold PBS was used for a third time wash and the cell 
suspension was transferred into a 1ml CryoTubes™ (Nunc, Thermo Scientific, UK) with the 
centrifuge at 720g for 3min. Samples to be investigated with NMR and subjected to extraction 
and isolation were snap-frozen in liquid nitrogen and stored in the -800C freezer to minimize 
the degradation.  
 
4.1.4.2 Cell suspension for staining 
The procedure for cell scraping and washing was similar to the pellet preparation. After the 
wash, cell number was counted and adjusted to 3-5x105/ml with ice-cold PBS. Cells were 
stained or spun onto the slides right after the harvest as described in section 4.2. 
4.2 Lipid droplets visualization 
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Both extracellular and intracellular lipid droplets were assessed using different staining and 
microscopic methods. 
4.2.1  Slides preparation 
For whole cell samples, Shandon cytospin 3 (Shandon, Thermo Scientific, UK) was used to 
separate and place a monolayer of the cells on slides while preserving their integrity. The slides 
were assembled with filter cards (Shandon, Thermo Scientific, UK) and cytofunnel sample 
chambers (Shandon, Thermo, Scientific, UK). They were then placed in cytoclips (Shandon, 
Thermo, Scientific, UK). 100μl of cell suspension containing 3-5x104 cells was placed in each 
cyto-funnel. The samples were then spun at 2000 rpm for 5 minutes at room temperature and 
dried for at least 20min before staining. For the isolated fraction, an aliquot around 10µl was 
dropped onto the slide and dried from at least 2 hours to overnight at room temperature. 
4.2.2 Fluorescent microscopy 
4.2.2.1 Nile red staining 
Prepared slides were stained with 4µg/ml Nile red in PBS (made from 1mg/ml Nile red stock 
solution in acetone, Sigma-Aldrich, Dorset, UK) for about 15 min under dark conditions. The 
whole cell sample was usually followed with a DAPI staining. After the removal of staining 
solution, a drop of 10µl anti-quenching mounting medium (Vector Laboratories Inc, CA) was 
placed on the sample and covered with a 22x22mm cover slip.  
 
4.2.2.2 Observation and fluorescent image capture 
The slides were visualized with a Nikon Eclipse E600 microscope using 100X objective lens 
and images were taken using a DXM1200 Nikon digital camera. The green fluoresce of Nile 
red was observed with FITC (B-2A) filter set, with excitation wave length of 465-495 nm and 
emission wave length of 550nm. 
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4.2.3 Light microscopy 
4.2.3.1 Oil red O staining 
Saturated Oil Red O (MERCK KGaA, Darmstadt, Germany) in 70% ethanol was applied to the 
slides for 20 min, and then washed in running water. After haematoxylin staining, slides were 
mounted with aqueous mounting medium and dried on a 370C heater for 2 hours. 
 
Slides were observed with a Nikon Eclipse E600 under 100X oil objective lens using visual 
light source. Pictures were taken by a DXM1200F digital camera attached to the microscope. 
 
4.2.4 Transmission electron microscopy (TEM) 
4.2.4.1 Negative staining  
The isolated fraction was dropped onto a 300 mesh copper electron microscopy grid with 
formvar coating. A 2% aqueous uranyl acetate solution was applied to the sample for 1 min. 
 
4.2.4.2 TEM observation and image capture 
After the negative staining, the grid with isolated LDs was observed using JEOL 1200EX TEM 
(Jeol Ltd, Tokyo, Japan) with 120K amplification and images were captured with the camera 
attached. 
 
4.2.5 Post-processing for stained LD images  
LD sizes were measured using the image analysis program ImageJ (National Institute of 
Health, USA) (Figure 4.1) and presented as mean value ± standard deviation. The diameter of 
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all the LDs inside one cell was measured. The total LD volume of one cell was estimated with 
the sum of the volume for each LD. The resolution limit of light microscopy is 200 nm. An 
Inter Pixel Stepping (IPS) technique was used by the camera (DXM1200 digital camera, 
Nikon) and ACT-1 software to increase the resolution of captured images by a factor of 9. 
 
 
Figure 4.1 Image J 1.41O platform for image measurements. The diameter of a lipid droplet 
is measured by drawing a line across the droplet and measuring the length of the line.  
4.3  Lipid droplets isolation  
 
A protocol developed by Weller et al. was used to isolate LDs [121, 140, 146]. In order to 
minimise the enzyme activity and component degradation, the whole process was performed 
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with as low a temperature (40C) as possible and all the solution used was ice-cold prior to use. 
At least three independent samples were prepared for each isolation. 
  
4.3.1 Homogenous preparation 
Approximately 40-60 million cells were taken out from -800C freezer, thawed at room 
temperature and ground in either 600µl deionised water or D2O with a glass grinder (Sigma, 
UK). The homogenate was transferred into an eppendorf tube and centrifuged at 2000g at 40C 
for 10 min. 
4.3.2 Sucrose-gradient ultracentrifuge 
The supernatant after the first centrifuge was adjusted to 18.46% sucrose [140] by adding 1:4 
(v:v) of 2.16M sucrose, topped with the same volume (600µl) as the sucrose fraction of 
deionised water or D2O and centrifuged at 142,000g for 90min at 4
0C (Optima MAX 
Ultracentrifuge, Beckman, Rotor TLA55, USA).Fraction collection 
 
After ultracentrifugation, the sample was separated into three fractions, the upper isolated 
fraction, the middle sucrose fraction and the pellet. The isolated fraction was collected for 
extraction and subsequent NMR analyses. In order to control sucrose contamination, only the 
top 300µl was collected for direct NMR experiment and top 450-500 µl was collected for lipid 
extraction. 
4.4  Gel electrophoresis of extracted protein from 
different fractions after isolation 
 
An experiment was performed to investigate the protein concentrations present in the fractions 
after gradient centrifugation. 
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4.4.1 Protein extraction and measurement of concentration 
The CytoBuster™ Protein Extraction Reagent (Novagen, UK) with complete proteinase 
inhibitor (Roche Diagnostics GmbH, Germany) was used to extract the protein from different 
fractions. Extraction reagent was added into each fraction at 4:1 (v/v), incubated on ice for 
10min and centrifuged for 5 min at 16,000 × g at 4°C. The supernatant containing soluble 
protein were transferred to a new eppendorf tube. 
4.4.2 Measurement of total protein concentration 
The concentration of total protein in each fraction was measured with the Bio-rad Protein 
Assay following the manufacturer’s instruction (Bio-Rad, USA). 
 
Five dilutions of bovine serum albumin (BSA) from 0.1 to 0.5mg/ml and a blank control were 
prepared as standards to represent protein concentration. 10µl of each standard and sample 
solution was pipetted into a flat-bottomed 96 well plate in a duplicate manner. 200ul of 1 x 
working solution containing protein-binding dye reagent (Bio-Rad, USA) was added into each 
well. Sample was mixed by pipetting at least 3 times while adding the working solution. The 
plate was incubated at room temperature for 5 min before the reading. The absorbance at 595 
nm was measured with a micro-plate reader (Bio-Rad, Model 680, USA). A linear standard 
curve (Figure4.2) was produced using the absorbance of standard BSA and the concentration 
of sample solution was calculated accordingly.  
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Figure 4.2 The standard curve of BSA the Bio-rad Protein Assay 
4.4.3 SDS-PAGE gel electrophoresis  
30µg proteins of each sample (3.5-10µl) were loaded on an 8%-12% sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) gel except for the isolated fraction, which 
was loaded at a maximum volume (40µl). After 100 min electrophoresis at 120V, gel was 
stained with the Coomassie Blue. 
4.4.4 Coomassie blue staining 
Coomassie blue staining solution was made up with 1.25g Coomassie blue, 250ml Methanol, 
25ml Acetic acid and the deionized water to a total volume at 550ml. The Coomassie de-stain 
solution was made up with 300ml Methanol, 100ml Acetic acid and deionized water to a total 
volume of 1 liter. After electrophoresis, the gel was washed with deionized water and stained 
with Coomassie blue staining solution for 20min. After the staining, the gel was put into the 
de-stain solution from 4h to overnight until the clear protein band showed up. Images were 
taken under UV light using a digital camera (Syngene, UK). 
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4.5  Lipid and metabolite extraction from cell pellets and 
isolated fraction  
 
A dual phased methanol-chloroform extraction protocol was used to prepare the metabolite and 
lipid extracts for NMR analysis [39]. At least three independent preparations were used for 
isolation and extraction. 
4.5.1 Homogenate preparation in methanol and deionised water  
Cell pellets were taken out from the -800C freezer prior to the extraction and thawed at room 
temperature. 400µl ice-cold methanol and 85µl ice-cold deionised water were added into 10-
20million cells. The mixture was then ground using a 2ml glass grinder (Sigma, UK). The 
homogenate was transferred to a 1.5ml eppendorf tube and sonicated 10 to 15s on ice using an 
ultrasonic cell disruptor (Misonix). 
 
4.5.2 Partition of sonicated homogenate on ice  
200 µl deionised water (ice cold) and 200 µl chloroform (ice cold) was added into the 
sonicated homogenate. The mixture was vortexed at high speed for 10~20 seconds and shaken 
at 20rpm for 20 minutes. The sample was then centrifuged at 2000g for 5 minutes at 4 0C. 
After the centrifugation, the homogenate was separated into three phases due to the relative 
density, the upper aqueous phase, the middle precipitated protein phase and the bottom 
chloroform phase. The upper water phage and the lower chloroform phase was transferred into 
new eppendorf tubes and extracted again with 200µl chloroform. The upper aqueous phase and 
lower chloroform phase was collected after the second extraction.  
4.5.3 Vacuum centrifugation 
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The aqueous phase was dried with a vacuum centrifuge (Eppendorf Concentrator 5301, 
Germany) for 3 hours to overnight. The lower chloroform phase was collected and dried 
overnight in a fume hood.   
4.6 Cell Viability assessment 
 
4.6.1 Alamar blue assay 
Alamar blue assay to analysis of cell proliferation and cytotoxicity was performed on cancer 
cells according to the standard protocol from the manufacturer (AbD Serotec, UK) as follows. 
 
4.6.1.1 Cell growth curve   
To determine the proper cell number for seeding, the cell growth curve assay was performed 
on each cell line as a pre-test for Alamar blue assay. Cells were seeded in the 96-well plate at a 
density ranging from 5000 to 40000/well and the cell number was counted as described in 4.1.2  
at the indicated times (24h, 48h, 72h, 96h,120h). The proper cell density, which allows the 
cells to have an exponential growth two days after seeding, was chosen. 1x104 for DAOY, 
BT4C, PFSK-1, U87-MG and 2x104 for BE(2)M17 cells (Figure 4.3). 
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Figure 4.3 The growth curve of BE(2)M17 cells to assess the proper seeding density. 
4.6.1.2 Cisplatin treatment and cell incubation 
Cells were seeded in flat-bottomed IWAKI 96-well culture plates at a density of 1-
2x104cells/well and cultured for 24h for a 50~70% confluent. Cisplatin at the indicated 
concentration was added into each well and no cisplatin was added into control cells. The 
plates were incubated at 37°C and 5% CO2 for 48h. 10 µl of Alamar Blue (AbD Serotec, UK) 
was then added to each well and the plates were incubated for another 2h before measurement. 
 
4.6.1.3 Fluorescence measurement and calculation 
The fluorescence intensity was measured using a Victor 1402 multilabel counter (Wallac) with 
an excitation wave length of 550 nm and an emission wavelength of 590 nm using a one-
second scan. The cell survival rate (the percentage difference between treated and control cells) 
was calculated with the amount of fluorescence according to the following equation where FI 
590 = Fluorescent Intensity at 590nm emission (550nm excitation). 
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4.6.2 DAPI staining 
Cells were spun and stained with 0.4ug/ml 4',6-diamidino-2-phenylindole (DAPI, a fluorescent 
stain that binds strongly to A-T rich regions in DNA) for 15 min. The slides were visualized 
with a Nikon Eclipse E600 microscope using 100X objective lens and images were taken using 
a DXM1200 digital camera. DAPI UV (UV-2A) filter with excitation wavelength of 340- 380 
nm was used to detect DAPI stained nuclei. In this study, DAPI staining is performed 
immediately after the Nile red staining. 
4.6.3 RNA fragmentation 
RNA degradation was assessed with gel electrophoresis of total RNA extracted from cisplatin 
untreated and treated cells.   
 
4.6.3.1 RNA extraction 
To extract the total RNA from cells, 2.5ml TRIzol Reagent (Invitrogen, UK) was added into 
one 25cm2 flask with cells ready to harvest. 500µl chloroform was added to each cell lysate to 
achieve phase separation. The upper aqueous phase with RNA was transferred into a fresh tube 
and the RNA was precipitated with 1.25ml 3 ml 100% isopropanol (Sigma-Aldrich, UK). After 
being washed twice with 75% ethanol, RNA was dissolved in 30µl RNAse-free solution. 
 
4.6.3.2 Agarose gel electrophoresis 
1% agarose gel (Invitrogen, UK) was made in 0.5 x Tris/Borate/ Ethylenediaminetetraacetic 
acid (TBE) solution containing (2x105 : 1) ethidium bromide (10 mg/ml). The gel was placed 
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on a plastic tray in an electrophoresis tank and submerged just beneath 0.5 x TBE. 1µg of 1Kb 
plus DNA Ladder (invitrogen, UK) and 10µg RNA of each sample was added on the 1% 
agarose gel and electrophoresized at 120V for 90min. The RNA fragments were observed 
under ultraviolet light. 
4.7   Nuclear Magnetic Resonance 
4.7.1 Sample preparation for liquid state 1H NMR  
Metabolite extracts were re-suspended in 600µl deuterated water and 5µl 10mM 
trimethylsilylproprionate d4 (TMS) (Sigma Aldrich, UK) resonating at 0ppm was added as a 
chemical reference[147]. Lipid extracts were re-suspended in 600µl deuterated chloroform 
containing 0.03 % (v/v) TMS (Sigma Aldrich, UK). All the liquid state samples were tested 
with Norell s600 NMR tubes (Norell, USA).  
 
4.7.2 Sample preparation for HR-MAS  
Prior to HR-MAS, frozen cells were defrosted at room temperature.  36µl of cell pellets, 
containing approximately 5-10 x 106 cells, were pipetted into a wide-mouthed zirconium oxide 
sample tube (Varian Inc, Palo Alto, CA, USA) with a transferpette (Brand, German). 4 µL 10 
mmol/L TMS in D2O was added as a chemical shift standard. To prepare the samples for the 
HR-MAS probe (Bruker), 45µl cell pellets and 5 µL 50 mmol/L TMS in D2O was pipetted into 
a 50μl rotor (Bruker, German). 
 
4.7.3 Performing NMR spectroscopy 
A Varian 600 spectrometer with a HCN probe and a nano-probe and a Bruker 500 spectrometer 
(Figure 4.2) with a cryo-probe and a HR-MAS probe were used in this study.  
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Figure 4.4 A Varian 600 MHz spectrometer (left) and a Bruker DRX 500MHz spectrometer 
(right) at the Henry Wellcome Building for Biomolecular NMR Spectroscopy, The 
University of Birmingham.    
 
4.7.3.1 Liquid-state 1H NMR with HCN probe 
1H NMR spectra of cell extracts and the isolated LDs suspended in D2O were recorded on a 
Varian 600-MHz (14.1 T) vertical bore spectrometer using a proton, nitrogen, carbon (HCN) 
probe. The probe temperature was set to 200C. Tuning and matching and was optimized for 
each sample. Presaturation pulse frequency was optimized by adjusting the transmitter offset. 
A standard pulse and acquire sequence was used which consisted of a single 900 pulse 
preceded by one second of water presaturation. The acquisition was of 16K complex points at a 
sampling frequency of 7200Hz. Usually 256 scans were used for both metabolite and lipid 
extracts and 1024 scans were used for isolated fraction samples. At least three independent 
samples was used. 
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4.7.3.2 HR-MAS  
HR-MAS for untreated cells was performed on a Varian 600-MHz (14.1 T) vertical bore 
spectrometer using a 4-mm gHX nanoprobe (Varian NMR Inc) with a three channel Inova 
console running VNMRj software. The probe temperature was set to 0.10C, which equated to a 
temperature inside the rotor of 6.7 0C determined by calibration using methanol[148] with a 
rotor speed of 2500 Hz. Shims were optimised at the beginning of the day using a solution of 
95% acetone d-6 and 5% chloroform. Shimming for each sample was optimised using the 
largest metabolite peak in the sample. Tuning and matching and presaturation pulse frequency 
was optimized for each sample. The pulse sequence consisted of a single 900 pulse with a one 
second duration water presaturation pulse. The receiver bandwidth was 7200 Hz with 16K 
complex points in the free induction decay. A total of 256 scans were acquired with a repetition 
time of 3.3 s giving a 14-min acquisition time. Spectra were manually phased, referenced to 
TMS at 0ppm. 
 
HR-MAS for cisplatin treated and control cell pellets were performed on Bruker 500-MHz 
(11.75T) spectrometer using a HR-MAS probe (Bruker German). The probe temperature was 
set to 2780K (equal to 50C). The rotor speed was 4800 Hz in all experiments. A same pulse-
acquire sequence incorporating one second water presaturation pulse was used. At least three 
independent samples was used. 
 
4.7.3.3 HSQC (1H and 13C) 
A phase-sensitive gradient enhanced 2D 1H-13C HSQC, similar to the protocol developed by 
Tesiram et al.[54], was performed on the cell extracts on a Bruker DRX 500MHz spectrometer 
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using a cryoprobe at 250C. 1D NMR spectra are plots of intensity vs. frequency. In two-
dimensional spectroscopy intensity is plotted as a function of two frequencies, usually called 
F1 and F2. 1024 points were acquired in F2 for 256 increments in F1 with spectral widths of 
13ppm and 166ppm respectively.  128 to 144 averages were performed resulting in a total 
experiment time of approximately 14 to 17 hours. Data was zero-filled to twice the original 
length and multiplied by a sine function prior to Fourier transformation. 
 
4.7.3.4 TOCSY  
A 2D TOCSY as described[54] was performed on a Bruker DRX 500MHz spectrometer using 
a cryoprobe at 250C. 2048 points were acquired in F2 for 256 increments in F1 with spectral 
widths of 12ppm and 12ppm respectively.  8 to 32 averages were performed resulting in a total 
experiment time of approximately 2 to 5 hours. Data was zero-filled to twice the original 
length and multiplied by a sine function prior to Fourier transformation. 
 
4.7.4 Spectra post-process and analysis 
The raw free induction decay (FID)  was Fourier transformed, manually phased and referenced 
to creatine at 3.03ppm for HR-MAS spectra and to TMS at 0ppm for the spectra of cell 
extracts. The signal intensity of spectra acquired from lipid extracts were measured using line-
fitting and integration function provided by wxNUTS (Acron NMR Ltd, CA) in Chapter 7 and 
8. Totally Automatic Robust Quantitation in NMR (TARQUIN) algorithm[149] was used in 
the analysis of HR-MAS spectra of untreated cells in Chapter 6. An algorithm designed with R 
was used in Chapter 8 and 9 to determine the relative alteration of metabolites and lipids after 
cisplatin treatment. Both algorithms for TARQUIN and R were designed and developed by Dr. 
Martin Wilson. 
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4.7.4.1 Totally Automatic Robust Quantitation in NMR (TARQUIN) 
The spectra of untreated cell pellets were phased and referenced to the Cr signal at 3.03 ppm 
and the peaks were assigned and quantified. 1H HR-MAS visible lipids were quantified using a 
modified version for lipids of the automated algorithm, TARQUIN. The TARQUIN algorithm, 
by fitting a series of simulated individual metabolite and lipid signals to the experimentally 
acquired data, measures the metabolite and lipid quantities. The relative quantity of 1H HR-
MAS visible lipids was determined in relation to the macromolecule signals at 0.94, 1.68, and 
3.00 ppm. The assignment of the resonances at 0.94, 1.68, and 3.00 ppm to macromolecules 
rather than mobile lipids follows assignments by Opstad et al [37] and is substantiated by their 
broad nature, strong correlation with each other and invariance during cisplatin treatment when 
compared with other spectral features.  
 
The relative concentrations of metabolites were measured in relation to the sum of the 
metabolites in each sample. In other words, the spectra were normalised to the whole spectra 
excluding the water peak. Where serial 1H NMR is undertaken to investigate different cell lines 
and their response to treatment, water may alter considerably between investigations and 
relative metabolite concentrations are likely to be the most consistent measurements hence this 
approach was used in this in vivo work to measure the relative concentration of the metabolites.  
 
4.7.4.2 wxNUTS software 
Signal intensity of lipid peaks in spectra of extracts were measured with a  line fitting method 
provided by the wxNUTS, a commercial software designed for spectral analysis purposes. 
Each raw spectrum was applied with phase and baseline correction before the measurement. 
The spectral region with the peaks of interest was expanded and peaks were selected manually, 
the algorithm of the software can simulate each peak and measure the signal intensities. The 
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quality of the simulation can be monitored by the signal residue and fitted set of peaks (Figure 
4.5). 
  
 
Figure 4.5 Line fitting of 1H NMR signals from the –CH3 group of a lipid extract with 
wxNUTs. (Blue: peaks of interest, Green and red: simulated peaks, Grey: residue) 
 
4.7.4.3 Spectral analysis with R  
All spectra were manually phased and referenced to Cr at 3.03ppm. Baseline correction [150] 
was performed and the signal intensity of the different regions were measured using integration 
to estimate the relative abundance of interested metabolites and lipids. Signal integrals were 
normalised to the total intensity of the spectral region from 0.5 to 4.5ppm. 
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4.8 Characterization of lipid species in isolated LDs by 
mass spectrometry 
 
Lipid extracts were dissolved in 200 μl of chloroform/methanol (1:1 v/v): half was used for gas 
chromatography with flame-ionization detector (GC-FID) analysis of total fatty acids and half 
for liquid chromatography mass spectrometry (LC-MS) analysis of intact lipids. For the GC-
FID analysis 50 μl of D-25 tridecanoic acid (200 μM in chloroform), 650 μl of 
chloroform/methanol (1:1 v/v) and 250 μl BF3/methanol (Sigma-Aldrich) was added to the 
extract and the vials were incubated at 80 ºC for 90 min. 500 μl H2O and 1 ml hexane was 
added and each vial vortex mixed. The organic layer was evaporated to dryness before 
reconstitution in 100 μl hexane for analysis. The derivatised organic metabolites were injected 
in a Focus gas chromatography (GC) and the column eluent was introduced into a flame-
ionization detector (FID, Thermo Electron Corporation). The column used was ZB-WAX 
(Phenomenex; 30 m × 0.25 mm ID × 0.25 μm; 100% polyethylene glycol). The initial column 
temperature was 60 ºC and was held for 2 min. This was increased by 15ºC min-1 to 150 ºC 
then increased at a rate of 3 ºC min-1 to 230 ºC. This final temperature was held for 10 minutes. 
Peaks were assigned using Food Industry FAME Mix (Restek 6098) solution. 
 
For LC-MS 5 μl of each sample was analysed on a Waters Q-Tof Ultima mass spectrometer 
combined with an Acquity Ultra Performance Liquid Chromatography (HPLC). The sample 
was injected onto a 1.7 μm bridged ethyl hybrid C8 column (2.1 × 100 mm; Waters 
Corporation) held at 65°C. The binary solvent system (flow rate 0.200 ml/min) included A. 
HPLC grade water (1% 1 M NH4Ac, 0.1% HCOOH) and B. LC/MS grade 
acetonitrile/isopropanol 5:2 (1% 1 M NH4Ac, 0.1% HCOOH). The gradient started from 65% 
A/35% B, reached 100% B in 6 min and remained there for the next 7 min.  The data was 
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collected over the mass range of m/z 100–1400 with a scan duration of 0.5 sec and an interscan 
delay of 0.1 s. The source temperature was set at 100°C and nitrogen was used as desolvation 
gas (600 L/h) at 300°C. The voltages of the sampling cone and capillary were 40 V and 3 kV, 
respectively and collision energy 5 V. Reserpine (50 μg/L) was used as the lock spray 
reference compound (10 μl/min; 10 sec scan frequency). 
 
To assign the lipid species present, a representative sample for each strain was analysed by 
tandem mass spectrometry (MS/MS). MS/MS runs were performed using ESI+ mode and 
collision energies of 18, 20, 24, 30 V and a mass range of 80 to 1,100 m/z. Other conditions 
were as described above. 
4.9 Statistical tests 
The statistical analysis in this work was performed with SPSS version for windows (Version 
17 &18, SPSS Inc, USA). The significant differences presented are between control samples 
and treated samples with Student’s t-test when the samples were normally distributed (Figure 
4.6).  
 
Figure 4.6 Normality test of signal intensity ratio of Cholesterol ester (CholE)/Cholesterol 
(Chol) for five cell lines. 
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Chapter 5 The lipid composition of 
isolated cytoplasmic lipid droplets 
from a human cancer cell line, 
BE(2)M17 
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5.1  Introduction 
Proton nuclear magnetic resonance spectroscopy (NMR) allows the direct detection and 
quantification of specific lipid species in situ[98]. The resonances of lipids have been observed 
in 1H NMR spectra of cultured brain tumour cells[151] and tissues[38] both in vivo and ex 
vivo. The origin of these lipid signals was first thought to be from globular plasma membrane 
microdomains [74, 75], but more recent direct evidence suggests that the NMR signals are also 
likely to be from mobile lipid droplets (LDs) in the cytoplasm [38, 50, 77]. Initially, the 
function of these droplets was thought to be solely the storage of excess fatty acids present in 
the cytoplasm.  However, recent research has revealed that LDs dynamically interact with other 
cell compartments and participate in several cellular processes such as membrane trafficking, 
lipolysis and phospholipid recycling [113, 152]. 
 
The accumulation of intracellular LDs has been implicated in important cellular processes such 
as proliferation, apoptosis and necrosis [37, 59, 122, 153]. There is evidence showing the 
presence of LDs in necrotic regions of brain tumours [37, 77] and hypoxic-necrotic tumour 
stroma of a C6 glioma [154]. It has been shown that modifications of intracellular LDs are 
correlated with cell growth and growth arrest [68]. Many clinical studies have suggested that 
the resonance signals from mobile lipids can be used as potential markers in the differential 
diagnosis and grading of brain tumours [155]. These lipid signals may also be predictive of 
treatment response [156]. These findings associate LDs with the cell cycle, malignancy and 
cell death and consequently are an attractive topic for cancer research. The elucidation of their 
composition and biochemical features is vital to the understanding of their function in these 
cell processes and may provide novel information related to cell biology. 
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High resolution 1H NMR spectra of cell lipids can provide information on the number and type 
of chemical entities of a molecule and has been widely used in the analysis of lipid structure 
and composition [25, 157]. The standard method to obtain high resolution NMR spectra of 
lipids from cells and tissue is to perform a chemical extraction of the tissue prior to the 
acquisition of data in the liquid state. The resonances of lipids in NMR spectra from cell 
extracts are usually dominated by membrane lipids which can mask the signals from sub-
cellular compartments, such as LDs.  It is therefore desirable to isolate the LDs in order to 
eliminate the signals from membrane lipids. Isolation of LDs from human cell lines has been 
performed previously [146]. A commonly used method is density gradient ultra-centrifugation 
[121, 140], but to the best of our knowledge, 1H NMR analysis of isolated LDs from tumour 
cells has not been reported earlier. 
 
This chapter presents the 1H NMR spectra acquired from isolated LDs of a human 
neuroblastoma cell line, chemical analyses of lipid using gas chromatography with mass 
spectrometry (GC-MS) and provides a new insights to the investigation of these highly 
dynamic organelles separated from tumour cells. 
5.2 Methods 
BE(2)M17, a human neuroblastoma cell line, was cultured in 75 cm2 flasks and maintained in 
20 ml complete DMEM and harvested at around 90% confluence (chapter 4.1).  
 
Nile red and DAPI staining was performed on BE(2)M17 whole cells. Nile red staining, Oil red 
O and haematoxylin staining, negative staining followed by TEM were performed on isolated 
LDs (chapter 4.2). 
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HR-MAS on cell pellets and liquid-state 1H NMR spectroscopy on lipid extracts and isolated 
LDs was performed with Varian 600-MHz (14.1 T) vertical bore spectrometer. 2D 1H-13C 
HSQC was performed on the lipid extracts on a Bruker DRX 500MHz spectrometer using a 
cryoprobe at 250C  (chapter 4.7). 
5.3 Results 
5.3.1 LDs from BE(2)M17 cells 
Nile red staining (Figure 5.1A) illustrated that there were a considerable number of 
cytoplasmic LDs inside the cells, which tended to localise near to the cell membrane. The 
mean diameter of these LDs with Nile red staining (Figure 5.1B) inside BE(2)M17 cells was 
0.23±0.14µm (1.55-0.12µm,n=257) whereas in the isolated fraction it was 0.22±0.17µm (1.23-
0.10µm, n=79).  The diameter of isolated LDs with Oil red O staining (Figure 5.1C) was 0.22 
±0.05µm (0.47-0.17µm, n=52) 
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Figure 5.1 Nile red and DAPI staining (A) of BE(2)M17, Nile red staining (B), Oil red O and 
haematoxylin staining (C) and Negative staining (D) of isolated fraction. 
 
Membranes can be visualised with Oil red O and haematoxylin staining, appearing as annular 
structures easily distinguishable from LDs.  Figure 5.1c shows membrane structures were 
absent from the isolated fraction and the middle sucrose fraction although they could be 
visualized in other fractions (Figure 5.2).  In addition, the transmission electron microscopy 
(Figure 5.1D) shows the existence of LDs and the absence of membrane bound vesicles in the 
isolated fraction, in accordance with Figure 5.1C. 
D C 
A B 
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Figure 5.2 Oil red O and haematoxylin staining of different fractions after isolation. Bars 
represent 50µm. A isolated fraction, B middle sucrose zone, C pellet, Upper (D) and lower 
(E) fraction after first 2000xg centrifuge The membrane structure (pointed by arrows) were 
absent from isolated fraction and middle sucrose zone.  
 
The protein bands from the different fractions after gradient centrifugation are shown in Figure 
5.3.  Lane three shows that no detectable proteins present in the isolated fraction, excluding the 
possibility of significant contamination from cytoplasmic proteins and other cellular 
organelles. 
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Figure 5.3 Protein extracts from different fractions after gel electrophoresis and Coomassie 
Blue staining.1.SeeBlue® Plus2 Pre-Stained Standard (invitrogen), 2. whole cell lysate, 3. 
isolated fraction, 4. middle sucrose zone, 5.pellet, 6. upper fraction and 7. lower fraction of 
2000xg centrifuge. 
 
5.3.2 1H NMR spectra of lipids 
Figure 5.4 shows the liquid-state 1H NMR spectrum acquired directly from the isolated LDs 
together with the HR-MAS spectrum of intact cells.  The region between 0.5ppm to 3.5ppm 
has been plotted to exclude signals from sucrose from 3.5-5.5ppm. Metabolites and lipid peaks 
were observed in both spectra and the lipid peaks were assigned according to previously 
published values [50, 158, 159]. An attempt was also made to remove sucrose using dialysis 
and ultrafiltration, but the concentration of LDs was not high enough for detection of lipid 
resonances in the 1H NMR spectrum due to the breakdown and loss of LDs in these processes.   
1       2       3       4       5       6       7       
250Kd 
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d 
98Kd 
64Kd 
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Figure 5.4 Liquid-state 1H NMR spectrum from the buoyant fraction (A) and HR-MRS 
spectrum from intact cell (B)   
Structural assignments are made with the possible parent molecules listed in brackets: 1 CH3(Ch,ChE), 
2 CH3(L,Ch), 3 CH3(Ch,ChE),CH2(Ch,ChE) 4 CH2(L,Ch), 5 CH2CH2CO(L), 6 CH2CH=CH(L), 7 
CH2COO(L), 8 =CHCH2CH=, 9 N(CH3)3 (PtdCho), Ch, cholesterol; ChE, cholesteryl ester Cho, 
choline residue; L, lipid ; PtdCho, phosphatidylcholine; 
 
Figure 5.5 shows the liquid-state 1H NMR spectra from lipid extracts in deuterated chloroform 
(CDCl3) of (a) isolated LDs and (b) whole cells. A HR-MAS spectrum from intact cells is also 
shown for comparison. Peaks were found to be consistent with those given in the literature 
[158-160] and assignments were made accordingly (Table 5.1).  Lipid peaks are better resolved 
in the liquid state spectra allowing the assignment of extra molecules such as cholesterol and 
cholesterol ester.  Some shifts in peak positions are seen compared with the HR-MAS data 
consistent with different solvents and experimental conditions. The residual water peak 
exhibits a larger shift from around 4.95ppm in the HR-MAS to 1.6-1.7ppm in the extracted 
samples, which is primarily due to solvent differences [159]. 
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Figure  5.5 Liquid-state 1H NMR spectra vertically scaled to the resonance intensity at 
0.9ppm of the chloroform component from a methanol chloroform extraction of A: the 
isolated lipid droplet fraction and B: whole cells. C: the HR-MAS spectrum from intact cells 
is given for comparison. Structural assignments are made with the possible parent molecules listed 
in brackets: 1 CH3(Ch,ChE), 2 CH3(L,Ch), 3 CH3(Ch,ChE),CH2(Ch,ChE) 4 CH2(L,Ch), 5 
CH2CH2CO(L), 6 CH2CH=CH(L), 7 CH2COO(L), 8 =CHCH2CH=, 9 N(CH3)3 (PtdCho), 10 
CH2OCOR,CH2OPO2, 11 CHOCOR(L), 12 HC=CH(L,Ch), 13 H2O. Ch, cholesterol; ChE, 
cholesteryl ester Cho, choline residue; L, lipid; PtdCho, phosphatidylcholine  
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Table 5.1 1H NMR resonance of extracted lipids from BE(2)M17 cells in CDCl3 
 
 
 
Figure 5.6 shows an expansion of the three spectra showing a clear separation between the 
cholesteryl ester and cholesterol peaks at 1.01 and 0.99ppm [25].  A higher ratio of cholesterol 
ester to cholesterol was present in the isolated LDs (1.25±0.54, n=3) compared to the whole 
cell extract (0.22±0.03, n=3) and there is a statistically significant difference between the two 
groups (Student’s t test P <0.05). 
 
Some prominent singlet peaks at 1.28, 1.33, 2.10 and 2.17ppm in the isolated fraction extracts 
were observed compared with the whole cell extracts (Figure 5.6A.B). In HR-MAS data 
(Figure 5.6 C) these peaks are not observed, either being overlapped by signals from 
metabolites or shifted and merged as a broader lipid peak. 
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Figure  5.6 Liquid-state 1H NMR spectra vertically scaled to the resonance intensity at 
2.0ppm (left),1.25ppm  (centre) and 0.9ppm (right) highlighting the resonances around 2.0–
2.9ppm, 1.2–1.4ppm and 0.5-1.0ppm. A: lipid extract from the isolated lipid droplet fraction. 
B: whole cell lipid extracts and C: HR-MAS spectra from intact cells. 
 
5.3.3 HSQC spectra of extracted lipids 
Figure 5.7 shows the 5.45 to 5.25ppm region of the 500MHz HSQC (1H and 13C) spectra of the 
lipid extracts from isolated LDs and whole cells. The double bond protons of unsaturated fatty 
acids which were all superimposed at 5.3-5.4ppm in 1D proton spectra (Figure 5.4) were 
separate into distinguishable signals and were assigned to oleic acid (C18:1) and linoleic acid 
(C18:2) according to the literature [54] and HSQC experiments using standard oleic acid and 
linoleic acid (Sigma, UK). The 2D spectra were manually processed and the signal intensity 
was measured using Topspin 3.0 (Bruker Inc, German). The double bond protons in linoleic 
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acid give two signals with an equal intensity at the 5.4ppm region makes it possible to estimate 
the ratio of these two unsaturated fatty acids. The ratio of oleic acids to linoleic acids was 
1:0.42 in isolated LDs and 1:4 in whole cell lipids.   
 
Figure 5.7 The region of 5.45 to 5.25ppm of proton axis of HSQC spectra from the extracts of 
A: whole cells and B: isolated lipid droplet fraction. 
 
5.3.4 Characterization of isolated LDs by mass spectrometry 
Using GC-FID to profile total fatty acid content of the cells and LDs, both chromatograms 
(Figure 5.8) were dominated by palmitic acids stearic acids and oleic acids (no significance 
difference for these fatty acids). The percentage of fatty acids composition was shown in Table 
5.2 as mean ± SD. Between both whole cells and LDs, there were similar concentrations of 
linoleic acid either as a percentage of total fatty acids detected or as a ratio to oleic acid. 
However, LDs were almost devoid of arachidic acid derivatives (fatty acids containing 20 
carbons in their backbone). There were reductions in arachidic acid (p<0.04), 9-eicosenoic acid 
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(p<0.005) and arachidonic acid (p<0.007). Similar concentrations of cholesterol derivatives 
were detected in the chromatograms.  
 
Figure 5.8 GC-FID chromatograms of lipid extracts from isolated LDs (A) and BE(2)M17 
cells (B).The peaks labelled on the bottom spectrum are as follows: 1. Deuterated tridecanoic 
acid (retention time and concentration standard), 2. myristic acid (C14:0), 3. palmitic acid 
(C16:0), 4. palmitoleic acid (C16:1, cis-9), 5. stearic acid (C18:0), 6. oleic acid (C18:1, cis-
9), 7. linoleic acid (C18:2, cis-9, 12), 8. arachidic acid (C20:0), 9. gondoic acid (C20:1, cis-
11), 10. arachidonic acid (C20:4, cis-5, 8, 11, 14) 
 
Table 5.2 Summary of fatty acid composition as percentage of total fatty acids in lipid 
extracts studied by GC-FID (*P<0.05) 
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To further characterise the lipid species, LC-MS was performed on lipid extracts of LDs 
(Figure 5.9).  MS/MS was used to fragment intact lipids to identify individual lipid species. As 
a crude measure of the polar-to-neutral lipids ratio the MS total ion intensity for the two types 
of lipid species were integrated. The polar lipids-to-triglycerides (TG) ratio was ~2:1. The 
major polar lipids were identified as phosphatidylcholine (PC) (16:0/18:1), 
phosphatidylethanolamine (PE) (10:0/22:6), PC (10:0/18:2), PC(16:0/16:0), PC(16:0/16:1) and 
PE(20:1/20:4), where the numbers indicates the fatty acids present. The TGs contained within 
these droplets included TG(14:0/16:0/20:2), TG(16:0/18:1/16:0), TG(16:0/18:1/18:1), 
TG(14:0/16:0/18:0), TG(14:0/16:0/18:1) and TG(16:1/20:2/18:0). 
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Figure 5.9 A two dimensional chromatogram and mass spectrum plot of the intact lipids 
detected in isolated lipid droplets by liquid chromatography mass  
spectrometry. Each peak corresponds to an individual intact lipid and the  
chromatography separates the polar lipids, largely phosphatidylcholines, and  
the triglycerides. Mass and fragmentation patterns are then used to identify  
the individual lipid species. 
5.4 Discussion 
 
In agreement with other published studies [104, 146, 152], LDs can be isolated from whole 
cells and our study found an excellent agreement between the diameter of the lipid droplets 
observed within the cell and in their isolated state, confirming the isolated ones have a similar 
size with those seen in the whole cell. Both the Nile red and Oil red staining also showed that 
those lipid droplets are not free floating in the cytoplasm but connected to each other through 
some cytoskeleton structure, which might be capable of providing certain protection to the 
isolated LDs from the stress caused by the different physico-chemical conditions, such as 
osmotic pressure and pH between deionised water and the intracellular environment. No lipid 
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bilayer structures were seen on transmission electron microscopy or vesicles on haematoxylin 
and Oil red O staining indicating that there is a low level of contamination from other lipid 
containing structures.  Oil red O staining of the re-suspended pellet obtained after gradient 
ultracentrifugation shows that some LDs are present in the lower fraction of the sample. The 
absence of proteins in isolated fraction indicates there was low contamination from other 
fractions.  
 
The current results demonstrate a strong agreement between the line shape and relative 
amplitudes of the lipid resonances at 0.9, 1.3, 1.6, 2.2 and 2.8ppm present in HR-MAS from 
the whole cell and isolated LD. A signal at 5.4ppm likely to be from vinyl protons present in 
lipids was also observed despite being partially overlapped with sucrose.  These results support 
the data presented by Griffin et al 4 which suggest that lipids in LDs present in cells and 
tumour tissue possess a high degree of rotational freedom.   
 
GC-FID detected a relatively low content of linoleic acid both in LDs and whole cell extracts, 
when HSQC showed much lower oleic-to-linoleic acid ratio in whole cells. In order for GC-
FID to detect individual fatty acids, they must be converted into methyl esters which for fats 
within triglycerides or phospholipids require a process of trans-esterification.  A high oleic-to-
linoleic acid ratio in LDs suggests that a significant proportion of the linoleic acid is found in 
lipid species such as triglycerides which may not be easily derivizated by direct methylation. 
Indeed, LC-MS detected a number of oleic acid containing triglycerides in the LDs. 
Furthermore, in vivo triglycerides are usually found on the inner-side of lipid droplets in a 
relatively restricted environment compared with polar lipids which form the outer membrane 
of the lipid droplet. 
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We observed a significant reduction in the phosphatidylcholine peak at 3.42ppm in isolated LD 
extracts which is consistent with the assumption that LDs are surrounded with a single-layer 
phospholipid. Differences in the total cholesterol peaks around 1.0ppm and 0.68ppm not only 
explain the decrease of total signal intensity but also in the ratio between the esterified 
cholesterol (CholE) and the unesterified cholesterol (Chol) peaks between the whole cell and 
isolated lipid fraction samples.  This variation may be due to differences in polarity of the two 
forms of cholesterol. The main structure of LDs is a core of neutral lipids that are surrounded 
by a monolayer of polar phospholipids [113]. Within the droplets, CholE would be 
concentrated in the non-polar regions such as the core, whereas Ch would be located on or near 
the droplet surface contributing to the biophysical stability of the droplet in the cytoplasm 
[145]. Cell membranes contain more than 90% of the total cellular Chol [161, 162]; therefore 
the Chol present in a whole cell extract is likely to be dominated by Chol present in the cell 
membrane. After esterification, cholesterol esters are either stored in LDs or in hepatocytes and 
certain epithelial cells secreted outside the plasma membrane as lipoproteins [163]. Therefore, 
the isolated LDs are likely to have a low level of Chol and high level of CholE compared to the 
whole cell lipids. 
 
Key differences were apparent in the methylene lipid peak at 1.3ppm between the three spectra 
shown in Figure 5.4. A broad lipid peak and a doublet from lactate were observed in the HR-
MAS spectrum, whereas a broad peak with four additional narrower peaks was present in the 
lipid extracts at 1.25, 1.27, 1.28 and 1.33ppm. The narrower peaks were more prominent in the 
isolated LDs and their relative intensities are different compared to the whole cell extract 
spectra.  In addition, two narrow peaks around 2.10 and 2.17ppm and one triplet near 2.25ppm 
are also absent from the HR-MAS spectrum and much higher in the isolated LD spectrum than 
in the whole cell extract. A comparison of these peaks between the isolated LD extract and the 
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whole cell extract indicates that these peaks mainly come from the LDs and may be a potential 
marker of LDs reflecting the proportion of lipid signals arising from LDs within a whole cell 
extract sample. The relatively low intensity of these peaks in whole cell extracts again indicates 
that the lipids in the droplets only account for a small part of the lipids in the whole cell lipids.  
The unsaturated fatty acid peak at 5.3ppm is clearly visible in the isolated LD spectrum 
confirming their presence in LDs, which is of particular interest as unsaturated fatty acids are 
linked with cell cycle arrest and programmed cell death in cancer cells and treated tumour 
xenografts [50]. 
 
The relative intensities of the narrow peaks at 1.27, 1.28 and 1.33ppm in the isolated LD 
spectra may indicate that the length of fatty acids in LDs is on average shorter than those in the 
whole cells. The study of Subramanian et al [158] show that the most intense 1.25ppm signal 
arises from the methylene between methylenes (x–CH2–(CH2)n–CH2–y) while signals around 
1.27-1.33ppm arise from methylenes adjacent to different subunits ( x–CH2–(CH2)n–CH2–y). 
The high intensity of the peak at 1.25ppm compared with the resonances at 1.27-1.33ppm in 
the whole cell extract indicates that there are more –(CH2)n- inside these lipid samples. The 
ratio between the peak at 1.25ppm and those around 1.27-1.33ppm could therefore be used to 
estimate the mean length of the fatty acid chains. Comparison with the HR-MAS spectrum 
indicates that these lipid peaks are broadened and overlapped by signals from metabolites and 
macromolecules.   
 
 
High resolved HSQC spectra are a promising technique to assign individual fatty acid signals, 
also for constituents with minor concentrations [54]. In our study, the HSQC spectra confirmed 
that oleic acid and linoleic acid were presented in the lipid extracts of isolated LDs. It is 
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possible for other unsaturated fatty acids containing one or two double bond Carbons, such as 
eicosanoid acid (20:1) and eicosadienoic acid (20:2), to give a signal at a similar position. 
However, only oleic acid (18:1), linoleic acid (18:2) and eicosanoid acid (20:1) were identified 
by GC-FID. Furthermore, oleic acid (18:1) is about 20 folds more than eicosanoid acid (20:1) 
(Table 5.2), therefore, these HSQC signals are most likely predominated by oleic acid and 
linoleic acid. Palmitic acid (C16:0) and stearic acid (C18:0), oleic acid (C18:1) and linoleic 
acid (C18:2) are both common to membrane and storage lipids in human body and the 
membrane lipids contain a much higher proportion of PUFAs [164]. It is consistent with the 
finding that the linoleic acid as an n-6 PUFA is almost 10 times less in LDs than that of whole 
cell lipids compared with oleic acids as the whole cell lipids are dominated by membrane 
lipids. A high level of C16:0, C18:0 and C18:1 was confirmed by mass spectrometry.  
5.5  Conclusion 
 
An excellent agreement was observed between the lipid resonances present in the HR-MAS of 
BE(2)M17 cells and the NMR spectra of their isolated LDs, strongly supporting that NMR 
visible lipid resonances originate primarily from LDs.  A comparison between the 1H NMR 
spectra of lipid extracts from the isolated LDs and the whole cell preparations revealed a 
number of similarities, particularly in the presence of unsaturated lipids. However, differences 
were also detected, in particular a large dissimilarity was seen in the ratio between the 
cholesteryl ester and cholesterol peaks. 
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Chapter 6 The size of cytoplasmic 
lipid droplets varies between tumour 
cell lines of the nervous system  
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6.1  Introduction 
1H Nuclear Magnetic Resonance (NMR) spectroscopy, originally an analytical chemistry 
technique, is now widely used for non-invasive detection of metabolites both in preclinical and 
clinical settings [84, 88]. In particular, NMR spectroscopy (MRS) has gained acceptance in 
cancer imaging by improving presurgical diagnostic accuracy and tumor grading [165], 
offering guidance for surgical intervention and determining efficacy of therapy [166].  
 
One group of chemical species used in cancer NMR investigation is the 1H NMR detectable 
lipids. Lipid NMR resonances have been detected ex vivo from different cancer cells and 
tumours [37, 59] and are commonly present in malignant human brain tumours. Preclinical and 
clinical observations have shown that lipid signals are related to tumour class, grade and 
prognosis [37, 62] suggesting the potential of these signals to serve as a diagnostic tool and a 
monitor for effective therapies. 
 
It has become evident that lipid droplets (LD) in the cytoplasm are the main source of the 
NMR detectable lipids in situ [50, 77]. A study on a myeloma cell line showed that the 
appearance of lipid resonances detected by 1H NMR was associated with formation of 
cytoplasmic LD in the presence of lipids in the culture medium [78]. In the past two decades, a 
growing body of evidence suggests that 1H NMR lipid signals arise from lipid species that are  
associated with several important cellular processes such as cell proliferation, activation, 
apoptosis and necrosis [50, 155]. Accumulation of cytoplasmic LD in cells and tissues 
undergoing apoptosis or necrosis has been reported, and this accumulation is accompanied with 
sharp increase in the 1H NMR lipid signals [12, 37].   
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LDs have been regarded as generic cellular structures storing neutral lipids. However, recent 
studies revealed that LDs are dynamic organelles with multiple cellular functions [113, 114]. 
Lipid accumulation into LDs is a common observation in several human diseases, such as 
atherosclerosis [167], diabetes and obesity [168]. Recently, increasing evidence suggests that 
LDs are also implicated in other diseases including inflammation [134], viral infections [135] 
and cancer [136]. An increased number of LDs displaying size variation have been reported in 
human colon [138] and brain tumour tissues [37]. 
 
It has been suggested that the NMR detection of lipids depends largely on the mobility of the 
detected molecules due to their fast transverse relaxation rate (R2) [50]. Therefore, the question 
of whether an increase in NMR lipid signals are due to an increase in overall lipid amount in 
these LDs or due to an increase in lipid mobility associated with greater LD size has been 
raised [68]. NMR lipid levels are known to be related to grade and survival in brain 
tumours[169], but the variation and its relationship to LD characteristics have not been fully 
explored in a panel of tumour cell lines. In addition, most studies on LDs using NMR have 
exploited the induction of LD accumulation in target cells through various procedures thereby 
potentially complicating interpretation of origin of lipid NMR signals. Therefore, it is attractive 
to investigate viable and unexposed cells by NMR in order to gain an understanding of the 
relationship between the size of LDs and lipid NMR signals for quantitative interpretation of 
cellular lipids. In the current study, the LD size and NMR lipid signal were measured in five 
nervous system cancer cell lines to examine their relationship. 
6.2 Methods 
Five nerve system tumour cell lines, BE(2)M17, a human neuroblastoma; DAOY, a human 
medullolbastoma; PFSK-1, a human supratentorial primitive neuroectodermal tumor; U87MG, 
  
 
90 
 
a human glioblastoma and BT4C, a rat glioblastoma were cultured in complete DMEM. 
Samples to be investigated with NMR were snap-frozen in liquid nitrogen and stored at -800C 
(chapter4.1)   
 
HR-MAS was performed on a Varian 600-MHz (14.1 T) vertical bore spectrometer 
(chapter4.7). FIDs were zero filled to 16 K data points prior to Fourier transformation, phased, 
referenced to the creatine peak at 3.03 ppm, water suppressed and normalized to the 
macromolecular peak at 1.68 ppm for display. The phased data was then transformed back to 
the time-domain and the TARQUIN algorithm as described in [20] was used to measure the 
lipid quantities by fitting a series of simulated individual lipid signals (similar to Figure 4.5) to 
the experimentally acquired data. 
 
The lipid peak variability was demonstrated using at least 3 independent repeats prepared from 
each cell line and a relative value of lipid intensity, a ratio of lipid to macromolecular signal, 
was used for the normalisation reason so that the final value is comparable in different cell 
lines. 
6.3 Results 
6.3.1 Size of LDs  
The Nile red and DAPI co-stained images of five different cells are presented in Figure 6.1. 
The lipid droplets appeared as green and the blue stain represents cell nuclei. The size bar 
marks a reference for 5 µm. Qualitative microscopy suggested that LD size and number vary 
between the five cell lines studied and therefore, LD diameter and number were determined 
in three typical cells for each cell line. 
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Figure 6.1 Nile red and DAPI staining of five brain and nerve system tumour cells. LDs 
appear as green spots and the cell nuclei are in blue.  
 
The distribution of LD diameters in cell lines is shown in Figure 6.2. BE(2)M17 was the only 
cell line that showed LDs larger than 1µm while the largest LD in DAOY cells was 0.4µm. 
BE2M17 had the largest LDs while PFSK-1 contained the highest number of LDs. The 
middle black line in box-plot (Figure 6.2) representing the median in each cell line was 
around 0.2 µm. BE(2)M17 had the biggest in size and the highest in number of outliers 
shown as stars and dots in the box-plot.  The dots and stars labelled with numbers in Figure 
6.2 are outliers to show the number of larger LDs and their distance to the mean value in each 
BE(2)M17 
DAOY 
BT4C 
PFSK-1 
U87MG 
  
 
92 
 
cell line. The histogram (Figure 6.3) of the diameter of LDs shows that the mean diameter 
was similarly around 0.2 µm for each cell line. 
 
Figure 6.2 Box-plot (B) of the diameters (µm) of lipid droplets to show the distribution and 
the number of LDs in five tumour cell lines. The middle black line represents the median and 
the box represents a distribution from 25% to 75%. The area between the whiskers 
represented the total distribution of all LDs except for the outliers shown as dots (mild 
outliers) and stars (extreme outliers). 
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Figure 6.3 Histogram of the diameters (µm) of lipid droplets to show the distribution of lipid 
droplet size in five tumour cell lines. 
 
The range, mean value, standard deviation of LD diameter together with the number of LDs 
is shown in Table 6.1. Total LD volumes are also shown for each cell line in Table 6.1. 
Table 6.1 Statistical information of LDs across cell lines. 
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Cell line 
range of  
diameter (µm) 
/ cell line 
Diameter 
(µm) 
/ cell line 
number of 
LDs 
/ cell 
Volume 
(µm
3
) 
/ cell 
BE(2)M17 1.48~0.08 0.22±0.15 246±12 5.11±0.31 
BT4C 0.75~0.08 0.20±0.09 237±46 1.89±0.48 
U87-MG 0.56~0.07 0.20±0.09 228±103 1.66±0.04 
PFSK-1 0.49~0.07 0.19±0.07 388±46 2.00±0.18 
DAOY 0.42~0.07 0.18±0.06 208±32 0.82±0.13 
 
6.3.2 1H NMR lipid signal  
HR-MAS spectra acquired from different cell types are presented in Figure 6.4. The lipid 
resonances are assigned as follows, the protons contributing to the resonances shown in bold: 
1–CH3 at 0.9ppm, 2–(CH2) –at 1.3ppm, 3–CH2–CH2–C=O at 1.58ppm, 4 –CH2–CH= at 
2.02ppm, 5–CH2–CH2–C=O at 2.2ppm, 6 =CH–CH2–CH= at 2.8ppm‚ 7 –CH=CH– at 
5.4ppm. The intensities of the 1.3 and 0.9ppm lipid signals are highest in BE(2)M17. These 
lipid signals represent the methylene and methyl group from both saturated and unsaturated 
lipids. It should be noted that the 2.8ppm resonance originating from poly unsaturated fatty 
acids was detected only in BE(2)M17 cells. Lipid signal intensities are intermediate in BT4C 
and U87-MG cells, while PFSK-1 and DAOY showed the lowest signal intensities. The 
resonance at 5.4ppm, which arises from unsaturated lipids, is close to the value of the noise in 
PFSK-1 and DAOY cells. 
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Figure 6.4 HR-MAS spectra of five nervous system and brain tumour cells.  
The assignment of lipid signals are as follows: 1–CH3 at 0.9ppm, 2–(CH2) –at 1.3ppm, 3–CH2–
CH2–C=O at 1.58ppm, 4 –CH2–CH= at 2.02ppm, 5–CH2–CH2–C=O at 2.2ppm, 6 =CH–CH2–
CH= at 2.8ppm‚ 7 –CH=CH– at 5.4ppm. 
 
6.3.3 Correlation  between LD size and NMR lipid signal intensity  
Plots for the largest LD present in each cell line with the NMR lipid the methyl and methylene 
signals are shown in Figure 6.5. Plots of estimated LD volume and the lipid NMR signal 
intensities are shown in Figure 6.6. Linear correlations were evident between the size of LDs 
BE(2)M17 
BT4C 
DAOY 
PFSK-1 
U87-MG 
7 
1 
2 
3 
4 
5 
5 4 3 2 1 
Chemical shift (ppm) 
6 
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and the intensities of lipid NMR signals as well as between LD volume and NMR signal 
intensities (P < 0.001 for all four plots). However, the line of best fit does not pass through the 
origin implying that no signal is observed from the smallest of the lipid droplets. The lipid 
signal intensity was normalised to total MM, the sum of signal intensity from macromolecular 
peaks at 0.9, 1.68 and 3.0ppm as referencing to protein signal has been shown to be a good 
approach in NMR signal quantification [170]. 
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Figure 6.5 Line fit plot for the largest LD in a single cell of each cell line and the lipid signal 
intensity of the methyl groups at 0.9ppm (A) and the methylene groups at 1.3ppm (B). 
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Figure 6.6 Line fit plot for the sum of total LD volume in each cell and the lipid signal 
intensity measured from 0.9ppm, CH3 groups (A) and 1.3ppm, CH2 groups (B)  
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6.4 Discussion  
6.4.1 Variations of LDs in five cell lines 
Intracellular LDs range in size from the massive droplets of 200µm in diameter, found in 
mature adipocytes, to the nascent LDs of only 50 nm in diameter, found in milk-secreting cells 
[73]. Growth conditions, such as confluence and serum supply,  influence the size of LDs in 
cell lines [68]. In the current study, nervous system cancer cells were harvested at log growth 
phase approaching confluence. In these cancer cells, an average LD diameter is approximately 
0.2µm. The difference between cell types mainly comes in the number and size of LDs with 
diameter larger than 0.4µm. These observations indicate that the nervous system cancer cell 
lines studied produce LDs of similar diameter, however, some of these cell lines, most notably 
BE(2)M17, also contain significantly larger LDs under the culture conditions used.  
 
The biogenesis of LDs remains poorly understood, the emerging proteomic studies of LDs 
suggested that LD proteins are the main controllers for the growth of nascent lipid droplets 
[111]. Various LD proteins have been identified in the LDs fraction purified from different 
tissues and cells [82, 112].  The difference of the LD size and  the observation that the 
accumulation of LDs in BE(2)M17 cells is more sensitive to the serum supply and over 
confluence compared with PFSK-1 and DAOY cells suggests that the lipid metabolism of LDs 
in these five cells might be different.   
 
6.4.2 NMR detection of LDs 
The qualitative patterns of lipid NMR resonances from all five cell lines (Figure 6.4) are 
similar, indicating that the chemical lipid species contributing to the NMR spectra are similar. 
Quantitative analysis of lipid peaks using –CH3 and –CH2- resonances shows that in cells 
  
 
100 
 
containing larger than 0.4 um LDs NMR concentrations of lipids is higher than in those 
devoid of large LDs.  NMR detected lipid signals have been reported to quantitatively 
correlate to LDs measured with phase contrast microscopy [171] and Nile red-stained LDs in 
a rat glioblastoma cell line [68]. In order to give narrow NMR lines, molecules must tumble 
fast to have long T2 (see section 2.1 for detailed discussion about T2). For example, lactate 
with a small molecular weight has a T2 around 150ms[172] and free fatty acids have a T2 
round 20ms[173]. LDs exist in numerous  types of cells [73], but lipids in LDs may not 
generate NMR signal due to their restricted mobility caused by dipolar effect in tiny droplets.  
It was proposed that LDs lower than 0.1µm are NMR invisible [68]. LDs in cell lines studied 
were larger than 0.07 m, PFSK-1 cells contained more LDs around 0.2µm than any other 
cell line, yet the NMR lipid signals from PFSK-1 cells are weaker than in BE(2)M17 cells, a 
cell line with lower average LD count per cell than PFSK-1. Thus, the volume of LDs in this 
diameter range is a more important determinant of the NMR lipid detectability than the total 
number of LDs. This is demonstrated by linear correlation between LD volume and NMR 
lipid signal intensities (Figure 6.7). However, the line of best fit does not pass through the 
origin, but rather extrapolating to where the lipid signal is zero gives a value on the lipid 
droplet size axis of around 0.34m diameter roughly in agreement with Quintero et al[68]. It 
should be noted that the HR-MAS spectra in this study were acquired under 6.7 0C. NMR 
lipid signal was better detected by HR-MAS at 370C [174], therefore, the limiting droplet size 
for NMR lipid detection could be lower.  
 
It should be borne in mind that other macromolecules than lipids, such as polypeptitides and 
proteins [175], contribute to the peaks at 0.9 and 1.3 ppm. We observed that the lipid signal 
intensity of –CH3 peak (Figure 6.6A) in DAOY cells appears greater than that from –CH2– 
(Figure 6.6B). The discrepancy is possibly due to the higher macromolecule contribution to 
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the 0.9ppm peak than by lipids. The relatively poor correlation between LD volume and lipid 
signal at 0.9ppm in DAOY and PFSK-1 cells is most likely due to large macromolecular 
contribution to this signal as these two cell lines have a relatively higher protein/lipid level 
compared with other cell lines (Figure 6.4).   
6.5 Conclusion  
In conclusion, cytoplasmic lipid droplets exist in large numbers prior to treatment in all the 
studied cell lines but the size of the largest droplets varies greatly from one cell line to another. 
High NMR lipid signals are associated with the presence of large lipid droplets and these cells 
also contain the greatest total volume of lipid. Some cell lines contain very large numbers of 
small lipid droplets and are associated with very small NMR lipid signals.  The NMR signal 
reflects both the total amount of lipid present and the mobility of the lipids within the droplets. 
LDs above certain size (here approximately 0.34µm) have a similar rotational freedom for 
NMR detection and the total LD volume then becomes the critical factor for NMR signal 
intensity. 
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Chapter 7 Lipids in cytoplasmic lipid 
droplets and whole cells in nervous 
system tumour cell lines 
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7.1 Introduction 
Increased biogenesis of cytoplasmic lipid droplets (LDs) is  reported in colon adenocarcinoma, 
cervical carcinoma, human brain tumour[37] and hepatocarcinoma [176]. LDs are found to be 
involved in the proliferation [138] apoptosis and differentiation of cancer cells [136]. Lipid 
droplet-specific protein ADRP has been proposed as a potential diagnostic and prognostic 
biomarker for renal carcinoma in a recent gene expression study [177]. It is also suggested that 
inhibition of LD formation could have an effect on neoplastic cell proliferation [138]. The 
commonly found LDs [73] have  spherical appearance surrounded by a monolayer of polar 
lipids [104] with attached proteins that encircles a hydrophobic core of  non-polar lipids [73]. 
LDs have been regarded as specialized structures to store triacylglycerols, sterol esters and 
other neutral lipids. Recently, LDs has been reported to be dynamic intracellular organelles 
being involved in lipid metabolism, cell proliferation, apoptosis and necrosis [59, 113, 122].  
 
Nuclear magnetic resonance (NMR) signals from cellular lipids have been detected in brain 
tumour cells and tissues [37, 59]. A growing body of clinical and experimental observations 
show that the lipid NMR resonances are linked to tumour type, grade [37, 62] and treatment 
response [34, 61] suggesting the potential of NMR signals to aid diagnosis and treatment 
monitoring. Recent studies show that LDs in the cytoplasm are likely to be the main source of 
NMR signals [50, 77]. The absence of prominent lipid resonance in normal brain parenchyma 
[50] suggests that LDs, as the main subcellular origin of NMR lipid signal, may play an 
important imaging biomarker role for brain tumours. 
 
1H NMR can be used as an analytical chemistry technique to elucidate the chemical nature of 
lipid molecules. It was first used to determine the unsaturation and average molecular weight 
of natural lipids [178]. Later, the use of 1H NMR has expanded to determine the lipid profile of 
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human tissue [157] and evaluate the lipid composition of human healthy and neoplastic renal 
tissues [72]. A study of  HepG2 cells elucidated that the surface of lipid droplets is a 
phospholipid monolayer containing cholesterol (Chol) with a unique fatty acid composition 
[104]. The main feature of LD lipids and their difference compared with whole cell lipids in 
cancer cells remains poorly understood.  
 
Lipid species in LDs can be analysed with LD isolation together with various analytical 
methods. In this study, LDs isolated from two glial and three neuronal nervous system tumour 
cell lines were investigated. The morphology of LDs was assessed by Nile red staining. 
Density-gradient ultracentrifugation was used to isolate the LDs from whole cell homogenates. 
The lipid composition of different tumour cells was assessed by analysing 1H NMR lipid 
signals from lipid extracts of both LD and whole cell lipids. Identifying the constituents of 
these LDs can improve our understanding of lipid metabolism in tumour cells and help to 
identify potential diagnostic and therapeutic targets.    
7.2 Methods 
Five nervous system tumour cell lines as described in Chapter 4.1 were maintained in 20 ml 
DMEM media. The cells were harvested at around 95% confluence (chapter 4.1). HR-MAS 
and liquid-state 1H NMR spectroscopy was performed on a Varian 600-MHz (14.1 T) vertical 
bore spectrometer (chapter 4.7). 
 
The lipid extracts spectra were manually phased, baseline corrected and referenced to TMS at 
0ppm. Signal intensity of the peaks around 0.9, 1.1, 1.2-1.4, 2.8, 3.4 and 5.4ppm was measured 
using the line fitting method from wxNUTs. The group statistical difference was analysed 
using Student’s t-test. 
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7.3 Results 
7.3.1 Isolation of  LDs 
Lipid droplets stained with Nile red in intact BE(2)M17 and DAOY cells and their isolated 
fraction are shown in Figure 7.1. LDs were observed at a similar size before and after the 
isolation in both cell lines.  The diameter of LDs was measured for each image using Image J 
(USA, see chapter 4.2.5) and the results are shown in Table 7.1. The range of diameters is 
presented with the maximum and minimum observation. The number of LDs represents all the 
LDs that have been counted. 
 
Figure 7.1 Nile red stained LDs in whole cells (a, c) and isolated fraction after isolation (b, d) 
from two cell lines: BE(2)M17 (a, b) and DAOY (c, d). The size bars represent 5µm. 
 
Table 7.1 Statistical information of LD diameter from whole cell and isolated fraction of 
BE(2)M17 and DAOY cells. 
a 
c d 
b 
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The HR-MAS spectra acquired from BE(2)M17 and DAOY cells and their isolated  fractions 
containing LDs are shown in Figure 7.2. The region from 3.2 to 0.8ppm was plotted to exclude 
the huge sucrose peaks in the isolated LD fraction. The spectra were manually phased, 
referenced the Cr signal at 3.03ppm, baseline corrected and scaled to the height of the lipid 
peak at 0.9ppm. A similarity between the lipid peaks was observed between whole cells and 
the isolated LDs in both cell lines. 
 
                                                      Chemical shift              
a 
1 
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4 5 6 
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Figure 7.2 HR-MAS spectra acquired from BE(2)M17 (a) and DAOY (c) whole cell pellets 
and lipid-state 1H NMR spectra acquired from the isolated fraction of BE(2)M17 (b) and 
DAOY (d). Spectra were normalised to the maximum point of lipid peaks at 0.9ppm. The 
peaks labelled with numbers in the top spectrum are assigned as follows: 1–CH3 at 0.9ppm, 
2–(CH2) –at 1.3ppm, 3–CH2–CH2–C=O at 1.58ppm, 4 –CH2–CH= at 2.02ppm, 5–CH2–
CH2–C=O at 2.2ppm, 6 =CH–CH2–CH= at 2.8ppm. 
 
The ratio of lipid signal intensity to macromolecular signal intensity at 0.9ppm for whole cells 
and their isolated fractions was shown in Figure 7.3. Each point represents an average value for 
each cell line. The error bars represent standard error from at least three independent replicates.  
A good linear correlation (R2=0.9169, P=0.005) between the NMR lipid signal from isolated 
LDs and that of the whole cells in five cell lines was found.    
 
Figure 7.3 Linear regression of the ratio of lipid/macromolecular at 0.9ppm peaks between 
HRMAS spectra and isolated LDs spectra for five cell lines. Each point in the plot represents 
one cell line and the error bars represent standard errors.  
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7.3.2 Lipid composition analysis 
1H NMR spectra acquired from lipid extracts of whole cells and their isolated LDs from 
BE(2)M17 and DAOY cells are shown in Figure 7.4 and Figure 7.5. All spectra are 
referenced to TMS at 0ppm and normalized to the height of methyl group signal at 0.9ppm 
for display. The lipid peaks were assigned to the methyl group, the end of fatty acid chains 
(CH3), at 0.9ppm, the methylene group (CH2) at 1.3ppm, the choline-head group [N(CH3)3] at 
3.4ppm  and the unsaturated lipid group (CH=CH) at 5.4ppm. Lower levels of Chol, choline-
containing lipids and unsaturated lipids were observed in isolated LDs compared with whole 
cell lipids. 
 
                                                 Chemical shift 
Figure 7.4 The whole spectra of lipid-state 1H NMR spectra acquired from the lipid extracts 
of isolated LDs of five cell lines: a BE(2)M17,  b BT4C, c U87MG, d PFSK-1 and e DAOY. 
5 4 3 2 1 ppm 
b 
a 
d 
c 
e 
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2 4 5 
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The assignment for the peaks labelled in top spectra is as follows: 1 –CH3 at 0.9ppm, 2 
Chol+CholE at 1.0ppm 3 –(CH2) –at 1.3ppm, 4 N(CH3)3 at 3.4ppm 5, CH= at 5.4ppm. 
 
                                                 Chemical shift 
 
Figure 7.5 The whole spectra of lipid-state 1H NMR spectra acquired from the lipid extracts 
of whole cells of five cell lines a BE(2)M17,  b BT4C, c U87MG, d PFSK-1 and e DAOY. 
The assignment for the peaks labelled in top spectra is as follows: 1 –CH3 at 0.9ppm, 2 
Chol+CholE at 1.0ppm 3 –(CH2) –at 1.3ppm, 4 N(CH3)3 at 3.4ppm 5, CH= at 5.4ppm. 
 
The spectrum region around 5.4, 3.4, 2.8 and 1.0ppm was expanded (Figure 7.6 and Figure 
7.7). Differences were observed in spectra between isolated LDs and whole cell lipids, 
particularly in the decrease of the lipid peaks at 5.4ppm, 3.4ppm 2.8ppm and 1.0ppm in the 
spectra of isolated-LD extracts. 
5 4 3 2 1 ppm 
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                                                     Chemical shift 
Figure 7.6 The expanded region of CH= around 5.4ppm (A), TG around 4.3ppm (B), 
N(CH3)3 around 3.4ppm (C), =CHCH2CH= around 2.8ppm (D), and Chol+CholE around 
1.0ppm (E) of 1H NMR spectra of lipid extracts of LDs   a BE(2)M17,  b BT4C, c U87MG, d 
PFSK-1 and e DAOY.  
5.3 4.3 3.4 2.8 1.0 ppm 
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                                                   Chemical shift 
Figure 7.7 The expanded region of CH= around 5.4ppm (A), TG around 4.3ppm (B), 
N(CH3)3 around 3.4ppm (C), =CHCH2CH= around 2.8ppm (D),and Chol+CholE around 
1.0ppm (E) of 1H NMR spectra of lipid extracts of whole cells. a BE(2)M17,  b BT4C, c 
U87MG, d PFSK-1 and e DAOY.  
 
 
Figure 7.8 shows the composition of LDs in five cell lines. Error bar represents standard 
deviation. The ratio of the signal intensity from the free cholesterol (Chol) and cholestorl ester 
(CholE) peaks at 1.01 and 1.02ppm over methyl group (-CH3) at 0.9ppm was used to estimate 
the proportion of total cholesterol (T-Chol). The ratio of methylene group (-CH2) at 1.2-
1.3ppm over methyl group was used to estimate the mean chain length of fatty acids. The poly 
unsaturated lipids were estimated by the signal from (=CH-CH2-CH=) at 2.8ppm. The 
proportion of choline-containing lipids was estimated with the signal from choline head group 
5.3  4.3 3.4 2.8 1.0 ppm 
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[N(CH3)3] at 3.4ppm. The unsaturated lipids was estimated with the signal of proton next to the 
double bonds (CH=) at 5.4ppm. A decrease is observed in choline-containing lipids, 
unsaturated lipids and cholesterols. CholE/Chol was increased in isolated LDs. The mean chain 
length of fatty acids remained similar. The intensity of the peak at 2.8ppm in isolated LD 
extracts of PFSK-1 and DAOY cells was too low for analysis. 
 
Student’s t test was performed on the NMR signal intensity of lipid extracts from isolated LDs 
versus that of the whole cells (Figure 7.8, *P<0.05, **P<0.001). There are statistically 
significant differences in the proportion of unsaturated lipids and choline containing lipids. 
However, the statistical significance in mean chain length of fatty acids was only observed in 
one cell line. The data indicates the lipid composition of LDs is different from that of the 
whole cell lipids.  
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*P<0.05 **P<0.001 
Figure 7.8 Bar plots of the signal intensity of different lipid groups in five cell lines. Black 
bars for isolated LDs and white bars for whole cells. The error bars represent standard 
deviation. 
7.4  Discussion 
The similarity of LD diameters in the cytoplasm of cancer cells and in the isolated fraction 
shows that the isolation process was successful. Thus, we believe that the 1H NMR spectra 
from LDs and their extracts are representative for these intracellular bodies. The 
macromolecule peaks at 3.0, 2.2, 2.0 and 1.68ppm were hardly detectable in LD HR-MAS 
spectra, but clearly discernible in the whole cell preparations, indicating that these NMR 
signals probably arise from soluble cytoplasmic proteins or proteins from other sub-cellular 
structures. The macromolecule signal at 0.9ppm showed decreased intensity in both cell lines 
after the isolation suggesting that the residual protein signals arise from species associated 
with  LDs or from microtubule network surrounding LDs. LD lipids account for a small 
proportion of whole cell lipids [179]. The similarity of lipid signal patterns between isolated 
LDs and whole cells, together with the linear correlation of signal ratios (Figure 7.3), agree 
with the proposal that LDs are the main contributors to the cellular 1H NMR lipid signals.  
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LDs were thought to be lipids storage depots as excess fatty acids are converted into neutral 
lipids and deposited in them. In mammalian cells, the neutral lipid core of LDs are 
predominated by triacylglycerols and cholesteryl esters [113]. The fact that LDs are 
surrounded by a mono-layer membrane structure [104] means that LDs are expected to 
contain a certain amount of phospholipids. Phosphatidylcholine(PC) is found in all the sub-
cellular components of the nervous system [180] and a higher level of PC was suggested to 
be correlated with a low degree of differentiation of tumour cells [181]. The lipid signal from 
choline-head groups around 3.40ppm in whole cells and at 3.42ppm in LDs found in this 
study match PC chemical shift, suggesting that PC is the main component in the choline-
containing lipids also in the nervous system cancer cells.  
 
Unsaturated fatty acids are important structural components that confer membrane fluidity and 
selective permeability [182]. The proportion of unsaturated fatty acids is similar to that of the 
choline-containing lipids suggesting that unsaturated lipid signal in whole cell extracts mainly 
are from plasma membrane and therefore, contribution of LD lipids to the unsaturated lipid 
NMR signals detected in HR-MAS spectra from cell preparations is negligible. Recent 
evidence shows LDs contain functional fatty acids such as eicosanoids, signalling molecules 
synthesized by oxidation of twenty-carbon PUFAs and have key roles in controlling cellular 
processes, including cell activation, migration, proliferation and cell apoptosis [131, 132, 183]. 
High relative concentration of unsaturated lipids compared to the lipids containing a choline-
head in LDs suggests that LDs may contain functional free fatty acids of unsaturated chemical 
nature. An increasing number of studies found that LDs were actively involved in many 
important cellular processes such as protein synthesis, cell apoptosis and necrosis [37, 59, 122, 
153]. The observation of excess unsaturated lipids other than structural ones and the presence 
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of polyunsaturated lipid signal at 2.8ppm (Figure 7.8) argue the possibility that LDs may 
provide some key lipidic molecules for these processes. 
 
Cholesterol is the most prevalent steroid in humans. The majority of cellular free cholesterol, 
as an essential structural component, is a residue on the plasma membrane [113]. The brain is 
the most cholesterol rich organ in the body and the mean concentration of un-esterified 
cholesterol in the central nerve system (CNS) is higher than that in any other tissue [184]. 
All of brain cholesterol is synthesized locally [185], but the cholesterol biosynthesis in 
nervous system is still partly understood. Glial and neuronal cells are also implicated to be 
capable of cholesterol synthesis [185]. Cholesterol is abundant in the brain. Nerve system 
tumour cells used in this study show different levels of cholesterol (Figure 7.6). High 
cholesterol levels are observed in glioblastoma cell lines U87-MG and BT4C relative to cell 
lines originating from other CNS cells (Figure 7.8) possibly due to their high proliferation 
rate. The rapid growth of cancer cells is regulated by the availability of nutrients such as 
cholesterol[186]. 
 
Normal adult brain contains very small concentration of cholesteryl ester (CholE) that 
amounts only to 0.1 to 0.2% of that of  total cholesterol [187]. Cholesterol and especially its 
estificated form are associated with cell malignancy. The presence of CholE was found to be 
correlated with high grade brain tumours while no CholE was observed in normal brain 
tissues in a NMR spectroscopy study [25]. A study of U87-MG cells reported that the 
inhibition of cholesterol esterification significantly reduced cell proliferation and invasion 
indicating the importance of CholE in high grade tumour cell growth [188]. In our study, the 
esterification rate of cholesterol was varied from 7.7±5.0% (mean±SD) of total cholesterol in 
DAOY to 58.4±4.7% in BT4C.  LDs play an important role in intracellular cholesterol 
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regulation as excess cholesterol can be stored in LDs in the form of cholesteryl esters [189]. 
A higher ratio of CholE to Chol was presented in LDs compared with whole cell lipids.  
 
The multiplet centred at 4.20ppm with a symmetric appearance was attributed to a glycerol 
residue from triacylglycerol (TG) according to the literature [25] and the TG spectrum 
acquired from standard sample (Sigma, UK). The relative signal intensity of the glycerol 
backbone of 4.3ppm (arrowed pointed in Figure 7.6) over methyl group was measured. In 
BT4C cells, the ratio of signal intensity was 0.03±0.015 (mean ± SD) in LDs and 0.01±0.003 
in whole cell lipids. In U87-MG cells, it was 0.04±0.004 in LDs and 0.03±0.003 in whole cell 
lipids. The increase was statistically significant (Student’s t-test, P<0.05) in both cell lines. 
This data shows that LDs have a higher TG proportion than whole cell lipids.  
7.5 Conclusion 
Cytoplasmic LDs are an important component of childhood brain and nervous system tumour 
cells which can be imaged using NMR. LDs contain phosphatidylcholine, cholesterol and 
cholesterol ester with fatty acid chains being saturated, mono-unsaturated and 
polyunsaturated.Their composition is different from the lipid pool of whole cells implicating an 
important role of LDs in tumour lipid metabolism. 
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Chapter 8 An increase in 
unsaturated lipids of cytoplasmic lipid 
droplets in DAOY cells responding to 
cisplatin treatment 
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8.1 Introduction 
A growing body of evidence show that 1H magnetic resonance spectroscopy (NMR) bears a 
promise in detecting the early responses of tumours to therapy. In particular, 1H NMR visible 
lipids have been observed in successful cancer treatment [34, 38] indicating a potential 
biomarker role in clinical cancer management.  
 
Both cell work in vitro [190] and that using preclinical tumour models [38] have demonstrated 
that apoptosis induced by various anti-cancer therapies result in subtle increase in saturated 
aliphatic 1H NMR signals as well as unsaturated bis-allylic and vinyl peaks. Increase in 1H 
NMR lipids is closely associated with appearance of cytoplasmic lipid droplets (LD) [68], the 
principal source of NMR detectable lipids in vivo.  
 
While some studies [81, 191] have reported increase in CH2/CH3 ratio reflecting lengthening of 
fatty acyl chain, others[141, 151] have failed to confirm this observation indicating that NMR 
lipids do not change chemically during cell death. Several studies have observed an increase in 
unsaturated NMR signals during cell death. It was proposed that NMR lipids accumulating 
during apoptosis originate from membranous cell structures due to lipolysis and repartitioning 
[38], however a recent cell study [192] concluded that de novo lipid synthesis may also 
contribute to the accumulation of 1H NMR lipid signals. We have shown in Chapter 5 that LDs 
were isolated from nervous system cancer cells for lipid analyses. It was observed that LDs 
contain phospholipids, triglyceride, cholesterol and cholesteryl esters with their fatty acid 
chains being saturated and unsaturated.  
 
In the current study, two human primitive neuroectodermal tumour cell lines were treated with 
cisplatin (see chapter3.6)to examine lipid species both at the whole cell and LD levels. Both 
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1D 1H NMR and 2D HSQC were used to characterise chemical nature of lipid species in 
untreated and treated cancer cells. We expect that comparison of chemical nature of lipid both 
at whole cell and LD levels may provide vital information for role of lipids in cell death 
pathways.  
8.2 Methods 
DAOY, human medulloblastoma and PFSK-1, human supratentorial primitive 
neuroectodermal tumour (ST-PNET) cell lines maintained in 15 ml DMEM with or without 
cisplatin (chapter4.1.3). Untreated cells were harvested at around 90% confluence. After 
washing with 10ml ice-cold phosphate buffered saline three times, cells were then removed 
from the flask using a rubber policeman and centrifuged to form a pellet. Cisplatin-treated and 
control cells were removed from the flask first and then washed with ice-cold PBS to collect 
the dead cells.  
 
HR-MAS and 2D 1H-13C HSQC on cell pellets were performed on a Bruker 500MHz 
spectrometer using a HR-MAS probe (Bruker, German) and 1H NMR spectra of lipid extracts 
were recorded on a Varian 600-MHz (14.1 T) vertical bore spectrometer using a HCN probe. A 
standard pulse-acquire sequence was used. All spectra were manually phased and referenced to 
TMS at 0ppm (chapter4.7). 
 
The spectra were manually phased, referenced to TMS (0ppm) for the extract spectra and 
creatine (3.03ppm) for the HR-MAS spectra. The extract spectra were analysed with spectral 
analysis software, wxNUTs. The lipid signal intensity was calculated using the line fitting 
function provided by wxNUTs which fits a series of peaks to the experimental spectrum and 
extracts the signal amplified parameter from the fit. Student’s t test was performed on the 
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treated data versus the untreated one. R was used in the analysis for the HR-MAS spectra. The 
signal intensity of the 0.9, 1.3, 2.8 and 5.4ppm regions were measured using integration to 
estimate the relative abundance of saturated and unsaturated lipids.  
8.3 Results 
8.3.1 Survival with cisplatin treatment  
Cell survival curve after cisplatin treatment assessed by Alamar blue assay is shown in Figure 
8.1. With a 48h treatment at 10µM concentration, the survival rate for DAOY is 5%±0.2% 
(mean ± SD) while around 60%±1.1% PFSK-1 cells were left. DAOY showed a good response 
to 10µM cisplatin treatment whereas PFSK-1 did not, thus, this concentration was chosen from 
subsequent experiments. 
 
Figure 8.1 Cell survival curve of DAOY and PFSK-1 cells after exposed to cisplatin with 
indicated concentrations at 48h. 
8.3.2 Lipid droplet accumulation with cell death 
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LDs appear as green vesicles in Nile red stained cells (Figure 8.2), while cell nuclei were 
stained with DAPI and appear blue. There was an increase in the number of small LDs 
(diameter around 0.2µm) by 12h of cisplatin treatment, while nuclei remained intact. A ring-
like arrangement of small LDs was evident in cells when the LD size increased by 24h of 
cisplatin treatment. After 48h treatment, large LDs were seen with concomitant fragmentation 
of nuclei (Figure 8.2). There was no obvious increase in either the number or the size of LDs 
observed in PFSK-1 cells exposed to 10 µM cisplatin or untreated cells (Figure 8.3). 
 
0h control 
12h 
24h 
48h 
48h  control  
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Figure 8.2 Nile red and DAPI staining of DAOY cells with and without 10µM cisplatin 
exposure. The size bars represent 5µm. 
 
Figure 8.3 Nile red and DAPI staining of PFSK-1 cells with and without 10µM cisplatin 
exposure. The error bars represent 5µm. 
 
8.3.3 Validation of isolation 
Nile red-stained lipid droplets in whole cells and in the isolated fraction were shown in Figure 
8.4. The morphology of the LDs remained similar to the LDs in whole cells after the isolation.  
24h treated 
48h treated 
0h control 
48h  control  
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Figure 8.4 Nile red stained LDs in whole cell (a, c) and in isolated fractions (b, d) of DAOY 
(a, b) and PFSK-1 (c, d). The size bars represent 5µm. 
8.3.4 NMR Lipid signal  
Lipid signal intensities in 1H HR-MAS spectra of DAOY and PFSK-1 cells, as a function of 
cisplatin exposure times, are shown in Figure 8.5. The spectra were normalized to the height of 
macromolecule peak at 1.68ppm for display. In DAOY cells, the lipid signal at 0.9, 1.3, 2.8 
and 5.4ppm starts to rise with 24 hours of treatment and continues to rise with further treatment 
and at 48h the lipid resonance was predominant in the spectra with few visible metabolites. An 
increase in peaks from unsaturated lipids (2.8 and 5.4ppm) is evident. There is no obvious 
increase in the lipid peaks from the spectra of cisplatin exposed or untreated PFSK-1 cells. The 
lipid signal remained similar in all spectra of control cells (Figure 8.6).  
c 
a 
d 
b 
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Figure 8.5 HR-MAS spectra from whole cell pellets of DAOY (A) and PFSK-1 (B) with and 
without cisplatin exposure.  The assignment for peaks labelled with numbers are as 
follows:1–CH3 at 0.9ppm, 2–(CH2) –at 1.3ppm, 3–CH2–CH2–C=O at 1.58ppm, 4 –CH2–
CH= at 2.02ppm, 5–CH2–CH2–C=O at 2.2ppm, 6 =CH–CH2–CH= at 2.8ppm‚ 7 –CH=CH– 
at 5.4ppm. 
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                                              Chemical shift 
Figure 8.6 HR-MAS spectra from whole cell pellets of control cells: DAOY (A) and PFSK-1 
(B).  The assignment for peaks labelled with numbers is as follows: 1–CH3 at 0.9ppm, 2–
(CH2) –at 1.3ppm.  
 
The lipid signal intensity measured with R was plotted in Figure 8.7. Lipid peaks at 0.9ppm, 
1.3ppm, 2.8ppm and 5.4ppm were normalised to signal intensity from integration of the 
1.68ppm macromolecule (MM) peak. The lipid signal was raised after 24h and 48h treatment 
in treated DAOY cells. There is an increase in the ratios of CH2/CH3 and CH=/CH3 in treated 
DAOY cells.  
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Figure 8.7 Signal intensity of lipid peak at 0.9ppm (A), 1.3ppm (C), 2.8 ppm (B) 5.4ppm (D), 
double bond proton signal/methyl group proton signal (CH=/CH3) and methylene group proton 
signal/methyl group proton signal (CH2/CH3)  from HR-MAS spectra of treated and control 
DAOY and PFSK-1 cells. Each data point represents the mean and SD of at least three 
independent repeats. 
 
The 1H NMR spectra of LDs isolated from DAOY cells treated with cisplatin with indicated 
times is shown in Figure 8.8. Spectra were normalised to the maximum point of MM peaks at 
0.9ppm. The lipid signal increased with cisplatin exposure and continued to increase with 
further exposure. A similar pattern to what was observed in HR-MAS spectra of treated DAOY 
cells. 
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Figure 8.8 Liquid-state 1H NMR spectrum from the isolated fraction of cisplatin exposed 
DAOY cells. Spectra were normalised to the maximum point of MM peak at 0.9ppm. 
Structural assignments are made as following:: 1 CH3 at 0.9ppm, 2 CH2 at 1.3ppm, 3 
CH2CH2CO at 1.58ppm , 4 CH2CH=CH at 2.02ppm, 5 CH2COOH at 2.2ppm, 6 
=CHCH2CH= at 2.8ppm. 
 
The 1H NMR spectra of lipid extracts from isolated LDs and whole cells untreated or cisplatin-
treated with the indicated time is shown in Figure 8.9 and Figure 8.10. The spectra were 
manually phased, referenced to TMS at 0ppm and normalised to the height of the methyl peak 
at 0.9ppm for dispaly. The regions around 5.4, 3.4 and 1.3ppm were expanded to show the 
variation of the signals from the protons in CH=, N (CH3)3 and CH2 groups. The CH2 signal 
raised from unsaturated fatty acids was pointed by black arrows. 
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Figure 8.9 1H NMR spectra of lipid extracts from LDs of DAOY cells exposed to cisplatin 
with indicated times. whole spectrum (A) and the expansion for peaks at 1.3ppm (B), 3.4ppm 
(C) and 5.4ppm (D). Arrows show the increased signal of methylene groups from unsaturated 
lipids.  
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Figure 8.10 1H NMR spectra of lipid extracts from DAOY cells exposed to cisplatin with 
indicated times. whole spectrum (A) and the expansion for peaks at 1.3ppm (B), 3.4ppm (C) 
and 5.4ppm (D).  
 
8.3.5 Lipid composition analysis 
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The bar plots showing the processed signal intensity data is shown in Figure 8.11 and 8.12. The 
ratio of methylene group (CH2) and methyl group (CH3) was used to estimate the mean chain 
length of fatty acids. The ratio of signal intensity rose from protons next to the double bonds 
and methyl group was used to estimate the proportion of unsaturated lipids. Student’s t-test was 
performed with controls versus treated cells. There is an increase with statistical significance in 
unsaturation in LDs with cisplatin treatment in DAOY cells but not in PFSK-1. No significant 
change was observed in the mean chain length of fatty acids in LDs. In whole cell lipids, both 
the unsaturation and chain length of fatty acids remained stable after treatment.  
Isolated LDs 
 DAOY 
 
PFSK-1 
 
*P<0.05 
0
0.2
0.4
0.6
0.8
1
0h 24h 48h
CH=/CH3  
* * 
0
2
4
6
8
10
0h 24h 48h
CH2/CH3  
0
0.2
0.4
0.6
0.8
1
0h 24h 48h
CH=/CH3  
0
2
4
6
8
10
0h 24h 48h
 CH2/CH3  
  
 
131 
 
Figure 8.11 The ratio of signal intensity of different lipid groups from the lipids extracted 
from isolated LDs of DAOY and PFSK-1 cells with and without cisplatin exposure. The error 
bars represent standard deviation. 
                                      Whole cell 
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Figure 8.12 The ratio of signal intensity of different lipid groups from the lipids extracted 
from DAOY and PFSK-1 cells with and without cisplatin exposure. The error bars represent 
standard deviation. 
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Figure 8.13 shows the 500MHz HSQC (1H and 13C) spectrum acquired from exposed DAOY 
cells. Figure 8.13A shows the whole spectrum from 0-6ppm (1H) and 0-140ppmm (13C) and 
Figure 8.13B shows the expanded 5.44 to 5.35ppm region. The double bond protons of 
unsaturated fatty acids which were all superimposed at 5.3-5.4ppm in 1D proton spectra 
(Figure 8.12) were separated into disguisable signals and were assigned to oleic acid (C18:1) 
and linoleic acid (C18:2) according to the literature [54] and HSQC experiments using oleic 
acid and linoleic acid standards. The 2D spectra were manually processed using the software 
Topspin 3.0 (Bruker, Germany). The spectra were phased, referenced to TMS at 0ppm and 
peak intensity were measured with peak selection and integration. The double bond protons in 
linoleic acid give two signals with an equal intensity at the 5.4ppm region makes it possible to 
estimate the ratio of these two unsaturated fatty acids and the oleic-to-linoleic acid ratio was 
close to 1:1.   
                                     
 
Figure 8.13 HSQC spectra of 10μM cisplatin 48h treated DAOY cells 
A:Full spectrum, B:The expansion of 5.40-5.30ppm region of proton axis 
 
 
A B 
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8.4 Discussion  
8.4.1 Cell death and LD accumulation  
LD accumulation was a common feature frequently observed in tumour cells [193]  and tissues 
[37] undergoing apoptosis and necrosis. LDs were proposed to be actively involved in 
important cellular processes including cell death [153]. DAOY and PFSK-1 are both primitive 
neuroectodermal tumour cells with a similar appearance of LDs without treatment. Most of 
their diameters of LDs are less than 0.5µm (Figure 8.2). DAOY underwent apoptosis (Figure 
8.2) while PFSK-1 could still becomeover-confluent with intact nuclei (Figure 8.3) after 10µM 
cisplatin exposure. LDs in apoptotic DAOY can accumulate to 1.5µm after 48h treatment 
while no obvious increase in LD size was observed in PFSK-1 cells suggesting that it is 
possible to use LD accumulation as an indicator for cancer cell death.            
 
8.4.2 1H NMR of isolated LDs  from treated DAOY cells  
An early study suggested that the increased lipid signal in cell death was possibly  originated 
from the apoptotic cell membrane due to the increased membrane fluidity[80]. However, the 
hypothesis was questioned by the anisotropic motion of fatty acid chains located in a 
membrane bilayer. More recent evidence showed these lipid signals are associated with the 
presence of cytoplasmic lipid droplets [68] and most likely originated from a non-membrane 
source of lipid [38]. An increase in NMR visible lipids [71] and LDs [141] has been shown in 
cancer cells undergoing apoptosis after treated with chemotherapeutic drugs. In this study, 
DAOY cells with varied size of LDs induced by cisplatin treatment were assessed. The NMR 
lipid signal rose  with the accumulation of LDs, which supports the contention that the lipid 
signal in cell death is due to the accumulated lipids in LDs.  
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8.4.3 Lipid composition analysis  
Phosphatidylcholine (PC) is predominant in phospholipids in mammals and also the main 
component of cell membrane in brain tumour cells.  The proton signal from –N(CH3)3 moiety 
around 3.3ppm is mainly raised from PC according to literature [157] and spiking experiment 
with standard PC sample (P3556, sigma, UK). A decrease of choline-containing lipid was 
observed in both whole cell and LD lipids indicate a reduced level of PC possibly due to the 
cisplatin exposure. Less phospholipid was detected after cisplatin exposure and the relative 
decrease is possibly due to a smaller surface to volume ratio of bigger LDs with neutral lipids 
accumulated into their core.  
From the lipid signal intensity analysis (Figure 8.12), the mean chain length of fatty acid 
estimated with the ratio of –CH2 group over –CH3 showed no obvious change in both whole 
cell and LD lipid after cisplatin exposure except for a slight decrease in LD lipids of 24h 
treated DAOY cells. This observation suggests the length of fatty acid probably remained 
stable in viable and dying cells.  
 
The unsaturation of fatty acid estimated with the ratio of CH= to CH3 is significantly 
increased in LDs of apoptotic DAOY cells (Figure 8.11) but not whole cell lipids indicating a 
unique role for lipids of LDs in cell death that is different to membrane lipids. The 
accumulation of mono-unsaturated fatty acids occurred in LDs isolated from apoptotic 
DAOY cells but not in the non-responding PFSK-1 (Figure 8.11) suggests the accumulation 
is closely associated with cell kill and could be utilized as a promising indicator and a 
potential target for effective therapy. Fatty acids accumulation in cell proliferation [194] and 
apoptosis [80] was reported in previous studies. Our result further confirms that the 
accumulation of fatty acids induced by effective drug treatment occurs in cytoplasmic LDs 
and some of these accumulated fatty acids are unsaturated.   
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In spectra of drug-exposed DAOY cells, the PUFA signal of the peak at 2.8ppm started to rise 
up in 24h and continue to rise with further treatment and the same increase was reported in a 
study of gliomas under gene-therapy [38]. PUFAs are thought to be naturally occurring anti-
cancer agents. In human glioma, PUFA may stimulate tumour regression and apoptosis and has 
been introduced to cancer therapy [195, 196]. It is not known yet whether any of these lipid-
based approaches to cancer therapy will show selectivity for malignant cells. But 
polyunsaturated fatty acid supplementation may make certain forms of cancer treatment more 
effective [28]. Enrichment with polyunsaturated fatty acids makes cancer cells more 
susceptible to lipid peroxidation and increase lipid radical formation in response to oxidant 
stress and photodynamic therapy and more sensitive to drug treatment. In addition, the immune 
response in cancer can be improved by manipulating the lipid levels in dendritic cells [13]. 
Therefore, these accumulated PUFAs after cisplatin exposure could be either simply an end 
product of cell collapse or functional lipid mediators actively involved in cell death pathway.  
 
There is hardly any PUFA signal presented in isolated LDs (Figure 8.8) and their lipid 
extracts (Figure 8.9). The predominant unsaturated fatty acids accumulated in LDs of 
apoptotic DAOY cells are mono-unsaturated. The absence of PUFA signal is most likely due 
to the difficulty to extract them into a sufficient amount for detection. 
 
The current results from HR-MAS indicate an increase in fatty acid chain length estimated 
from CH2 to CH3 ratio in agreement with several recent studies [81, 197]. In DAOY cells the 
CH2 to CH3 ratio is 3 fold greater at 48 hour of cisplatin exposure than before it. Unexpectedly, 
the respective ratio determined in extracts of LDs from the same cells does not change, an 
observation pointing to different origin of lipid species determined by NMR. There is no 
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obvious explanation for this discrepancy in our data, however, it should be borne in mind that 
in cell preparations non-lipid macromolecules contribute to both aliphatic peaks [175]. 
Furthermore, it is possible that some UFAs, especially PUFAs with long aliphatic chain fatty 
acids, were lost in the extraction procedure. 
 
HSQC spectroscopy identified oleic acid and linoleic acid as the two major UFAs 
accumulating during cisplatin-induced cell death in DAOY cells (Figure 8.13). The increase of 
unsaturated lipid peaks in isolated LD spectra (Figure 8.8) suggests these fatty acids are likely 
to be located in cytoplasmic LDs.  
8.5 Conclusion 
The increase in 1H NMR detected lipids in cisplatin exposed DAOY cells was associated 
with the accumulation of LDs and occurred before DNA fragmentation. Isolation and 
extraction of LDs shows that there is an increase in unsaturated fatty acids in these LDs 
during drug treatment. A more detailed understanding of the changes in LD architecture can 
be obtained by isolating the LDs from cells furthering our understanding of the role of lipids 
in cell stress and death and identifying them as a potentially important NMR-detectable 
target for novel therapy. 
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Chapter 9 An in vitro metabonomic 
study detects increase UDP-GlcNAc 
and UDP-GalNAc in early phase of 
cisplatin treatment in brain tumour 
cells 
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9.1 Introduction 
O-linked β-N-acetylglucosamine glycosylation (O-GlcNAcylation) is the post-translational 
glycosylation of proteins with O-linked β-N-acetylglucosamine (O-GlcNAc) [198], with 
around one thousand such modified proteins being identified to date[199, 200].  O-
GlcNAcylation has been shown to be important in a number of biological processes and 
diseases including cell stress [201], transcription [202], diabetes [203] and neurodegeneration 
[204]. However, few studies have investigated the role of O-GlcNAcylation in cancer 
progression and treatment, but a recent report demonstrates an increase in O-GlcNAcylation 
in breast tumour metastasis compared with their primary tissues, suggesting that O-
GlcNAcylation may be a potential target for therapeutic agents [205]. 
 
The biosynthesis of O-GlcNAc begins with intracellular glucose, with 2-5% entering the 
hexosamine biosynthesis pathway (HBP, Figure 9.1).  The direct donor of O-GlcNAc is 
UDP-N-acetylglucosamine (UDP-GlcNAc) [206].  Recently the detection of molecules in the 
HBP by 1H magnetic resonance spectroscopy (1H NMR), including UDP-GlcNAc and 
Uridine diphospho-N-acetylgalactosamine (UDP-GalNAc) has been demonstrated from liver 
tissues [207] and intact tumour cells. In addition to UDP-GlcNAc, 1H NMR can detect a 
number of metabolites which have been shown to change in response to cell growth arrest 
[69] or early events of cell death [208] making this a promising technique for monitoring 
cancer cell treatment. 
  
 
139 
 
 
Figure 9.1The hexosamine biosynthesis pathway (HBP) 
 
1H NMR has been shown to be a powerful method for detecting metabolite and lipid changes 
related to cell growth arrest and death both in vitro and in vivo. The most widely studied 
metabolites in this context are choline containing metabolites (CCMs) and lactate. Decreases 
in phosphocholine (PC) and increases in glycerophosphocholine (GPC) have been observed 
in apoptotic rat glioma, human breast cancer and leukaemia cells induced by various drugs 
[95, 208, 209].  Similarly, reduced levels of PC were detected in herpes simplex virus 
thymidine kinase (HSV-tk) gene therapy treated BT4C glioma cells leading to arrest in the 
G2/M phase of the cell cycle [34] and tumour necrosis factor-alpha (TNF-α) treated breast 
cancer cells arrested in the G0/G1+S phase [210]. However, the concentrations of PC and 
GPC undergo changes during cell proliferation [211] complicating interpretation of cell status 
from these choline containing metabolites (CCMs). Lactate has been shown to increase in 
human colon adenocarcinoma cells treated with TNF-α / interferon-gamma (IFN-γ) [212] and 
has also been shown to decrease in neutrophils treated with TNF-α in vitro [213] and 5-
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fluorouracil treated fibrosarcoma in vivo [214]. These observations reflect the involvement of 
glycolysis, and hence the production of lactate, for the production of adenosine triphosphate 
(ATP) in cells with a high proliferative capability as well as during the cell death process. In 
addition to CCM and lactate, a number of 1H NMR detectable metabolites such as taurine, 
glycine, alanine, succinate and glutamate have been observed to undergo changes in cisplatin 
treated apoptotic BT4C cells [69]. Therefore, a number of endogenous metabolites may have 
potential for treatment monitoring by 1H NMR.  
 
Particular attention has also been paid to 1H NMR detected lipids as imaging biomarkers for 
cancer treatment response. 1H NMR-observable lipids are often prominent in malignant 
tumours, in some cases reflecting hypoxia [154]. In addition, in response to cytotoxic 
treatment, both saturated and unsaturated lipids have been shown to increase in responding 
tumours [34, 38, 141]. Accumulation of 1H NMR visible lipids has been demonstrated in 
apoptotic cells [80, 191] and tumours in vivo [38] and has been correlated with the increase in 
cytoplasmic lipid droplets [50, 59].  
 
In the present study we have examined 1H NMR metabolite profiles of two glioma cell lines 
and two neural tumour cell lines, with differing sensitivities to cisplatin. Cell survival and 
death was assessed with Alamar Blue assay[215] and DAPI-staining[216]. We show that in 
the responding cells, UDP-GlcNAc and UDP-GalNAc, in parallel with 1H NMR detected 
lipids, increase with cisplatin exposure before or at the onset of the microscopic signs of 
evolving cell death. To the authors’ knowledge, this study is the first to report the 
concentration of UDP-N-acetylglucosamine in intact tumour cells exposed to a 
chemotherapeutic agent. 
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9.2 Methods 
BT4C, rat glioblastoma, U87-MG, human glioblastoma, DAOY, human medulloblastoma 
and PFSK-1, human supratentorial primitive neuroectodermal tumour (ST-PNET) cell lines 
were maintained in 15 ml DMEM with or without cisplatin exposure (chapter4.1). 
 
Metabolite extraction was performed on all four cell lines with and without cisplatin exposure 
for assignment purposes. A dual phase methanol-chloroform extraction protocol was used to 
extract cell metabolites for 1H NMR. The upper water phase was collected and dried in a 
vacuum centrifuge at room temperature.  
 
HR-MAS was performed with Varian 600-MHz spectrometer to measure the alteration of 
UDP-GlcNAc and UDP-GlaNAc with treatment. At least three independent preparations 
were assessed for each time point of each cell line. 
 
Statistical total correlation spectroscopy (STOCSY)[217] has been used to generate a pseudo-
two-dimensional NMR spectrum that displays the correlation among the intensities of the 
various peaks across the whole sample. 
 
Dried metabolite extracts were resuspended in 600µl D2O containing 5µl 10mM TMS. 
10mM UDP-GlcNAc and UDP-GalNAc (Sigma Aldrich, Dorset, UK) solution was made 
with D2O and the pH was adjusted to 7.0 with 0.01M hydrochloric acid and 0.01M sodium 
hydroxide. 10µl of the compound solution was added into cell extracts for spiking 
experiments. 1H NMR spectra of cell extracts were recorded on a Varian 600-MHz 
spectrometer. 
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For the spectra analysis with software R, all spectra were manually phased, referenced to Cr at 
3.03ppm. Baseline correction [150] was performed and the signal intensity of the 7.85-
8.05ppm and 5.2-5.4ppm regions were measured using integration to estimate the relative 
abundance of UDP-GlcNAc/UDP-GalNAc and unsaturated lipids, respectively. Signal 
integrals were normalized to the total intensity of the spectral region from 1.4 to 4.5ppm as 
absolute concentrations were not available and to exclude lactate signal as it varies extensively 
in samples due to the degradation of glucose . Since the spectra were dominated by lipid 
signals at later time points an additional step of baseline correction, with increased flexibility, 
was performed prior to the calculation of the normalisation integral. The additional baseline 
correction was performed to reduce the spectral contribution from increasing lipid signals that 
would otherwise mask the UDP-GlcNAc & UDP-GalNAc increase.  The statistical total 
correlation spectroscopy (STOCSY) analysis method [217] was performed to aid assignment of 
metabolites in the HR-MAS spectra acquired.  Student’s t test was performed for statistical 
analysis on the treated data versus the unexposed ones. 
9.3 Results  
9.3.1 Cell survival and cell death 
The Alamar blue assay (Figure 9.2) showed that the half lethal concentration (LC50) for 48h 
cisplatin treatment for DAOY and BT4C cells was 1 - 10 µM, while the LC50 was 10 -100 
µM for PFSK-1 and U87-MG cells. Based on the dose-response curve, we used 10 µM 
cisplatin for the majority of experiments rendering DAOY and BT4C cells responders and 
PFSK-1 and U87-MG cells non-responders in terms of cell death. Error bars represent 
standard deviation. 
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Figure 9.2 Cell survival curve of four brain tumour cells treated with cisplatin for 48h at the 
indicated concentration 
 
Electrophoresis of RNA extracted from cisplatin-exposed BT4C cells showed that the 
degradation of 28S ribosomal RNA and RNA fragments were detected by 12h exposure to 
50µM cisplatin (Figure 9.3). The RNA degradation and fragmentation increased with 
prolonged exposure to cisplatin.  
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Figure 9.3 total-RNA of 50 µM cisplatin treated BT4C cells 1:1kb Plus DNA Ladder, 2: 0h, 
3-7: 3h, 6h, 12h, 24h and 48h exposed cells.  
 
Nuclei of neural tumour cells (DAOY, PFSK-1) were larger than those in glioma cells (BT4C 
and U87-MG) prior to cisplatin treatment (Figure 9.4). Interestingly, morphological changes 
of nuclei in responders of each cell group were much different. Nuclear fragmentation was 
detected in DAPI stained DAOY cells by 24h of treatment while nuclei in PFSK-1 cells 
remained intact until 48h of treatment. In BT4C cells nuclear condensation and/or swelling 
was evident by 48h exposure to 10µM-cisplatin while nuclei in U87-MG cells remained 
unchanged. DAOY and BT4C showed evidence for apoptosis in response to cisplatin, but 
PFSK-1 and U87-MG did not. 
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Figure 9.4 DAPI-stained cell nuclei with 10µM cisplatin treatment of DAOY(a), BT4C(b), 
PFSK-1(c) and U87-MG(d) at the following exposure time: 0h (i), 24h (ii) and 48h (iii). The 
size bar represents 10µm. 
 
9.3.2 HR-MAS peak assignment  
The peaks at 7.98, 5.98, 5.5 and 2.09ppm were tentatively assigned to UDP-GlcNAc and 
UDP-GalNAc according to the literature [207, 218]. The assignment was confirmed by 
spiking cell extracts (Figure 9.5) both with pure UDP-GlcNAc and UDP-GalNAc and 
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acquiring 1H NMR. U5, U6, and G2 positions refer to the fifth and sixth postion of the uridine 
ring and the second position of the glucose from UDP-GluNAc and UDP-GalNAc. 
 
Figure 9.5 1H NMR spectra for the metabolites extracted from 48h cisplatin- treated U87-MG 
cells with or without pure glycosylated UDP-compounds a: cell extracts, b: cell extracts and 
UDP-GlcNAc, c: cell extracts, UDP-GlcNAc and UDP-GalNAc. The peaks labelled in the 
bottom spectrum are 1. GCH3 at 2.09ppm, 2. G2 at 5.5ppm 3. U5 at 5.98ppm, 4.U6 at 7.98ppm.  
A whole spectrum region. B Expansion of the 2.09ppm region. C Expansion of the 5.5ppm 
region. 
 
The STOCSY analysis of HR-MAS data from the BT4C whole cell experiments (Figure 9.6) 
showed that the peak at 2.09ppm is correlated (R>0.9, P<0.05) with the downfield peaks at 
around 5.98 and 7.98ppm. STOCSY also revealed correlations for a number of other peaks, 
in particular one around 5.5ppm and the region from 3.6-4.5ppm.  
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Figure 9.6 STOCSY analysis of all HR-MAS spectra acquired from BT4C cells. Peaks 
represent highly correlated spectral regions (the circled points). 
 
The TOCSY spectra of cell extracts and pure UDP-GlcNAc+UDP-GalNAc confirmed the J-
coupling between 7.98ppm with 5.98ppm, 5.5ppm and the signals in 4.5ppm region 
(highlighted with rectangles in Figure 9.7). These analytic results are in good agreement with 
the 1H NMR spectra of pure UDP-GlcNAc and UDP-GalNAc.  
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Figure 9.7 TOCSY spectra from A: extracts of 48h 10µM cisplatin exposed U87-MG cells B: 
pure UDP-GlcNAc and UDP-GalNAc. (Rectangles to show the correlated peaks between 
7.98ppm with 5.98ppm, 5.5ppm and the signals in 4.5ppm region.) 
9.3.3 HR-MAS spectral changes in cisplatin exposed tumour cells 
The HR-MAS spectra from cisplatin treated BT4C and U87-MG cells are shown in Figure 
9.8 and Figure 9.9. The HR-MAS spectra from BT4C cells showed that signal intensities of 
peaks at 2.09, 5.98 and 7.98ppm increased by 12h and continued to further increase with 
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time. However, in non-responding U87-MG cells, the signals at 2.09, 5,5, 5.98 and 7.98ppm 
peaks remained unchanged with cisplatin treatment. 
 
 
Figure 9.8  HR-MAS spectra of a responder, 50 µM cisplatin treated BT4C cells. In the 0h 
spectra represent the peaks as follows 1,CH3 at 0.9ppm. 2,CH2 at 1.2ppm. 3,CH2CH2CO at 
1.58ppm. 4,GCH3 at 2.09ppm. 5,=CHCH2CH= at 2.8ppm. 6,Creatine at 3.03ppm. 7,CH= at 
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5.4ppm. 8,G2 at 5.5ppm. 9,U5 at 5.98ppm. 10,U6 at 7.98ppm. GCH3 and G2 indicate signals 
compatible with the –CH3 and carbon 2 position of the hexose protons whereas U5 and U6 
refer to protons on carbons 5 and 6 in the uracil ring of UDP. 
 
 
Figure 9.9 HR-MAS spectra of a non-responder,10 µM cisplatin treated U87-MG cell. 
Numbers in the 0h spectra represent the peaks as follows 1,CH3 at 0.9ppm. 2,CH2 at 1.2ppm. 
3,CH2CH2CO at 1.58ppm. 4,GCH3 at 2.09ppm. 5,=CHCH2CH= at 2.8ppm. 6,Creatine at 
3.03ppm. 7,CH= at 5.4ppm. 8,G2 at 5.5ppm. 9,U5 at 5.98ppm. 10,U6 at 7.98ppm. GCH3 and 
G2 indicate signals compatible with the –CH3 and carbon 2 position of the hexose protons 
whereas U5 and U6 refer to protons on carbons 5 and 6 in the uracil ring of UDP. 
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The downfield region (8-5ppm) of 1H NMR spectra from cell extracts of cisplatin treated 
BT4C and U87-MG cells are shown in Figure 9.10. The proton signal from U5, U6 and G2 
position showed a similar increase as that of the HR-MAS spectra in BT4C cells and 
remained stable in U87-MG cells. 
 
                                                 Chemical shift (ppm) 
Figure 9.10 1H NMR spectra of cell extracts from A BT4C B U87-MG cells exposed to 
cisplatin at 0h, 24h and 48h The peaks labelled on the bottom spectrum are 1. U5 at 5.98ppm, 
2.U6 at 7.98ppm,3. G2 at 5.5ppm  
 
Measurements of the 7.98ppm peak and unsaturated lipid peak at 5.4ppm for all cell lines are 
given in Figure 9.11 with error bars representing standard errors. The level of UDP-GlcNAc 
+ UDP-GalNAc in untreated cells are shown in Table 9.1 
(mean ± SD). Large increases were shown in glycosylated UDP compounds with treatment in 
both of the responding cell lines (DAOY and BT4C) but no change in the non-responding 
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U87-MG and PFSK-1 cells (Figure 9.11). In BT4C cells, UDP-GlcNAc and UDP-GalNAc 
started to increase by 12 hours of exposure and continued to increase with further exposure. 
In DAOY cells, the concentrations of UDP-GlcNAc and UDP-GalNAc were the highest of  
all four cell lines prior to treatment and the increase started to show a statistical difference 
(Student’s t-test, p=0.03) by 24h exposure coinciding with the initiation of morphological 
changes in the cell nuclei. Proton NMR-detected lipids at 5.4ppm increased extensively with 
cisplatin treatment in both BT4C and DAOY cells up to 24h (Figure 9.11). There was a 
smaller increase in 1H NMR detected lipids in U87-MG cells at 24h but PFSK-1 cells showed 
no significant increase in lipids up to that time point. The lipids increased significantly in all 
cell lines at 48h and in DAOY the HR-MAS spectra acquired at 48 hours were dominated by 
lipid peaks with hardly any metabolite peaks visible.  
 
Table 9.1 The level of UDP-GlcNAc + UDP-GalNAc in untreated cells 
 
 
 
cell line DAOY PFSK-1 BT4C U87-MG
UDP-GluNAc+UDP-GalNAc 0.024 ± 0.005 0.012 ± 0.002 0.006 ± 0.001 0.021 ± 0.002
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Figure 9.11 Measurement of HR-MAS spectra. A, the UDP-GlcNAc and UDP-GalNAc peak 
at 7.98ppm. B, the lipid peak at 5.3ppm at 0h, 12h, 24h and 48h treatment with 10µM 
cisplatin. The error bars represent standard errors. *P<0.05 **P<0.001 
The HR-MAS spectra of treated and untreated BT4C cells were plotted in Figure 9.12 to show 
there is no obvious increase in the over-confluence BT4C cells after 48h culture. 
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Figure 9.12  The A 8.1-5.4ppm and B 4.5-0.5ppm region of HR-MAS proton spectra of 
BT4C cells at a: control at 0h, b: 24h untreated, c: 48h untreated d:24h cisplatin treated. The 
peaks labelled on the bottom spectrum are 1. Choline at 3.2ppm, 2. Lipid at 5.4ppm, 3. G2 at 
5.5ppm, 4.H5 at 5.98ppm, 5. U6 at 7.98ppm C: The expansion to show the choline peak. 
9.4 Discussion 
In tumour cells undergoing cisplatin-induced apoptosis/cell death, UDP-GlcNAc and UDP-
GalNAc increase in parallel with 1H NMR detectable lipids. In the cisplatin resistant cells, no 
increase in these two UDP-compounds was observed during exposure to the drug suggesting 
that the effects are due to ongoing cell death. UDP-GlcNAc and UDP-GalNAc are already 
implicated in cancer proliferation and malignant transformation, owing to their role in protein 
and lipid glycosylation. However, the current data also points to an involvement for these 
compounds in cancer cell death. 
 
The most intense signals from UDP-GlcNAc and UDP-GalNAc arise in the region of the 
spectrum between 2 and 2.1ppm, where the protons in the N-acetyl moieties appear as a 
singlet.  However, this region can also be occupied by signals from glutamate and glutamine, 
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potentially making assignment ambiguous.  To confirm the correct assignment of these 
resonances two approaches were taken: firstly the aqueous fraction of cell extracts was spiked 
with solutions of UDP-GlcNAc and UDP-GalNAc. Signals originating from these solutions 
were found to be co-resonant with signals present in the extract spectra (Figure 9.5).  
Secondly, a STOCSY analysis was performed using the HR-MAS spectra from BT4C.  
Strong correlations were found between the primary resonances of UDP-GlcNAc and UDP-
GalNAc (Figure 9.6).  These approaches confirm that the resonances at 2.09, 5.5, 5.98 and 
7.98ppm originate from a combination of UDP-GlcNAc and UDP-GalNAc. 
 
Although UDP-GlcNAc and UDP-GalNAc are stereo-isomers, it is still possible to 
differentiate between them using 1D 1H NMR.  From the aqueous extract data, sufficient 
resolution was available to distinguish between UDP-GlcNAc and UDP-GalNAc based on 
two well resolved resonances at 5.5ppm [207] and the 2.09ppm which had an asymmetric 
appearance   In all extract spectra where resonances at 2.09 ppm were visible, the peaks from 
UDP-GlcNAc and UDP-GalNAc were estimated to be present at a similar ratio of 3:2. 
 
UDP-GlcNAc and UDP-GalNAc are synthesised in the cell cytoplasm and are the end 
products of the HBP. They are both important donor molecules for glycosylation reactions 
taking place in the nucleus, cytoplasm, endoplasmic reticulum or in the Golgi complex [201, 
219, 220]. Glycosylation is a crucial post-transcriptional modification for many functional 
proteins, proteoglycans and lipids [199, 204] determining three dimensional structures of 
these macromolecules. Diabetes, cardiac myopathy and severe injury from trauma are found 
to be associated with transient or prolonged hyperglycemias leading to an increase of glucose 
uptake in mammalian cells followed with a accelerated flux in the HBP and increased protein 
O-glycosylation [201, 221]. This indicates the important role of UDP-GlcNAc and UDP-
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GalNAc in cellular response to stressful conditions. Proteins involved in apoptotic pathways 
such as ERK, PKC and Bcl-2 have been reported to have their activity or expression levels 
altered in response to the increased O-GlcNAc formation [221].  
 
UDP-GlcNAc and UDP-GalNAc have been reported to inhibit differentiation of human colon 
cancer cells [222] and correlate with the degree of proliferation in malignant breast cells 
[223]. The level of UDP-GlcNAc was found to be a critical factor in the production of β1,6-
branched oligosaccharides which have been thought to be closely associated with tumour 
progression and metastasis [224]. In contrast, very little is known about UDP-GlcNAc and 
UDP-GalNAc in the response of cancer cells to treatment. Our study is the first to indicate a 
role for glycosylated UDPs in cancer cell death. There are some reports in the literature of O-
glycosylated compounds, but not directly with glycosylated UDPs. It has been shown in 
colon cancer cells (HT29) that mitotic arrest by means of microtubule-destablising agents 
causes an increase in O-GlcNAc [225]. This compound has the N-acetyl signal, but not the 
UDP part seen in the low-field range of the 1H NMR. Similarly, reports have been published 
that the N-acetyl signal from either N-acetyl groups of glycoproteins [226] or N-
acetylhexoseamines [227] is detectable in vivo either in a solid tumour or cystic fluid. These 
studies have demonstrated the presence of O-linked acetyl compounds in cancer cells or 
tumours, but not indicated any specific function for these compounds.  
 
Until recently little attention has been paid to the downfield side of the 1H NMR in the 
context of cancer treatment response monitoring. Using HR-MAS of ex vivo specimens from 
untreated and HSV-tk gene therapy treated BT4C gliomas, numerous peaks in the downfield 
part of the spectrum were detected. These peaks were tentatively assigned as adenine, uridine 
and cytosine nucleotides based on the chemical shifts[190]. The assignment of a doublet at 
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7.95ppm to UDP was confirmed by spiking experiments of tumour extracts in conjunction 
with 1H and 31P NMR [190].  
 
The early increase in UDP-GlcNAc and UDP-GalNAc in response to cisplatin treatment 
response could be caused by a decrease in utilisation, an increase in production or a 
combination of both. The degradation of 28S ribosomal RNA, a signature of apoptosis [228, 
229] and associated with the inhibition of protein synthesis [230], was evident by 12 hours of 
cisplatin treatment (Figure 9.2). Under these conditions there is likely to be less protein and 
lipid glycosylation with a concomitant increase in UDP-GlcNAc and UDP-GalNAc.  
Decreased utilisation of UDP-GlcNAc & UDP-GalNAc may also result directly from reduced 
activity of O-linked UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl 
transferase (OGT). OGT catalyzes the addition of O-GlcNAc  from UDP-GlcNAc to proteins 
and is located predominantly within the nucleus as determined by immunofluorescence and 
subcellular fractionation [204]. The destruction of the nucleus after cisplatin treatment is 
likely to result in a decreased activity of OGT. The increase of UDP-GlcNAc and UDP-
GalNAc could also be due to an increase in their synthesis. It is known that glycosylated 
UDPs are needed to change the antigenicity of dying cancer cells to attract macrophages for 
clearance of dying cells, similar to externalisation of PtdSer [231]. Furthermore, UDP-
GlcNAc and UDP-GalNAc levels could be elevated as a result of the increased cellular 
glucose uptake which is known to occur under conditions of cell stress and has been 
associated with an increase in their synthesis [201, 204].   
  
Recent evidence from T98G and A172 human glioblastoma cells, indicates that cell growth 
arrest without cell death does not cause an increase in either UDP-GlcNAc or UDP-GalNAc 
[218]. We determined the level of these two metabolites in over-confluent BT4C cells and 
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found no increase in UDP-GlcNAc or UDP-GalNAc (Figure 9.12). Our data indicates that 
UDP-GlcNAc and UDP-GalNAc are early 1H NMR detectable indices of positive treatment 
response in brain tumour cells rather than markers of proliferation inhibition. 
 
In our study, the increase of UDP-GlcNAc and UDP-GalNAc was found to be closely 
correlated with the increase in 1H NMR detectable lipids in responding cells. It has 
previously been reported that, in the hepatic cell line HepG2, HBP flux promotes 
endoplasmic reticulum stress and intracellular neutral lipids accumulation [231]. In turn, the 
concentration of UDP-GlcNAc within cells is proposed to be modulated by the availability of 
fatty acids [232, 233]. These observations show that there is a close association of lipid levels 
with hexosamine biosynthesis. The modest lipid increase in 1H NMR lipids in U87-MG cells 
is likely to be due to the growth pattern of this cell line with focally high cell density [59], but 
without effective overall growth inhibition.  
 
9.5 Conclusion 
UDP-GlcNAc and UDP-GalNAc are increased early in cancer cells which are responding to 
treatment and are potential candidates for treatment response monitoring by in vivo 1H NMR. 
The observation that these glycosylated UDP compounds increase in association with 1H NMR 
lipids may also provide mechanistic information about cell death processes, in particular to the 
biogenesis of lipid droplets, a hallmark process in the apoptotic cell death that renders cell 
lipids 1H NMR detectable. 
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Chapter 10 Conclusion 
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10.1 Contribution of LDs to NMR lipid signal 
An NMR lipid signal at 0.9 and 1.3ppm can be observed in brain tumour patients but not 
normal brains. There is an increase of these lipid signals with treatment response. These 
observations indicate the biomarker value of these NMR lipid signals in the clinic. NMR lipid 
signals were frequently observed in cancer tissues and cells. The clarification of their origin is 
therefore critical to explore the full potential of NMR application in both clinical and 
experimental settings.  
 
Two types of sub-cellular origin, the cytoplamic LDs and membrane micro-domains,  are under 
controversy ever since the first proposal of the membrane origin of NMR mobile lipid signal, 
which is challenged by the isotropic mobility of membrane lipids. Later, a similar lipid signal 
of intact tumour cells was reported in isolated detergent-resistant membrane domains further 
suggesting the possible contribution of plasma membrane micro-domains to the NMR lipid 
signal. But, the difference between the segments of a broken membrane and an intact cell 
membrane was not taken into consideration. To the best of the author’s knowledge, in this 
study it is the first time that NMR spectra acquired from isolated LDs has been presented. The 
morphology of LDs after isolation was assessed. The diameter of LDs in isolated fraction 
remained similar to that of the whole cells. The similarity of lipid signals between isolated LDs 
and whole cells found in five different cell lines supports the LD origin of NMR lipid signal. 
LD lipids only account for a small proportion of whole cell lipids in untreated cells. The 
massive membrane lipids can easily mask any difference seen in by LDs. Therefore, the 
correlation observed between lipid signal intensity and size of LDs in a panel of untreated 
tumour cells excludes a predominant contribution from membrane lipids to NMR lipid signal.  
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The NMR lipid signal is frequently observed in apoptosis and necrosis in vivo and in vitro. 
Both of these pathophysiological processes have a common feature of membrane turnover and 
collapse, which has been used to explain the increased membrane lipid mobility to make the 
NMR lipid detection possible. However, the observation of NMR lipid signal in either over-
confluent cells or rapidly proliferated malignant cells with intact membrane casts doubt on this 
hypothesis and favours the LD origin proposal. In this study, LD accumulation was evident 
with cisplatin exposure. The increase in lipid signal from the LDs isolated from cisplatin 
exposed cells with bigger LDs confirms that LDs are the main contributors to these NMR lipid 
signals. The absence of PUFA signal in the spectra of isolated LDs which was presented in 
whole cell spectra is most likely due to the difficulty to isolate and extract them into a 
sufficient amount for detection. 
 
All in all, this study confirms LDs are the main contributors of NMR lipid signals. They are 
possibly the only contributor in untreated tumour cells that have been assessed.                 
10.2  LDs in the progression of cancer cells  
LDs were long regarded as simply lipid storage depots. Recently, they have been recognised as 
a dynamic cellular organelle with diverse biological functions especially in lipid metabolism. 
In this study, the lipid content of LDs was analysed and the results show that LDs contain 
phosphatidylcholine, cholesterol and cholesterol ester with fatty acid chains being saturated, 
mono-unsaturated and polyunsaturated. The composition of LDs was found to be different 
between different types of tumour cells. The composition of LD lipids is different to that of the 
whole cell lipids, especially in the poly-unsaturated lipids. These observations indicate the 
composition of LD lipids might be cell type-specific.  Lipid metabolism in LDs is probably 
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regulated in a manner which is different to that of the whole cell, suggesting a dynamic and 
unique role of LDs in tumour cell biology.  
 
LD abnormalities are characteristic of many conditions such as obesity, diabetes, 
atherosclerosis and liver disease, therefore previous studies of LD accumulation were focused 
on adipocytes, hepatocytes and blood cells. The varied-sized LDs in different nervous system 
and brain tumour cells indicated a varied ability to accumulate LDs which might be important 
to the tumorigenesis and development.  
 
The increase of unsaturated lipids after effective treatment was observed in LDs but not in 
whole cell lipids. The changes in lipid composition especially in unsaturated lipids reveal the 
significance of LDs in tumour cell death. An improved understanding in the lipid composition 
in LDs with and without treatment could identify useful therapeutic targets for cancer therapy.  
 
10.3  Early detection of treatment response with NMR 
spectroscopy 
 
Tumour responses to treatment assessed from imaging measurements of reduction in tumour 
size might take weeks and not occur in some cases even with a positive response.  In this study, 
the changes of lipids and metabolites were observed as early as 12h treatment in cisplatin 
responding cells prior to the nuclei change showing the potential of these metabolites and 
lipids to be used as promising markers for an early detection of treatment response. 
 
It has been reported that the lipid signal in vitro studies correlates well with the lipid signal 
acquired from tumour patients supporting that NMR is a non-invasive method that can be used 
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to study the metabolism of cells and tissues as well as to monitor the level of metabolites and 
lipids in vivo. The cellular response to treatment was detected by NMR as alterations in 
metabolites and lipids specific to cell death rather than growth inhibition. These data 
demonstrates that NMR is a powerful tool that can be used in clinical trials of new drugs to 
assess the drug efficacy and select the most effective therapy at an early stage of treatment. 
 
UDP-GlcNAc and UDP-GalNAc are important donors of cellular glycosylation and is reported 
to be associated with cell survival in stressful conditions. It is the first time that their 
involvement in cancer cell death has been demonstrated implicating the important role of 
glycosylation in cancers. UDP-GlcNAc and UDP-GalNAc increased early in cancer cells 
which are responding to treatment implicating their role as potential candidates for treatment 
response monitoring by 1H NMR. 
10.4 Summary 
Overall, it has been shown that LDs can be isolated from tumour cells in a sufficient quantity 
for NMR analysis. LDs are important cellular organelles actively involved in tumour 
development. NMR visible lipids and some of the metabolites are important bio-makers to 
indicate cell type and cell death in brain tumour cell lines.  
10.5 Future work 
10.5.1 LD component analysis 
LD accumulation was observed in cancer cells undergoing growth inhibition and cell death. A 
difference in the increased level of the accumulated lipids was observed. However, it is unclear 
whether the composition of these lipids is different. The study of the composition of these 
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accumulated lipids under different growth status may provide useful information for the 
effective killing of cancer cells and may provide selective markers for cancer cell death. 
 
LDs are found to be important in intracellular protein management and delivery. Recent studies 
have uncovered many examples of LDs recruiting proteins from other cellular organelles. A 
proteomic study on the isolated LDs with mass spectrometry can possibly reveal the role of 
LDs in biological systems. 
 
10.5.2 Investigation on cancer cell survival 
UDP-GlcNAc and UDP-GalNA, the end products of the hexosamine biosynthesis pathway 
(HBP) were found to be involved in cancer cell death. Glutamine is the main supplier of the 
amine moiety in the biosynthesis of UDP-GlcNAc and UDP-GalNA. A study on the supply of 
glutamine, the intracellular level of these UDP compounds and cell survival can possibly 
reveal the association between cancer cell survival and the HBP pathway. 
 
Cisplatin is the only drug that has been tested in this study. The inclusion of different drugs and 
other treatments can assess the full potential of certain lipids and metabolites to be used as 
markers for effective cancer therapies. 
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1H nuclear magnetic resonance spectroscopy (NMR) resonances from lipids in tumours are
associated with tumour grade and treatment response. The origin of these NMR signals is mainly
considered to be cytoplasmic lipid droplets (LDs). Techniques exist for isolating LDs but little is
known about their composition and its relationship to NMR signals. In this work,
density-gradient ultracentrifugation was performed on homogenised human cancer cells to isolate
LDs. 1H NMR was performed on whole cells, isolated LDs and their extracts. Heteronuclear
single quantum coherence spectroscopy (HSQC) and liquid chromatography mass spectroscopy
(LC-MS) were performed on lipid extracts of LDs. Staining and microscopy were used to
characterize isolated LDs. An excellent agreement in chemical shift and relative signal intensity
was observed between lipid resonances in cells and isolated LD spectra supporting that
NMR-visible lipids originate primarily from LDs. Isolated LDs showed high concentrations of
unsaturated lipids, a oleic-to-linoleic acid ratio greater than two and a cholesteryl ester (ChE)-to-
cholesterol (Ch) ratio close to unity. These ratios were several-fold greater than respective ratios
in whole cells, demonstrating isolation is important to characterize LD composition. LDs contain
a speciﬁc group of lipid species that are likely to contribute to the 1H NMR spectrum of cells.
Introduction
Proton nuclear magnetic resonance spectroscopy (NMR) allows
the direct detection and quantiﬁcation of speciﬁc lipid species
in situ. The resonances of lipids have been observed in 1H NMR
spectra of cultured brain tumour cells and tissues both in vivo and
ex vivo. The origin of these lipid signals was ﬁrst thought to be
from globular plasma membrane microdomains,1,2 but more
recent direct evidence suggests that the NMR signals are also
likely to be from mobile lipid droplets (LDs) in the cytoplasm.3–5
Initially, the function of these droplets was thought to be solely
the storage of excess fatty acids present in the cytoplasm.
However, recent research has revealed that LDs dynamically
interact with other cell compartments and participate in several
cellular processes such as membrane traﬃcking, lipolysis and
phospholipid recycling.6,7
The accumulation of intracellular LDs has been implicated
with important cellular processes such as proliferation, apoptosis
and necrosis.8–11 There is evidence showing the presence of LDs
in necrotic regions of brain tumours5,9 and hypoxic-necrotic
tumour stroma of a C6 glioma.12 It has been shown that
modiﬁcations of intracellular LDs are correlated with cell growth
and growth arrest.13 Many clinical studies have suggested that
the resonance signals from mobile lipids can be used as potential
markers in the diﬀerential diagnosis and grading of brain
tumours.14,15 These lipid signals may also be predictive of
treatment response.16 These ﬁndings associate LDs with the
cell cycle, malignancy and cell death and consequently are an
attractive topic for cancer research. The elucidation of their
composition and biochemical features is vital to the under-
standing of their function in these cell processes and may
provide novel information related to cell biology.
High resolution 1H NMR spectra of cell lipids can provide
information on the number and type of chemical entities of a
molecule and has been widely used in the analysis of lipid
structure and composition.17,18 The standard method to obtain
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high resolution NMR spectra of lipids from cells and tissue is
to perform a chemical extraction of the tissue prior to the
acquisition of data in the liquid state. The resonances of lipids
in NMR spectra from cell extracts are usually dominated by
membrane lipids which can mask the signals from sub-cellular
compartments, such as LDs. It is therefore desirable to isolate
the LDs in order to eliminate the signals from membrane
lipids. Isolation of LDs from human cell lines has been
performed previously.19 A commonly used method is density
gradient ultracentrifugation,20,21 but to the best of our knowledge,
1HNMR analysis of isolated LDs from tumour cells has not been
reported earlier.
This paper presents the 1H NMR spectra acquired from
isolated LDs of a human neuroblastoma cell line, chemical
analyses of lipid using gas chromatography with mass spectro-
metry (GC-MS) and provides new insights to the investigation
of these highly dynamic organelles separated from tumour cells.
Methods
Cell culture and harvest
BE(2)M17, a human neuroblastoma cell line, was cultured in
75 cm2 ﬂasks with ﬁlter-vented caps (IWAKI, UK) and
maintained in 20 ml Dulbecco’s modiﬁed Eagles medium
(DMEM F:12), without L-glutamine (GIBCO, Invitrogen
Corporation, UK) supplemented with 10% (v/v) foetal calf
serum (PAA, UK), 1% 200 mM L-glutamine (100x) (GIBCO,
Invitrogen Corporation, UK), and 1% MEM non-essential
amino acid solution (100x) (Sigma Aldrich, UK). The cells
were incubated at 37 1C in a humidiﬁed atmosphere (5% CO2,
95% air) and harvested at around 90% conﬂuence. After
washing with 10 ml ice-cold phosphate buﬀered saline (Invitrogen
Ltd., Paisley, UK) 3 times, cells were then removed from the ﬂask
using a 25 cm cell scraper (Corning, UK) and centrifuged at 250 g
for 6min to form a pellet. Samples to be investigated by NMR
spectroscopy were snap-frozen in liquid nitrogen and stored
at 80 1C.
High-resolution magic angle spinning NMR (HR-MAS)
Prior to HR-MAS, frozen cells were defrosted, and 36 ml,
containing about 10  106 cells was pipetted into a wide-
mouthed zirconium oxide sample tube (Varian Inc, Palo Alto,
CA, USA); 4 mL 10 mmol L1 trimethylsilylproprionate d4
(TSP) in D2O was added as a chemical shift standard. HR-MAS
was performed on a Varian 600-MHz (14.1 T) vertical bore
spectrometer using a 4 mm gHX nanoprobe (Varian NMR Inc)
with a three channel Inova console running VNMRj software.
The rotor temperature was 6.7 1C as determined by calibration
using methanol.22 A rotor speed of 2500 Hz was used for all
experiments. The pulse sequence used for lipid investigation
consisted of a single 901 pulse preceded by a 1s duration water
presaturation pulse. The receiver bandwidth was 7200 Hz with
16 K complex points in the free induction decay. A total of
256 averages were acquired with a repetition time of 3.3 s giving a
14 min acquisition time. Spectra were manually phased, referenced
to TSP at 0 ppm and normalised to the maximum point within the
chemical shift range of 0.8–0.9 ppm.
Isolation of LDs
A protocol developed by Weller and co-workers was used to
isolate LDs (17–19). Brieﬂy, 40–60 million cells were ground in
600 ml deionised water or D2O using Dounce grinder (clearance
0.0005–0.0025 inch, Sigma Aldrich, UK) and the homogenate
was centrifuged at 2000 g at 4 1C for 10 min. The supernatant was
adjusted to 18.46% sucrose (600 ml in total), topped with the same
volume of deionised water or D2O and centrifuged at 142000 g
for 120 min at 4 1C (Optima TLX Ultracentrifuge, Beckman).
After ultracentrifugation, the sample was separated into three
fractions, the upper isolated fraction, the middle sucrose fraction
and the pellet. To control the sucrose contamination, only the top
300 ml of two preparations was combined into one sample for
subsequent NMR analyses.
Oil red O and haematoxylin staining
10 ml of the isolated fraction were aliquoted onto a microscopy
slide and dried overnight. Saturated Oil Red O (MERCK
KGaA, Darmstadt, Germany) in 70% ethanol was applied to
the slides for 20 min, and then washed in running water. After
haematoxylin staining, slides were mounted with aqueous
mounting medium and observed with a Nikon Eclipse E600
under 100X oil objective lens. Pictures were taken by a
DXM1200F digital camera.
Nile red and DAPI staining
Cells were spun and stained with 4 mg ml1 Nile red in PBS
(made from 1 mg ml1 Nile red stock solution in acetone,
Sigma-Aldrich, Dorset, UK) for about 15 min under dark
conditions. 10 ml of the isolated fraction were aliquoted onto a
slide, dried for 2 h and stained with 4 mg ml1 Nile red in 70%
ethanol for about 15 min. After Nile red staining, cells were
stained with 0.4 ug/ml DAPI for 15 min. The slides were
visualized with a Nikon Eclipse E600 microscope using 100X
objective lens and images were taken using a DXM1200 digital
camera. The green ﬂuorescence of Nile red was observed with
a FITC (B-2A) ﬁlter set, with excitation wave length of
465–495 nm and emission wave length 550 nm. DAPI UV
(UV-2A) ﬁlter with excitation wavelength of 340–380 nm was
used to detect DAPI stained nuclei. LD sizes were measured
using the image analysis program ImageJ (National Institute
of Health, USA) and presented as mean value  standard
deviation and distribution. The resolution limit of light microscopy
is 200 nm. An Inter Pixel Stepping (IPS) technique was used by the
camera (DXM1200 digital camera, Nikon) and ACT-1 software to
increase the resolution of captured images by a factor 9.
Transmission electron microscopy
The isolated LD fraction was dropped onto a 300 mesh copper
electron microscopy grid with formvar coating. A 2% aqueous
uranyl acetate solution was applied to the sample for 1 min.
After the staining, the grid was observed using JEOL 1200EX
TEM (Jeol Ltd, Tokyo, Japan) with 120 K ampliﬁcation.
Lipid extraction
A dual phased methanol-chloroform extraction protocol was
used to prepare the lipids for NMR analysis23 from both cells
and isolated lipid droplets. For the cell extracts, 20–40 million
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cells were ground and sonicated in methanol (400 ml)/deionised
water (85 ml). 200 ml chloroform was added to the homogenates
twice to form a dual-phase. For the isolated fraction, methanol
and chloroform was added directly into the sample. The lower
chloroform phase was collected and dried overnight in a fume
hood. At least three independent preparations were used for
isolation and extraction.
Liquid-state 1H NMR spectroscopy
Lipid extracts were resuspended in 600 ml deuterated chloroform
containing 0.03% (v/v) TMS (Sigma Aldrich, Dorset, UK).
1H-NMR spectra of cell extracts and the isolated LDs suspended
in D2Owere recorded on a Varian 600-MHz (14.1 T) vertical bore
spectrometer using a HCN probe. A standard pulse and acquire
sequence was used which consisted of a single 900 pulse preceded
by one second of water presaturation. The acquisition was of 16 K
complex points at a sampling frequency of 7200 Hz. All spectra
were manually phased, referenced to TSP at 0 ppm and normalised
to the maximum point within the range of 0.8–0.9 ppm. NMR
spectra were assigned with reference to the Human Metabolome
Database. Spectra were acquired from standards, including
phosphatidylcholine (P3556, sigma), triglyceride (D2157, sigma),
oleic acid (O1008, sigma) and linoleic acid (L1376, sigma) to
conﬁrm the assignments.
HSQC
A phase-sensitive gradient enhanced 2D 1H-13C HSQC was
also performed on the lipid extracts on a Bruker DRX
500MHz spectrometer using a cryoprobe at 25 1C. 1024 points
were acquired in F2 for 256 increments in F1 domain with spectral
widths of 13 ppm and 166 ppm respectively. 144 averages were
acquired resulting in a total experiment time of approximately 17 h.
Data was zero-ﬁlled to twice the original length andmultiplied by a
sine function prior to Fourier transformation.
Characterisation of isolated LDs by mass spectrometry
Lipid extracts were dissolved in 200 ml of chloroform/methanol
(1 : 1 v/v): half was used for gas chromatography with ﬂame-
ionization detector (GC-FID) analysis of total fatty acids and
half for liquid chromatography mass spectroscopy (LC-MS)
analysis of intact lipids. For the GC-FID analysis 50 ml of D-25
tridecanoic acid (200 mM in chloroform), 650 ml of chloroform/
methanol (1 : 1 v/v) and 250 ml BF3/methanol (Sigma-Aldrich)
was added to the extract and the vials were incubated at 80 1C
for 90 min. 500 ml H2O and 1 ml hexane were added and each
vial vortex mixed. The organic layer was evaporated to dryness
before reconstitution in 100 ml hexane for analysis. The deriva-
tised organic metabolites were injected in a Focus gas chroma-
tography (GC) and the column eluent was introduced into a
ﬂame-ionization detector (FID, Thermo Electron Corporation).
The column used was ZB-WAX (Phenomenex; 30 m 0.25 mm
ID  0.25 mm; 100% polyethylene glycol). The initial column
temperature was 60 1C and was held for 2 min. This was
increased by 15 1C min_1 to 150 1C then increased at a rate
of 3 1C min_1 to 230 1C. This ﬁnal temperature was held for
10 min. Peaks were assigned using Food Industry FAME Mix
(Restek 6098) solution. Fatty acids are also assigned according
to retention time matching to reference FAME standards
(FAME standard mix, Fish oil FAME standard mix and
microbial FAME standard mix, Sigma-Aldrich).
For LC-MS 5 ml of each sample was analysed on a Waters
Q-Tof Ultima mass spectrometer combined with an Acquity
Ultra Performance Liquid Chromatography (HPLC). The
sample was injected onto a 1.7 mm bridged ethyl hybrid C8
column (2.1  100 mm; Waters Corporation) held at 65 1C.
The binary solvent system (ﬂow rate 0.200 ml min1) included
A. HPLC grade water (1% 1 M NH4Ac, 0.1% HCOOH) and
B. LC/MS grade acetonitrile/isopropanol 5 : 2 (1% 1 M
NH4Ac, 0.1% HCOOH). The gradient started from 65%
A/35% B, reached 100% B in 6 min and remained there for
the next 7 min. The data was collected over the mass range of
m/z 100–1400 with a scan duration of 0.5 s and an interscan
delay of 0.1 s. The source temperature was set at 100 1C and
nitrogen was used as desolvation gas (600 L h1) at 300 1C.
The voltages of the sampling cone and capillary were 40 V and
3 kV, respectively and collision energy 5 V. Reserpine (50 mg L1)
was used as the lock spray reference compound (10 ml min1; 10 s
scan frequency).
To assign the lipid species present, a representative sample
for each strain was analysed by tandem mass spectrometry
(MS/MS). MS/MS runs were performed using ESI+ mode
and collision energies of 18, 20, 24, 30 V and a mass range of
80 to 1100 m/z. Other conditions were as described above.
Statistical analyses
Data on diameter of LDs are presented as mean  STD, the
range of maximum and minimum and the number of measured
LDs. Student’s t-test was performed as whole cell lipids versus
isolated LDs.
Results
LDs from BE(2)M17 cells
Nile red staining (Fig. 1A) illustrated that there were a
considerable number of cytoplasmic LDs inside the cells,
which tended to localise near to the cell membrane. The bars
represent 10 mm in Fig. 1A–C and 100 nm in Fig. 1D. The
mean diameter of these LDs with Nile red staining (Fig. 1B)
inside BE(2)M17 cells was 0.23  0.14 mm (1.55–0.12 mm, n=
257) whereas in the isolated fraction it was 0.22  0.17 mm
(1.23–0.10 mm, n=79). The diameter of isolated LDs with Oil red
O staining (Fig. 1c) was 0.22  0.05 mm (0.47–0.17 mm, n= 52).
The diameter of BE(2)M17 cells was approximately 10 to 20 mm.
Membranes can be visualised with Oil red O and haematoxylin
staining, appearing as annular structures easily distinguishable
from LDs. Fig. 1C and S1 shows membrane structures were
absent from the isolated fraction and the middle sucrose fraction
although they could be visualized in other fractions. In addition,
the transmission electronmicroscopy (Fig. 1D) shows the existence
of LDs and the absence of membrane structures in the isolated
fraction, in accordance with Fig. 1C.
1H NMR spectra of lipids
Fig. 2 shows the liquid-state 1H NMR spectrum acquired
directly from the isolated LDs together with the HR-MAS
spectrum of intact cells. The region between 0.5 ppm to 3.5 ppm
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has been plotted to exclude signals from sucrose. Metabolites and
lipid peaks were observed in both spectra and the lipid peaks
were assigned according to previously published values.3,24 An
attempt was also made to remove sucrose, which gives large
number of NMR peaks around 3.5–5.5 ppm, using dialysis and
ultraﬁltration, but the concentration of LDs was not high enough
for detection of lipid resonances in the 1HNMR spectrum due to
the breakdown and loss of LDs in the processes.
Fig. 3 shows the liquid-state 1H NMR spectra from lipid
extracts in CDCl3 of (A) isolated LDs and (B) whole cells. A
HR-MAS spectrum from intact cells is also shown for comparison.
Chemical shifts of the peaks were found to be consistent with those
given in the literature24–26 and assignments were made accordingly
(Table 1). Lipid peaks are better resolved in the liquid state spectra
allowing the assignment of molecules such as cholesterol (Ch) and
cholesterol ester (ChE). Some shifts in peak positions were evident
as compared with the HR-MAS data, an eﬀect that is due to
diﬀerent solvents and experimental conditions. The residual
water peak exhibits a larger shift from around 4.95 ppm in the
HR-MAS to 1.6–1.7 ppm in the extracted samples, which is
primarily due to solvent diﬀerences.
Fig. 4 shows an expansion of the three spectra showing a
clear separation between the ChE and Ch peaks at 1.01 and
0.99 ppm.18 A higher ChE-to-Ch ratio was present in the
isolated LDs (1.25  0.54, n = 3) compared to the whole cell
extract (0.22  0.03, n = 3) and there is a statistically
signiﬁcant diﬀerence between the two groups (p o 0.05).
Some more prominent singlet peaks at 1.28, 1.33 and
2.17 ppm in the isolated fraction extracts were observed relative
to the whole cell extracts (Fig. 4A and B). In HR-MAS data
(Fig. 4C) these peaks are not observed, as they merged with
near co-resonant metabolites.
HSQC spectra of extracted lipids
Fig. 5 shows the 5.45 to 5.25 ppm region of the 500 MHz
HSQC (1H and 13C) spectra of the lipid extracts from isolated
LDs and whole cells. The double bond protons of unsaturated
fatty acids which were all superimposed at 5.3–5.4 ppm in 1D
proton spectra (Fig. 3) were separated into distinguishable
signals and were assigned to oleic acid (18 : 1) and linoleic acid
(18 : 2) according to HSQC experiments using oleic acid and
linoleic acid standards (Fig. S2). The 2D spectra were manu-
ally processed and the signal intensity was measured using
standard Bruker software. The double bond protons in linoleic
acid give two signals with an equal intensity at the 5.4 ppm
region which makes it possible to estimate the ratio of these
two unsaturated fatty acids. The oleic-to-linoleic acid ratio
was 1 : 0.42 in isolated LDs and 1 : 4 in whole cell lipids. These
Fig. 1 Nile red and DAPI staining (A) of BE(2)M17 cells, Nile red
staining (B), Oil red O and haematoxylin staining (C) and Negative
staining followed by TEM (D) of the isolated fraction.
Fig. 2 A: Liquid-state 1H NMR spectrum from the isolated lipid
droplet fraction and B: HR-MAS spectrum from intact cells. Struc-
tural assignments are made with the potential parent molecules listed
in brackets: 1 CH3(Ch,ChE) at 0.7 ppm, 2 CH3(L,Ch) at 0.9 ppm,
3 CH3(Ch,ChE),CH2(Ch,ChE) at1.0 ppm 4 CH2(L,Ch) at 1.2–1.3 ppm,
5 CH2CH2CO(L) at 1.6 ppm, 6 CH2CH = CH(L) at 2.0 ppm,
7 CH2COO(L) at 2.3 ppm, 8 = CHCH2CH= at 2.8 ppm, 9 N(CH3)3
(PC) at 3.3 ppm Ch, cholesterol; ChE, cholesteryl ester; L, lipid; PC,
phosphatidylcholine.
Fig. 3 Liquid-state 1H NMR spectra vertically scaled to the resonance
intensity at 0.9 ppm of the chloroform component from a methanol
chloroform extraction of A: the isolated lipid droplet fraction and B:
whole cells. C: the HR-MAS spectrum from intact cells is given for
comparison. Structural assignments are made with the possible parent
molecules listed in brackets: 1 CH3(Ch,ChE) at 0.7 ppm, 2 CH3(L,Ch)
at 0.9 ppm, 3 CH3(Ch,ChE),CH2(Ch,ChE) at 1.0 ppm 4 CH2(L,Ch) at
1.2–1.3 ppm, 5 CH2CH2CO(L) at 1.6 ppm, 6 CH2CH = CH(L) at
2.0 ppm, 7 CH2COO(L) at 2.3 ppm, 8 =CHCH2CH= at 2.8 ppm,
9 N(CH3)3 (PtdCho) at 3.3–3.4 ppm, 10 CH2OCOR,CH2OPO2 at
4.0–4.5 ppm, 11 CHOCOR(L) at 5.2 ppm, 12 HC = CH(L,Ch) at
5.4 ppm, 13 H2O. Ch, cholesterol; ChE, cholesteryl ester; Cho, choline
residue; L, lipid; PC, phosphatidylcholine.
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signals can either be from free fatty acids or a larger entity
such as triacylglycerol (TG).
Characterisation of isolated LDs by mass spectrometry
Using GC-FID to proﬁle total fatty acid content of the cells
and LDs, both chromatograms (Fig. 6) were dominated by
palmitic acids stearic acids and oleic acids (no signiﬁcance
diﬀerence for these fatty acids). The percentage of fatty acids
composition was shown in Table 2 as mean  STD. Between
both whole cells and LDs, there were similar concentrations of
linoleic acid either as a percentage of total fatty acids detected
or as a ratio to oleic acid. However, LDs were almost devoid
of arachidic acid derivatives (fatty acids containing 20 carbons
in their backbone). There were reductions in arachidic acid
(po 0.04), 9-eicosenoic acid (po 0.005) and arachidonic acid
(p o 0.007). Similar concentrations of cholesterol derivatives
were detected in the chromatograms.
To further characterise the lipid species, LC-MS was
performed on lipid extracts of LDs (Fig. 7). MS/MS was used
to fragment intact lipids to identify individual lipid species. As
a crude measure of the polar-to-neutral lipids ratio the MS
total ion intensity for the two types of lipid species were
integrated. The polar lipids-to-triglycerides (TAG) ratio was
B2 : 1. The major polar lipids were identiﬁed as phosphatidyl-
choline (PC) (16 : 0/18 : 1), phosphatylethanolamine (PE) (10 : 0/
22 : 6), PC (10 : 0/18 : 2), PC(16 : 0/16 : 0), PC(16 : 0/16 : 1) and
Fig. 4 Liquid-state 1H NMR spectra vertically scaled to the
resonance intensity at 2.0 ppm (left),1.25 ppm (centre) and 0.9 ppm
(right) highlighting the resonances around 2.0–2.9 ppm, 1.2–1.4 ppm
and 0.5–1.0 ppm. A: lipid extract from the isolated lipid droplet
fraction. B: whole cell lipid extracts and C: HR-MAS spectra from
intact cells.
Fig. 5 The 5.45–5.25 ppm region of HSQC spectra of lipid extracts
from A: whole cells and B: isolated lipid droplet fraction.
Fig. 6 GC-FID chromatograms of lipid extracts from isolated LDs
(A) and BE(2)M17 cells (B) The peaks labelled on the bottom
spectrum are as follows: 1. Deuterated tridecanoic acid (retention time
and concentration standard), 2. myristic acid (C14:0), 3. palmitic acid
(C16 : 0), 4. palmitoleic acid (C16 : 1, cis-9), 5. stearic acid (C18 : 0), 6.
oleic acid (C18 : 1, cis-9), 7. linoleic acid (C18 : 2, cis-9, 12), 8. arachidic
acid (C20 : 0), 9. gondoic acid (C20 : 1, cis-11), 10. arachidonic acid
(C20 : 4, cis-5, 8, 11, 14)
Table 1 1H NMR resonances of extracted lipids from BE(2)M17 cells
in CDCl3
Assignments Chemical Shift (ppm)
1 CH3 (Ch) 0.7
2 CH3 0.9
3 CH2/CH3 (Ch/ChE) 1.0
4 CH2 1.2–1.3
5 CH2CH2CO 1.6
6 CH2CH=CH 2.0
7 CH2COO– 2.3
8 =CHCH2CH 2.8
9 N(CH3)3 3.3–3.4
10 CH2OCOR, CH2OPO2 4.0–4.5
11 CHOCOR 5.2
12 CH= 5.4
13 H2O 1.5–1.6
Table 2 Summary of fatty acid composition as percentage of total
fatty acids in lipid extracts studied by GC-FID (*Po0.05)
whole cell extracts LD extracts
palmitic acids 25.9  0.5% 26.3  8.9%
oleic acids 40.8  9.7% 42.8  11.9%
stearic acids 4.1  7.1% 10.3  7.5%
linoleic acids 1.5  1.3% 3.3  2.2%
arachidic acids* 2.0  2.0% 0.5  1.1%
9-eicosenoic acids* 2.2  1.9% 0.4  0.7%
arachidonic acids* 2.9  0.5% 0.7  1.3%
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PE(20 :1/20 :4), where the numbers indicate the fatty acids present.
The TAGs contained within these droplets included TG(14 :0/16 :0/
20 :2), TG(16 :0/18 :1/16 :0), TG(16 :0/18 :1/18 :1), TG(14 :0/16 :0/
18 :0), TG(14 :0/16 :0/18 :1) and TG(16 :1/20 :2/18 :0).
Discussion
In agreement with recent studies,7,19,27 LDs can be isolated
from neuroblastoma cells and our study found an excellent
agreement between the diameter of the lipid droplets observed
within the cell and in isolated state. No lipid bilayer structures
were seen on transmission electron microscopy in droplets or
vesicles on haematoxylin and Oil red O staining indicating that
there is a low level of contamination from other lipid containing
structures. Oil red O staining of the re-suspended pellet
obtained after gradient ultracentrifugation demonstrated that
some LDs were present in the lower fraction of the sample.
The current results demonstrate a similarity between the line
shape and relative amplitudes of the lipid resonances at 0.9,
1.3, 1.6, 2.2 and 2.8 ppm present in HR-MAS from the whole
cell and isolated LD. A signal at 5.4 ppm likely to be from
vinyl protons present in lipids was also observed despite being
partially overlapped with sucrose (data not shown). These
results support the data presented by Griﬃn et al.4 which
suggest that lipids in LDs present in cells and tumour tissue
possess a high degree of rotational freedom.
GC-FID detected a relatively low content of linoleic acid
both in LD and whole cell extracts, when HSQC showed much
lower oleic-to-linoleic acid ratio in whole cells. In order for
GC-FID to detect individual fatty acids, they must be converted
into methyl esters which for fatty acids within triglycerides or
phospholipids require a process of trans-esteriﬁcation. A high
oleic-to-linoleic acid ratio in LDs suggests that a signiﬁcant
proportion of the linoleic acid is found in lipid species such as
triglycerides which cannot be easily derivatized by methylation
and hence be poorly quantiﬁed in GC-FID when compared
with free fatty acids.
We observed a signiﬁcant reduction in the PC peak at 3.42 ppm
in isolated LD extracts which is consistent with the assumption that
LDs are surrounded with a single-layer phospholipid. Diﬀerences
in the total cholesterol peaks around 1.0 ppm and 0.68 ppm
not only explain the decrease of total signal intensity but also
in the ChE-to-Ch ratio from the whole cell to isolated LDs.
This variation may be due to diﬀerences in polarity of the two
forms of cholesterol. The main structure of LDs is a core of
neutral lipids, as shown here by the GC-MS data, that are
surrounded by a monolayer of polar phospholipids.6 Within
the droplets, ChE could be concentrated in the non-polar
regions such as the core, whereas Ch is located on or near
the droplet surface contributing to the biophysical stability of
the droplet in the cytoplasm.28 Cell membranes contain more
than 90% of the total cellular Ch,29,30 therefore the Ch present
in a whole cell extract is likely to be derived from Ch present in
cell membranes. After esteriﬁcation, ChEs in cancer cells could
be stored in LDs.31 Therefore, the isolated LDs are likely to
have a low level of Ch and high level of ChE compared to the
whole cell lipids. The presence of Ch and its esters were
conﬁrmed by GC analysis of both the LDs and whole cells.
Both NMR of intact LDs and GC of their extracts gave
similar Ch-to-ChE ratios indicating comparable degree of
NMR visibility of these species in LDs.
Key diﬀerences were apparent in the methylene lipid peak at
1.3 ppm between the three spectra shown in Fig. 4. A broad
lipid peak and a doublet from lactate were observed in the
HR-MAS spectrum, whereas a broad peak with four additional
narrower peaks was present in the lipid extracts at 1.25, 1.27,
1.28 and 1.33 ppm. The narrower peaks were more prominent
in the isolated LDs and their relative intensities are diﬀerent
compared to the whole cell extract spectra. In addition, two
narrow peaks around 2.10 and 2.17 ppm and one triplet near
2.25 ppm are absent from the HR-MAS spectrum, but much
higher in the isolated LD spectrum compared with the whole
cell extract. A comparison of these peaks between the spectra of
the isolated LD extract and the whole cell extract is consistent
with the NMR signals of the lipid species mainly arising from
the LDs and they may be a potential marker of LDs reﬂecting
the proportion of lipid signals arising from LDs within a whole
cell extract sample. The relatively low intensity of these peaks in
whole cell extracts indicates that the lipids in the droplets most
likely account for a small part of the lipids detected in the whole
cell lipid extracts. The unsaturated fatty acid peak at 5.3 ppm is
visible in the isolated LD spectrum conﬁrming their presence in
LDs, which is of particular interest as unsaturated fatty acids
are linked with cell cycle arrest and programmed cell death in
cancer cells and treated tumour xenografts.32 From the GC
analysis of the total fatty acids, the detectable unsaturated fatty
acids are largely oleic and linoleic acid, with the LDs having
lower concentrations of arachidonic acid, reﬂecting a general
reduction in all C20 containing fatty acids in the LDs compared
with the whole cell extracts (Table 2).
HSQC is a promising NMR technique for assigning individual
fatty acid signals.33 In our study, the HSQC spectra were
consistent with oleic and linoleic acid being present in the lipid
extracts of isolated LDs. It is possible for other unsaturated fatty
acids containing one or two double bond Carbons, such as
eicosanoid acid (20 : 1) and eicosadienoic acid (20 : 2), to give a
signal at a similar position. However, only oleic acid (18 : 1),
linoleic acid (18 : 2) and eicosanoid acid (20 : 1) were identiﬁed by
GC-FID. Furthermore, there is about 20 fold more oleic acid
(18 : 1) present than eicosanoid acid (20 : 1) (Table 2), therefore,
Fig. 7 A two dimensional chromatogram and mass spectrum plot of
the intact lipids detected in isolated lipid droplets. Each peak corre-
sponds to an individual intact lipid.
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these HSQC signals are most likely predominated by oleic acid
and linoleic acid. Palmitic acid (16 : 0) and stearic acid (18 : 0),
oleic acid (18 : 1) and linoleic acid (18 : 2) are all common to
membrane and storage lipids in the human body and the
membrane lipids contain a much higher proportion of poly-
unsaturated fatty acids (PUFAs).34 This is consistent with the
ﬁnding that the linoleic acid, an n-6 PUFA, is present at an
almost 10 times lower concentration in LDs than in whole cell
lipid extracts relative to oleic acids. A high level of 16 : 0, 18 : 0
and 18 : 1 was conﬁrmed by LC-MS.
In conclusion, the lipid resonances in the HR-MAS of
BE(2)M17 cells are consistent with the NMR spectra of their
isolated LDs, which supports that NMR visible lipid resonances
originate primarily from LDs. Analysis using 1H NMR and
LC-MS revealed a number of similarities between the isolated
LDs and the whole cell preparations, particularly in terms of the
presence of unsaturated lipids. However, diﬀerences were also
detected, in particular a large dissimilarity was seen in the ratio
between the ChE and Ch peaks in lipid extracts studies.
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